U.S. patent application number 14/185980 was filed with the patent office on 2014-06-19 for maize cellulose synthases and uses thereof.
This patent application is currently assigned to Pioneer Hi Bred International Inc. The applicant listed for this patent is Pioneer Hi Bred International Inc. Invention is credited to Kanwarpal S Dhugga, Timothy George Helentjaris, Dwight Tomes, Haiyin Wang.
Application Number | 20140173782 14/185980 |
Document ID | / |
Family ID | 32046034 |
Filed Date | 2014-06-19 |
United States Patent
Application |
20140173782 |
Kind Code |
A1 |
Dhugga; Kanwarpal S ; et
al. |
June 19, 2014 |
Maize Cellulose Synthases and Uses Thereof
Abstract
The invention provides isolated cellulose synthase nucleic acids
and their encoded proteins. The present invention provides methods
and compositions relating to altering cellulose synthase levels in
plants. The invention further provides recombinant expression
cassettes, host cells, and transgenic plants comprising said
nucleic acids.
Inventors: |
Dhugga; Kanwarpal S;
(Johnston, IA) ; Helentjaris; Timothy George;
(Tucson, AZ) ; Tomes; Dwight; (Grimes, IA)
; Wang; Haiyin; (Johnston, IA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Pioneer Hi Bred International Inc |
Johnston |
IA |
US |
|
|
Assignee: |
Pioneer Hi Bred International
Inc
Johnston
IA
|
Family ID: |
32046034 |
Appl. No.: |
14/185980 |
Filed: |
February 21, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
13887430 |
May 6, 2013 |
8697842 |
|
|
14185980 |
|
|
|
|
13459370 |
Apr 30, 2012 |
8481682 |
|
|
13887430 |
|
|
|
|
13079071 |
Apr 4, 2011 |
8207302 |
|
|
13459370 |
|
|
|
|
12903472 |
Oct 13, 2010 |
7982009 |
|
|
13079071 |
|
|
|
|
12782738 |
May 19, 2010 |
7838632 |
|
|
12903472 |
|
|
|
|
12486129 |
Jun 17, 2009 |
7851597 |
|
|
12782738 |
|
|
|
|
12277418 |
Nov 25, 2008 |
7579443 |
|
|
12486129 |
|
|
|
|
11859968 |
Sep 24, 2007 |
7524933 |
|
|
12277418 |
|
|
|
|
10963217 |
Oct 12, 2004 |
7307149 |
|
|
11859968 |
|
|
|
|
10209059 |
Jul 31, 2002 |
6930225 |
|
|
10963217 |
|
|
|
|
09550483 |
Apr 14, 2000 |
|
|
|
10209059 |
|
|
|
|
09371383 |
Aug 6, 1999 |
|
|
|
09550483 |
|
|
|
|
60096822 |
Aug 17, 1998 |
|
|
|
Current U.S.
Class: |
800/312 ;
435/193; 800/298; 800/314; 800/320; 800/320.1; 800/320.2;
800/320.3; 800/322 |
Current CPC
Class: |
Y02A 40/146 20180101;
Y02E 50/10 20130101; C12N 15/8241 20130101; C07K 14/415 20130101;
Y02E 50/17 20130101; C12N 15/8246 20130101; C12N 15/8251 20130101;
C12N 9/1059 20130101; C12N 15/8261 20130101 |
Class at
Publication: |
800/312 ;
435/193; 800/298; 800/314; 800/320; 800/320.1; 800/320.2;
800/320.3; 800/322 |
International
Class: |
C12N 9/10 20060101
C12N009/10; C12N 15/82 20060101 C12N015/82 |
Claims
1. A cellulose synthase product derived from the method of
processing of plant tissues expressing an isolated polynucleotide
encoding a functional cellulose synthase, the method comprising: a)
transforming a plant cell with a recombinant expression cassette
comprising a polynucleotide having at least 90% sequence identity
to the full length sequence of a polynucleotide selected from the
group consisting of SEQ ID NO: 13, 17, 21, 25, 27, 29, 45 and 49,
operably linked to a promoter; and b) culturing the transformed
plant cell under plant cell growing conditions; wherein the level
of cellulose synthase in said transformed plant cell is modulated;
c) growing the plant cell under plant-forming conditions to express
the polynucleotide in the plant tissue; and d) processing the plant
tissue to obtain a cellulose synthase product.
2. A cellulose synthase product according to claim 1, wherein the
polynucleotide further encodes a polypeptide selected from the
group consisting of SEQ ID NO: 14, 18, 22, 26, 28, 30, 46 and
50.
3. The transgenic plant of claim 1, wherein the plant is a
monocot.
4. The transgenic plant of claim 1, wherein the plant is selected
from the group consisting of: maize, soybean, sunflower, sorghum,
canola, wheat, alfalfa, cotton, rice, barley and millet.
5. A cellulose synthase product according to claim 1, which
improves stalk strength of a plant by overexpression of the
polynucleotide.
6. A cellulose synthase product according to claim 1, which reduces
green snap by improving nodal strength.
7. A cellulose synthase product according to claim 1, which is a
constituent of ethanol.
Description
RELATED APPLICATIONS
[0001] This application is a divisional of co-pending U.S. patent
application Ser. No. 13/887,430 filed May 6, 2013 which is a
continuation of U.S. patent application Ser. No. 13/459,370 filed
Apr. 30, 2012, now issued as U.S. Pat. No. 8,481,682 which is a
continuation of U.S. patent application Ser. No. 13/079,071 filed
Apr. 4, 2011, now issued as U.S. Pat. No. 8,207,302, which is a
divisional of U.S. patent application Ser. No. 12/903,472 filed
Oct. 13, 2010, now issued as U.S. Pat. No. 7,982,009, which is a
divisional of Ser. No. 12/782,738 filed May 19, 2010, now issued as
U.S. Pat. No. 7,838,632, which is a divisional of Ser. No.
12/486,129 filed Jun. 17, 2009, now issued as U.S. Pat. No.
7,851,597, which is a divisional of U.S. patent application Ser.
No. 12/277,418 filed Nov. 25, 2008, now issued as U.S. Pat. No.
7,579,443, which is a divisional of U.S. patent application Ser.
No. 11/859,968 filed Sep. 24, 2007, now issued as U.S. Pat. No.
7,524,933, which is a divisional of U.S. patent application Ser.
No. 10/963,217 filed Oct. 12, 2004, now issued as U.S. Pat. No.
7,307,149, which is a continuation-in-part of U.S. patent
application Ser. No. 10/209,059, filed Jul. 31, 2002, now issued as
U.S. Pat. No. 6,930,225, which is a continuation-in-part of U.S.
patent application Ser. No. 09/550,483, filed Apr. 14, 2000, now
abandoned, which is a continuation-in-part of U.S. patent
application Ser. No. 09/371,383, filed Aug. 6, 1999, now abandoned,
which claims benefit of U.S. Provisional Patent Application Ser.
No. 60/096,822, filed Aug. 17, 1998, now abandoned, all of which
are incorporated herein by reference. Also incorporated by
reference are U.S. patent application Ser. No. 11/493,187, filed
Jul. 26, 2006, now issued as U.S. Pat. No. 7,312,377 and U.S.
patent application Ser. No. 10/961,254 filed Oct. 8, 2004, now
issued as U.S. Pat. No. 7,214,852, U.S. patent application Ser. No.
10/160,719, filed Jun. 3, 2002, now issued as U.S. Pat. No.
6,803,498, which is a continuation of U.S. patent application Ser.
No. 09/371,383, filed Aug. 6, 1999, now abandoned, which claims
benefit of U.S. Provisional Patent Application Ser. No. 60/096,822,
filed Aug. 17, 1998, now abandoned.
TECHNICAL FIELD
[0002] The present invention relates generally to plant molecular
biology. More specifically, it relates to nucleic acids and methods
for modulating their expression in plants.
BACKGROUND OF THE INVENTION
[0003] Polysaccharides constitute the bulk of the plant cell walls
and have been traditionally classified into three categories:
cellulose, hemicellulose and pectin. Fry, (1988) The growing plant
cell wall: Chemical and metabolic analysis, New York: Longman
Scientific & Technical. Whereas cellulose is made at the plasma
membrane and directly laid down into the cell wall, hemicellulosic
and pectic polymers are first made in the Golgi apparatus and then
exported to the cell wall by exocytosis. Ray, et al., (1976) Ber.
Deutsch. Bot. Ges. Bd. 89:121-146. The variety of chemical linkages
in the pectic and hemicellulosic polysaccharides indicates that
there must be tens of polysaccharide synthases in the Golgi
apparatus. Darvill, et al., (1980) The primary cell walls of
flowering plants. In The Plant Cell (N E Tolbert, ed.), Vol. 1 in
Series: The biochemistry of plants: A comprehensive treatise, eds.
Stumpf and Conn, (New York: Academic Press), pp. 91-162.
[0004] Even though sugar and polysaccharide compositions of the
plant cell walls have been well characterized, very limited
progress has been made toward identification of the enzymes
involved in polysaccharides formation, the reason being their
labile nature and recalcitrance to solubilization by available
detergents. Sporadic claims for the identification of cellulose
synthase from plant sources were made over the years. Callaghan and
Benziman, (1984) Nature 311:165-167; Okuda, et al., (1993) Plant
Physiol. 101:1131-1142. However, these claims were met with
skepticism. Callaghan and Benziman, (1985), Nature 314:383-384;
Delmer, et al., (1993) Plant Physiol. 103:307-308. It was only
relatively recently that a putative gene for plant cellulose
synthase (CesA) was cloned from the developing cotton fibers based
on homology to the bacterial gene. Pear, et al., Proc. Natl. Acad.
Sci. USA 93:12637-12642; Saxena, et al., (1990) Plant Molecular
Biology 15:673-684; see also, WO 1998/18949; see also, Arioli, et
al., (1998). Molecular analysis of cellulose biosynthesis in
Arabidopsis. Science Washington D C. Jan. 279:717-720. A number of
genes for cellulose synthase family were later isolated from other
plant species based on sequence homology to the cotton gene
(Richmond and Somerville, (2000) Plant Physiology 124:495-498.)
[0005] Cellulose, by virtue of its ability to form semicrystalline
microfibrils, has a very high tensile strength which approaches
that of some metals. Niklas, (1992), Plant Biomechanics: An
engineering approach to plant form and function, The University of
Chicago Press, p. 607. Bending strength of the culm of normal and
brittle-culm mutants of barley has been found to be directly
correlated with the concentration of cellulose in the cell wall.
Kokubo, et al., (1989), Plant Physiology 91:876-882; Kokubo, et
al., (1991) Plant Physiology 97:509-514.
[0006] Although stalk composition contributes to numerous quality
factors important in maize breeding, little is known in the art
about the impact of cellulose levels on such agronomically
important traits as stalk lodging, silage digestibility or
downstream processing. The present invention provides these and
other advantages.
SUMMARY OF THE INVENTION
[0007] Generally, it is the object of the present invention to
provide nucleic acids and proteins relating to cellulose synthases.
It is an object of the present invention to provide transgenic
plants comprising the nucleic acids of the present invention and
methods for modulating, in a transgenic plant, expression of the
nucleic acids of the present invention.
[0008] Therefore, in one aspect the present invention relates to an
isolated nucleic acid comprising a member selected from the group
consisting of (a) a polynucleotide having a specified sequence
identity to a polynucleotide encoding a polypeptide of the present
invention; (b) a polynucleotide which is complementary to the
polynucleotide of (a) and (c) a polynucleotide comprising a
specified number of contiguous nucleotides from a polynucleotide of
(a) or (b). The isolated nucleic acid can be DNA.
[0009] In other aspects the present invention relates to: 1)
recombinant expression cassettes, comprising a nucleic acid of the
present invention operably linked to a promoter, 2) a host cell
into which has been introduced the recombinant expression cassette,
3) a transgenic plant comprising the recombinant expression
cassette and 4) a transgenic plant comprising a recombinant
expression cassette containing more than one nucleic acid of the
present invention each operably linked to a promoter. Furthermore,
the present invention also relates to combining by crossing and
hybridization recombinant cassettes from different transformants.
The host cell and plant are optionally from maize, wheat, rice or
soybean.
[0010] In other aspects the present invention relates to methods of
altering stalk lodging and other standability traits, including,
but not limited to brittle snap and improving stalk digestibility,
through the introduction of one or more of the polynucleotides that
encode the polypeptides of the present invention. Additional
aspects of the present invention include methods and transgenic
plants useful in the end use processing of compounds such ads
cellulose or use of transgenic plants as end products either
directly, such as silage, or indirectly following processing, for
such uses known to those of skill in the art, such as, but not
limited to, ethanol. Also, one of skill in the art would recognize
that the polynucleotides and encoded polypeptides of the present
invention can be introduced into an host cell or transgenic plant
wither singly or in multiples, sometimes referred to in the art as
"stacking" of sequences or traits. It is intended that these
compositions and methods be encompassed in the present
invention.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011] FIG. 1: Stalk breaking strength of hybrids and its
comparison with the lodging scores. The mechanical strength is very
similar to the lodging scores that have been assigned based on
field observations. The vertical light-colored bar in the upper
right corner of the figure is the least significant difference
(LSD) estimate at 5% level.
[0012] FIG. 2: Stalk strength of T.sub.0 transgenic plants. Plants
overexpressing ("up") ZmCesA4 and ZmCesA8 had significantly
stronger stalks than the controls. Overexpression of CesA5 did not
alter stalk strength whereas the overexpression of CesA1 led to
weaker and stunted stalks.
[0013] FIG. 3: Correlation between unit cellulose and stalk
breaking strength. Stalk breaking strength was highly correlated
with the amount of cellulose in a unit stalk length (correlation
coefficient, r: 0.76; 0.63; 0.92; 0.86.) While these correlations
are specifically related to the different CesA genes, it should be
noted that in general the same correlation would apply. In other
words, it is expected this would apply to low cellulose levels as
well as higher cellulose levels.
[0014] FIG. 4: Unrooted cladogram of CesA proteins from different
species. Sequences are labeled by prefixes. This cladogram
demonstrates the relevance of the maize genes to those of
Arabidopsis and rice. Prefixes: At, Arabidopsis thaliana; Gh,
Gossypium herbaceum; Lj, Lotus japonicus; Mt, Medicago truncatula;
Na, Nicotiana alata; Os, Oriza sativa; Pc, Populus canescens; Ptr,
Populus tremula.times.tremuloides; Ze, Zinnia elegans; Zm, Zea
mays.
[0015] FIG. 5: Expression pattern of CesA10, 11 and 12 in different
maize tissues. All three genes are nearly synchronously expressed
in tissues rich in secondary wall.
[0016] FIG. 6: Effect of overexpression of different CesA genes on
plant height in corn. Whereas the overexpression of CesA8 led to an
increase in height, CesA4 and CesA5 had not effect. Overexpression
of CesA1 resulted in stunted plants.
[0017] FIG. 7: Effect of the overexpression of different CesA genes
on the amount of cellulose in a unit length of the stalk tissue
below ear in corn. CesA4 and CesA8, when overexpressed, resulted in
an increased cellulose/length, CesA5 had no effect and CesA1
resulted in reduced cellulose/length.
[0018] FIG. 8: Contribution of different stalk components to dry
matter, diameter, volume and stalk strength in maize hybrids. The
data are derived from seven hybrids grown at three densities (27,
43 and 59 K per acre) in three replications each in 2001. Two
stalks were sampled from each replication. Internodes 3 and 4 below
the ear were broken with Instron model 4411 (Instron Corporation,
100 Royall Street, Canton, Mass. 02021). After breaking, the 3rd
internode was separated into rind and inner tissue. Path
coefficient analyses were performed using rind and inner tissue as
independent variables (X.sub.1 and X.sub.2, respectively) and the
whole stalk as the dependent variable (Y). The multiple regression
equation: Y=a+b.sub.1X.sub.1+b.sub.2X.sub.2+e where a is the
intercept and e error. Path coefficients were calculated as
follows: .rho.YXn=b.sub.n*.delta..sub.n/.epsilon..sub.Y where n is
1 or 2. The contribution of each independent variable to whole
stalk (Y) was calculated as follows: .rho.Yxn*rYxn where r is the
correlation coefficient.
[0019] FIG. 9: Expression of the maize CesA genes in the pulvinal
tissue of leaf derived from an elongating internode. The expression
was studied by the Lynx MPSS technology.
DETAILED DESCRIPTION OF THE INVENTION
Overview
A. Nucleic Acids and Protein of the Present Invention
[0020] Unless otherwise stated, the polynucleotide and polypeptide
sequences identified in Table 1 represent polynucleotides and
polypeptides of the present invention. Table 1 cross-references
these polynucleotide and polypeptides to their gene name and
internal database identification number (SEQ ID NO.). A nucleic
acid of the present invention comprises a polynucleotide of the
present invention. A protein of the present invention comprises a
polypeptide of the present invention.
TABLE-US-00001 TABLE 1 Database ID Polynucleotide Polypeptide SEQ
Gene Name NO: SEQ ID NO: ID NO: Cellulose synthase CesA-1 1 2
Cellulose synthase CesA-2 45 46 Cellulose synthase CesA-3 5 6
Cellulose synthase CesA-4 9 10 Cellulose synthase CesA-5 13 14
Cellulose synthase CesA-6 41 42 Cellulose synthase CesA-7 49 50
Cellulose synthase CesA-8 17 18 Cellulose synthase CesA-9 21 22
Cellulose synthase CesA-10 25 26 Cellulose synthase CesA-11 27 28
Cellulose synthase CesA-12 29 30
[0021] Table 2 further provides a comparison detailing the homology
as a percentage of the 12 CesA genes from maize that have been
described herein (see, also, "Related Applications" above).
TABLE-US-00002 TABLE 2 CesA1 CesA2 CesA3 CesA4 CesA5 CesA6 CesA7
CesA8 CesA9 CesA10 CesA11 CesA12 CesA1 93 60 59 60 55 55 57 61 51
51 46 CesA2 60 59 61 55 55 57 61 51 51 47 CesA3 47 48 49 45 46 49
46 52 50 CesA4 77 54 52 58 86 54 53 52 CesA5 55 53 57 75 52 52 51
CesA6 74 73 56 56 55 53 CesA7 70 54 50 48 46 CesA8 59 55 52 51
CesA9 52 52 50 CesA10 53 64 CesA11 56 CesA12
[0022] Further characterization of the CesA group is provided in
FIG. 4, as a consensus tree for plant Ces A proteins. It describes
the relationship between Ces A from maize, rice and Arabidopsis
sources.
B. Exemplary Utility of the Present Invention
[0023] The present invention provides utility in such exemplary
applications as improvement of stalk quality for improved stand
lodging or standability or silage digestibility. Further, the
present invention provides for an increased concentration of
cellulose in the pericarp, hardening the kernel and thus improving
its handling ability. Stalk lodging at maturity can cause
significant yield losses in corn. Environmental stresses from
flowering to harvest, such as drought and nutrient deficiency,
further worsen this problem. The effect of abiotic stresses is
exacerbated by biotic factors, such as stalk rot resulting from the
soil-living pathogens growing through the ground tissue.
[0024] Maize hybrids known to be resistant to stalk lodging have
mechanically stronger stalks. At the compositional level, cellulose
in a unit stalk length is highly correlated with breaking strength.
The present invention provides for modulation of cellulose synthase
composition leading to increased stalk strength.
DEFINITIONS
[0025] Units, prefixes and symbols may be denoted in their SI
accepted form. Unless otherwise indicated, nucleic acids are
written left to right in 5' to 3' orientation; amino acid sequences
are written left to right in amino to carboxy orientation,
respectively. Numeric ranges recited within the specification are
inclusive of the numbers defining the range and include each
integer within the defined range. Amino acids may be referred to
herein by either their commonly known three letter symbols or by
the one-letter symbols recommended by the IUPAC-IUBMB Nomenclature
Commission. Nucleotides, likewise, may be referred to by their
commonly accepted single-letter codes. Unless otherwise provided
for, software, electrical and electronics terms as used herein are
as defined in The New IEEE Standard Dictionary of Electrical and
Electronics Terms (5th edition, 1993). The terms defined below are
more fully defined by reference to the specification as a whole.
Section headings provided throughout the specification are not
limitations to the various objects and embodiments of the present
invention.
[0026] By "amplified" is meant the construction of multiple copies
of a nucleic acid sequence or multiple copies complementary to the
nucleic acid sequence using at least one of the nucleic acid
sequences as a template. Amplification systems include the
polymerase chain reaction (PCR) system, ligase chain reaction (LCR)
system, nucleic acid sequence based amplification (NASBA, Cangene,
Mississauga, Ontario), Q-Beta Replicase systems,
transcription-based amplification system (TAS) and strand
displacement amplification (SDA). See, e.g., Diagnostic Molecular
Microbiology Principles and Applications, Persing, et al., Ed.,
American Society for Microbiology, Washington, D.C. (1993). The
product of amplification is termed an amplicon.
[0027] As used herein, "antisense orientation" includes reference
to a duplex polynucleotide sequence that is operably linked to a
promoter in an orientation where the antisense strand is
transcribed. The antisense strand is sufficiently complementary to
an endogenous transcription product such that translation of the
endogenous transcription product is often inhibited.
[0028] By "encoding" or "encoded", with respect to a specified
nucleic acid, is meant comprising the information for translation
into the specified protein. A nucleic acid encoding a protein may
comprise non-translated sequences (e.g., introns) within translated
regions of the nucleic acid or may lack such intervening
non-translated sequences (e.g., as in cDNA). The information by
which a protein is encoded is specified by the use of codons.
Typically, the amino acid sequence is encoded by the nucleic acid
using the "universal" genetic code. However, variants of the
universal code, such as are present in some plant, animal and
fungal mitochondria, the bacterium Mycoplasma capricolumn or the
ciliate Macronucleus, may be used when the nucleic acid is
expressed therein.
[0029] When the nucleic acid is prepared or altered synthetically,
advantage can be taken of known codon preferences of the intended
host where the nucleic acid is to be expressed. For example,
although nucleic acid sequences of the present invention may be
expressed in both monocotyledonous and dicotyledonous plant
species, sequences can be modified to account for the specific
codon preferences and GC content preferences of monocotyledons or
dicotyledons as these preferences have been shown to differ
(Murray, et al., (1989) Nucl. Acids Res. 17:477-498). Thus, the
maize preferred codon for a particular amino acid may be derived
from known gene sequences from maize. Maize codon usage for 28
genes from maize plants is listed in Table 4 of Murray, et al.,
supra.
[0030] As used herein "full-length sequence" in reference to a
specified polynucleotide or its encoded protein means having the
entire amino acid sequence of a native (non-synthetic), endogenous,
biologically (e.g., structurally or catalytically) active form of
the specified protein. Methods to determine whether a sequence is
full-length are well known in the art, including such exemplary
techniques as northern or western blots, primer extension, S1
protection and ribonuclease protection. See, e.g., Plant Molecular
Biology: A Laboratory Manual, Clark, Ed., Springer-Verlag, Berlin
(1997). Comparison to known full-length homologous (orthologous
and/or paralogous) sequences can also be used to identify
full-length sequences of the present invention. Additionally,
consensus sequences typically present at the 5' and 3' untranslated
regions of mRNA aid in the identification of a polynucleotide as
full-length. For example, the consensus sequence ANNNNAUGG, where
the underlined codon represents the N-terminal methionine, aids in
determining whether the polynucleotide has a complete 5' end.
Consensus sequences at the 3' end, such as polyadenylation
sequences, aid in determining whether the polynucleotide has a
complete 3' end.
[0031] As used herein, "heterologous" in reference to a nucleic
acid is a nucleic acid that originates from a foreign species, or,
if from the same species, is substantially modified from its native
form in composition and/or genomic locus by human intervention. For
example, a promoter operably linked to a heterologous structural
gene is from a species different from that from which the
structural gene was derived, or, if from the same species, one or
both are substantially modified from their original form. A
heterologous protein may originate from a foreign species or, if
from the same species, is substantially modified from its original
form by human intervention.
[0032] By "host cell" is meant a cell which contains a vector and
supports the replication and/or expression of the vector. Host
cells may be prokaryotic cells such as E. coli, or eukaryotic cells
such as yeast, insect, amphibian or mammalian cells. Preferably,
host cells are monocotyledonous or dicotyledonous plant cells. A
particularly preferred monocotyledonous host cell is a maize host
cell.
[0033] The term "introduced" includes reference to the
incorporation of a nucleic acid into a eukaryotic or prokaryotic
cell where the nucleic acid may be incorporated into the genome of
the cell (e.g., chromosome, plasmid, plastid or mitochondrial DNA),
converted into an autonomous replicon, or transiently expressed
(e.g., transfected mRNA). The term includes such nucleic acid
introduction means as "transfection", "transformation" and
"transduction".
[0034] The term "isolated" refers to material, such as a nucleic
acid or a protein, which is: (1) substantially or essentially free
from components which normally accompany or interact with it as
found in its natural environment. The isolated material optionally
comprises material not found with the material in its natural
environment or (2) if the material is in its natural environment,
the material has been synthetically altered or synthetically
produced by deliberate human intervention and/or placed at a
different location within the cell. The synthetic alteration or
creation of the material can be performed on the material within or
apart from its natural state. For example, a naturally-occurring
nucleic acid becomes an isolated nucleic acid if it is altered or
produced by non-natural, synthetic methods or if it is transcribed
from DNA which has been altered or produced by non-natural,
synthetic methods. The isolated nucleic acid may also be produced
by the synthetic re-arrangement ("shuffling") of a part or parts of
one or more allelic forms of the gene of interest. Likewise, a
naturally-occurring nucleic acid (e.g., a promoter) becomes
isolated if it is introduced to a different locus of the genome.
Nucleic acids which are "isolated," as defined herein, are also
referred to as "heterologous" nucleic acids. See, e.g., Compounds
and Methods for Site Directed Mutagenesis in Eukaryotic Cells,
Kmiec, U.S. Pat. No. 5,565,350; In Vivo Homologous Sequence
Targeting in Eukaryotic Cells, Zarling, et al., WO 1993/22443
(PCT/US93/03868).
[0035] As used herein, "nucleic acid" includes reference to a
deoxyribonucleotide or ribonucleotide polymer or chimeras thereof
in either single- or double-stranded form and unless otherwise
limited, encompasses known analogues having the essential nature of
natural nucleotides in that they hybridize to single-stranded
nucleic acids in a manner similar to naturally occurring
nucleotides (e.g., peptide nucleic acids).
[0036] By "nucleic acid library" is meant a collection of isolated
DNA or RNA molecules which comprise and substantially represent the
entire transcribed fraction of a genome of a specified organism,
tissue or of a cell type from that organism. Construction of
exemplary nucleic acid libraries, such as genomic and cDNA
libraries, is taught in standard molecular biology references such
as Berger and Kimmel, Guide to Molecular Cloning Techniques,
Methods in Enzymology, Vol. 152, Academic Press, Inc., San Diego,
Calif. (Berger); Sambrook, et al., Molecular Cloning--A Laboratory
Manual, 2.sup.nd ed., Vol. 1-3 (1989) and Current Protocols in
Molecular Biology, Ausubel, et al., Eds., Current Protocols, a
joint venture between Greene Publishing Associates, Inc. and John
Wiley & Sons, Inc. (1994).
[0037] As used herein "operably linked" includes reference to a
functional linkage between a promoter and a second sequence,
wherein the promoter sequence initiates and mediates transcription
of the DNA sequence corresponding to the second sequence.
Generally, operably linked means that the nucleic acid sequences
being linked are contiguous and, where necessary to join two
protein coding regions, contiguous and in the same reading
frame.
[0038] As used herein, the term "plant" includes reference to whole
plants, plant parts or organs (e.g., leaves, stems, roots, etc.),
plant cells, seeds and progeny of same. Plant cell, as used herein,
further includes, without limitation, cells obtained from or found
in: seeds, suspension cultures, embryos, meristematic regions,
callus tissue, leaves, roots, shoots, gametophytes, sporophytes,
pollen and microspores. Plant cells can also be understood to
include modified cells, such as protoplasts, obtained from the
aforementioned tissues. The class of plants which can be used in
the methods of the invention is generally as broad as the class of
higher plants amenable to transformation techniques, including both
monocotyledonous and dicotyledonous plants. A particularly
preferred plant is Zea mays.
[0039] As used herein, "polynucleotide" includes reference to a
deoxyribopolynucleotide, ribopolynucleotide or chimeras or analogs
thereof that have the essential nature of a natural deoxy- or
ribo-nucleotide in that they hybridize, under stringent
hybridization conditions, to substantially the same nucleotide
sequence as naturally occurring nucleotides and/or allow
translation into the same amino acid(s) as the naturally occurring
nucleotide(s). A polynucleotide can be full-length or a subsequence
of a native or heterologous structural or regulatory gene. Unless
otherwise indicated, the term includes reference to the specified
sequence as well as the complementary sequence thereof. Thus, DNAs
or RNAs with backbones modified for stability or for other reasons
are "polynucleotides" as that term is intended herein. Moreover,
DNAs or RNAs comprising unusual bases, such as inosine, or modified
bases, such as tritylated bases, to name just two examples, are
polynucleotides as the term is used herein. It will be appreciated
that a great variety of modifications have been made to DNA and RNA
that serve many useful purposes known to those of skill in the art.
The term polynucleotide as it is employed herein embraces such
chemically, enzymatically or metabolically modified forms of
polynucleotides, as well as the chemical forms of DNA and RNA
characteristic of viruses and cells, including among other things,
simple and complex cells.
[0040] The terms "polypeptide", "peptide" and "protein" are used
interchangeably herein to refer to a polymer of amino acid
residues. The terms apply to amino acid polymers in which one or
more amino acid residue is an artificial chemical analogue of a
corresponding naturally occurring amino acid, as well as to
naturally occurring amino acid polymers. The essential nature of
such analogues of naturally occurring amino acids is that, when
incorporated into a protein, that protein is specifically reactive
to antibodies elicited to the same protein but consisting entirely
of naturally occurring amino acids. The terms "polypeptide",
"peptide" and "protein" are also inclusive of modifications
including, but not limited to, glycosylation, lipid attachment,
sulfation, gamma-carboxylation of glutamic acid residues,
hydroxylation and ADP-ribosylation. Further, this invention
contemplates the use of both the methionine-containing and the
methionine-less amino terminal variants of the protein of the
invention.
[0041] As used herein "promoter" includes reference to a region of
DNA upstream from the start of transcription and involved in
recognition and binding of RNA polymerase and other proteins to
initiate transcription. A "plant promoter" is a promoter capable of
initiating transcription in plant cells whether or not its origin
is a plant cell. Exemplary plant promoters include, but are not
limited to, those that are obtained from plants, plant viruses and
bacteria which comprise genes expressed in plant cells such
Agrobacterium or Rhizobium. Examples of promoters under
developmental control include promoters that preferentially
initiate transcription in certain tissues, such as leaves, roots or
seeds. Such promoters are referred to as "tissue preferred".
Promoters which initiate transcription only in certain tissue are
referred to as "tissue specific". A "cell type" specific promoter
primarily drives expression in certain cell types in one or more
organs, for example, vascular cells in roots or leaves. An
"inducible" or "repressible" promoter is a promoter which is under
environmental control. Examples of environmental conditions that
may effect transcription by inducible promoters include anaerobic
conditions or the presence of light. Tissue specific, tissue
preferred, cell type specific and inducible promoters constitute
the class of "non-constitutive" promoters. A "constitutive"
promoter is a promoter which is active under most environmental
conditions.
[0042] As used herein "recombinant" includes reference to a cell or
vector, that has been modified by the introduction of a
heterologous nucleic acid or that the cell is derived from a cell
so modified. Thus, for example, recombinant cells express genes
that are not found in identical form within the native
(non-recombinant) form of the cell or express native genes that are
otherwise abnormally expressed, under-expressed or not expressed at
all as a result of human intervention. The term "recombinant" as
used herein does not encompass the alteration of the cell or vector
by naturally occurring events (e.g., spontaneous mutation, natural
transformation/transduction/transposition) such as those occurring
without human intervention.
[0043] As used herein, a "recombinant expression cassette" is a
nucleic acid construct, generated recombinantly or synthetically,
with a series of specified nucleic acid elements which permit
transcription of a particular nucleic acid in a host cell. The
recombinant expression cassette can be incorporated into a plasmid,
chromosome, mitochondrial DNA, plastid DNA, virus or nucleic acid
fragment. Typically, the recombinant expression cassette portion of
an expression vector includes, among other sequences, a nucleic
acid to be transcribed and a promoter.
[0044] The terms "residue" or "amino acid residue" or "amino acid"
are used interchangeably herein to refer to an amino acid that is
incorporated into a protein, polypeptide or peptide (collectively
"protein"). The amino acid may be a naturally occurring amino acid
and, unless otherwise limited, may encompass non-natural analogs of
natural amino acids that can function in a similar manner as
naturally occurring amino acids.
[0045] The term "selectively hybridizes" includes reference to
hybridization, under stringent hybridization conditions, of a
nucleic acid sequence to a specified nucleic acid target sequence
to a detectably greater degree (e.g., at least 2-fold over
background) than its hybridization to non-target nucleic acid
sequences and to the substantial exclusion of non-target nucleic
acids. Selectively hybridizing sequences typically have about at
least 80% sequence identity, preferably 90% sequence identity and
most preferably 100% sequence identity (i.e., complementary) with
each other.
[0046] The term "stringent conditions" or "stringent hybridization
conditions" includes reference to conditions under which a probe
will selectively hybridize to its target sequence, to a detectably
greater degree than to other sequences (e.g., at least 2-fold over
background). Stringent conditions are sequence-dependent and will
be different in different circumstances. By controlling the
stringency of the hybridization and/or washing conditions, target
sequences can be identified which are 100% complementary to the
probe (homologous probing). Alternatively, stringency conditions
can be adjusted to allow some mismatching in sequences so that
lower degrees of similarity are detected (heterologous probing).
Generally, a probe is less than about 1000 nucleotides in length,
optionally less than 500 nucleotides in length.
[0047] Typically, stringent conditions will be those in which the
salt concentration is less than about 1.5 M Na ion, typically about
0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to
8.3 and the temperature is at least about 30.degree. C. for short
probes (e.g., 10 to 50 nucleotides) and at least about 60.degree.
C. for long probes (e.g., greater than 50 nucleotides). Stringent
conditions may also be achieved with the addition of destabilizing
agents such as formamide. Exemplary low stringency conditions
include hybridization with a buffer solution of 30 to 35%
formamide, 1 M NaCl, 1% SDS (sodium dodecyl sulphate) at 37.degree.
C. and a wash in 1.times. to 2.times.SSC (20.times.SSC=3.0 M
NaCl/0.3 M trisodium citrate) at 50 to 55.degree. C. Exemplary
moderate stringency conditions include hybridization in 40 to 45%
formamide, 1 M NaCl, 1% SDS at 37.degree. C. and a wash in
0.5.times. to 1.times.SSC at 55 to 60.degree. C. Exemplary high
stringency conditions include hybridization in 50% formamide, 1 M
NaCl, 1% SDS at 37.degree. C. and a wash in 0.1.times.SSC at 60 to
65.degree. C.
[0048] Specificity is typically the function of post-hybridization
washes, the critical factors being the ionic strength and
temperature of the final wash solution. For DNA-DNA hybrids, the
T.sub.m can be approximated from the equation of Meinkoth and Wahl,
(1984) Anal. Biochem., 138:267-284: T.sub.m=81.5.degree. C.+16.6
(log M)+0.41(% GC)-0.61(% form)-500/L; where M is the molarity of
monovalent cations, % GC is the percentage of guanosine and
cytosine nucleotides in the DNA, % form is the percentage of
formamide in the hybridization solution, and L is the length of the
hybrid in base pairs. The T.sub.m is the temperature (under defined
ionic strength and pH) at which 50% of a complementary target
sequence hybridizes to a perfectly matched probe. T.sub.m is
reduced by about 1.degree. C. for each 1% of mismatching; thus,
T.sub.m, hybridization and/or wash conditions can be adjusted to
hybridize to sequences of the desired identity. For example, if
sequences with >90% identity are sought, the T.sub.m can be
decreased 10.degree. C. Generally, stringent conditions are
selected to be about 5.degree. C. lower than the thermal melting
point ("T.sub.m") for the specific sequence and its complement at a
defined ionic strength and pH. However, severely stringent
conditions can utilize a hybridization and/or wash at 1, 2, 3 or
4.degree. C. lower than the T.sub.m; moderately stringent
conditions can utilize a hybridization and/or wash at 6, 7, 8, 9 or
10.degree. C. lower than the T.sub.m; low stringency conditions can
utilize a hybridization and/or wash at 11, 12, 13, 14, 15 or
20.degree. C. lower than the T.sub.m. Using the equation,
hybridization and wash compositions, and desired T.sub.m, those of
ordinary skill will understand that variations in the stringency of
hybridization and/or wash solutions are inherently described. If
the desired degree of mismatching results in a T.sub.m of less than
45.degree. C. (aqueous solution) or 32.degree. C. (formamide
solution) it is preferred to increase the SSC concentration so that
a higher temperature can be used. Hybridization and/or wash
conditions can be applied for at least 10, 30, 60, 90, 120 or 240
minutes. An extensive guide to the hybridization of nucleic acids
is found in Tijssen, Laboratory Techniques in Biochemistry and
Molecular Biology--Hybridization with Nucleic Acid Probes, Part I,
Chapter 2 "Overview of principles of hybridization and the strategy
of nucleic acid probe assays", Elsevier, New York (1993); and
Current Protocols in Molecular Biology, Chapter 2, Ausubel, et al.,
Eds., Greene Publishing and Wiley-Interscience, New York
(1995).
[0049] As used herein, "transgenic plant" includes reference to a
plant which comprises within its genome a heterologous
polynucleotide. Generally, the heterologous polynucleotide is
stably integrated within the genome such that the polynucleotide is
passed on to successive generations. The heterologous
polynucleotide may be integrated into the genome alone or as part
of a recombinant expression cassette. "Transgenic" is used herein
to include any cell, cell line, callus, tissue, plant part or
plant, the genotype of which has been altered by the presence of
heterologous nucleic acid including those transgenics initially so
altered as well as those created by sexual crosses or asexual
propagation from the initial transgenic. The term "transgenic" as
used herein does not encompass the alteration of the genome
(chromosomal or extra-chromosomal) by conventional plant breeding
methods or by naturally occurring events such as random
cross-fertilization, non-recombinant viral infection,
non-recombinant bacterial transformation, non-recombinant
transposition or spontaneous mutation.
[0050] As used herein, "vector" includes reference to a nucleic
acid used in introduction of a polynucleotide of the present
invention into a host cell. Vectors are often replicons. Expression
vectors permit transcription of a nucleic acid inserted
therein.
[0051] The following terms are used to describe the sequence
relationships between a polynucleotide/polypeptide of the present
invention with a reference polynucleotide/polypeptide: (a)
"reference sequence", (b) "comparison window", (c) "sequence
identity" and (d) "percentage of sequence identity".
[0052] (a) As used herein, "reference sequence" is a defined
sequence used as a basis for sequence comparison with a
polynucleotide/polypeptide of the present invention. A reference
sequence may be a subset or the entirety of a specified sequence;
for example, as a segment of a full-length cDNA or gene sequence or
the complete cDNA or gene sequence.
[0053] (b) As used herein, "comparison window" includes reference
to a contiguous and specified segment of a
polynucleotide/polypeptide sequence, wherein the
polynucleotide/polypeptide sequence may be compared to a reference
sequence and wherein the portion of the polynucleotide/polypeptide
sequence in the comparison window may comprise additions or
deletions (i.e., gaps) compared to the reference sequence (which
does not comprise additions or deletions) for optimal alignment of
the two sequences. Generally, the comparison window is at least 20
contiguous nucleotides/amino acids residues in length, and
optionally can be 30, 40, 50, 100 or longer. Those of skill in the
art understand that to avoid a high similarity to a reference
sequence due to inclusion of gaps in the polynucleotide/polypeptide
sequence, a gap penalty is typically introduced and is subtracted
from the number of matches.
[0054] Methods of alignment of sequences for comparison are
well-known in the art. Optimal alignment of sequences for
comparison may be conducted by the local homology algorithm of
Smith and Waterman, (1981) Adv. Appl. Math. 2:482; by the homology
alignment algorithm of Needleman and Wunsch, (1970) J. Mol. Biol.
48:443; by the search for similarity method of Pearson and Lipman,
(1988) Proc. Natl. Acad. Sci. 85:2444; by computerized
implementations of these algorithms, including, but not limited to:
CLUSTAL in the PC/Gene program by Intelligenetics, Mountain View,
Calif.; GAP, BESTFIT, BLAST, FASTA and TFASTA in the Wisconsin
Genetics Software Package.RTM., Genetics Computer Group (GCG.RTM.),
575 Science Dr., Madison, Wis., USA; the CLUSTAL program is well
described by Higgins and Sharp, (1988) Gene 73:237-244; Higgins and
Sharp, (1989) CABIOS 5:151-153; Corpet, et al., (1988) Nucleic
Acids Research 16:10881-90; Huang, et al., (1992) Computer
Applications in the Biosciences 8:155-65 and Pearson, et al.,
(1994) Methods in Molecular Biology 24:307-331.
[0055] The BLAST family of programs which can be used for database
similarity searches includes: BLASTN for nucleotide query sequences
against nucleotide database sequences; BLASTX for nucleotide query
sequences against protein database sequences; BLASTP for protein
query sequences against protein database sequences; TBLASTN for
protein query sequences against nucleotide database sequences and
TBLASTX for nucleotide query sequences against nucleotide database
sequences. See, Current Protocols in Molecular Biology, Chapter 19,
Ausubel, et al., Eds., Greene Publishing and Wiley-Interscience,
New York (1995); Altschul, et al., (1990) J. Mol. Biol.,
215:403-410 and Altschul, et al., (1997) Nucleic Acids Res.
25:3389-3402.
[0056] Software for performing BLAST analyses is publicly
available, e.g., through the National Center for Biotechnology
Information. This algorithm involves first identifying high scoring
sequence pairs (HSPs) by identifying short words of length W in the
query sequence, which either match or satisfy some positive-valued
threshold score T when aligned with a word of the same length in a
database sequence. T is referred to as the neighborhood word score
threshold. These initial neighborhood word hits act as seeds for
initiating searches to find longer HSPs containing them. The word
hits are then extended in both directions along each sequence for
as far as the cumulative alignment score can be increased.
Cumulative scores are calculated using, for nucleotide sequences,
the parameters M (reward score for a pair of matching residues;
always>0) and N (penalty score for mismatching residues;
always<0). For amino acid sequences, a scoring matrix is used to
calculate the cumulative score. Extension of the word hits in each
direction are halted when: the cumulative alignment score falls off
by the quantity X from its maximum achieved value; the cumulative
score goes to zero or below, due to the accumulation of one or more
negative-scoring residue alignments; or the end of either sequence
is reached. The BLAST algorithm parameters W, T and X determine the
sensitivity and speed of the alignment. The BLASTN program (for
nucleotide sequences) uses as defaults a wordlength (W) of 11, an
expectation (E) of 10, a cutoff of 100, M=5, N=-4, and a comparison
of both strands. For amino acid sequences, the BLASTP program uses
as defaults a wordlength (W) of 3, an expectation (E) of 10, and
the BLOSUM62 scoring matrix (see, Henikoff and Henikoff, (1989)
Proc. Natl. Acad. Sci. USA 89:10915).
[0057] In addition to calculating percent sequence identity, the
BLAST algorithm also performs a statistical analysis of the
similarity between two sequences (see, e.g., Karlin and Altschul,
(1993) Proc. Nat'l. Acad. Sci. USA 90:5873-5877). One measure of
similarity provided by the BLAST algorithm is the smallest sum
probability (P(N)), which provides an indication of the probability
by which a match between two nucleotide or amino acid sequences
would occur by chance.
[0058] BLAST searches assume that proteins can be modeled as random
sequences. However, many real proteins comprise regions of
nonrandom sequences which may be homopolymeric tracts, short-period
repeats or regions enriched in one or more amino acids. Such
low-complexity regions may be aligned between unrelated proteins
even though other regions of the protein are entirely dissimilar. A
number of low-complexity filter programs can be employed to reduce
such low-complexity alignments. For example, the SEG (Wooten and
Federhen, (1993) Comput. Chem. 17:149-163) and XNU (Claverie and
States, (1993) Comput. Chem 17:191-201) low-complexity filters can
be employed alone or in combination.
[0059] Unless otherwise stated, nucleotide and protein
identity/similarity values provided herein are calculated using GAP
(GCG.RTM. Version 10) under default values.
[0060] GAP (Global Alignment Program) can also be used to compare a
polynucleotide or polypeptide of the present invention with a
reference sequence. GAP uses the algorithm of Needleman and Wunsch,
(J. Mol. Biol. 48: 443-453 (1970)) to find the alignment of two
complete sequences that maximizes the number of matches and
minimizes the number of gaps. GAP considers all possible alignments
and gap positions and creates the alignment with the largest number
of matched bases and the fewest gaps. It allows for the provision
of a gap creation penalty and a gap extension penalty in units of
matched bases. GAP must make a profit of gap creation penalty
number of matches for each gap it inserts. If a gap extension
penalty greater than zero is chosen, GAP must, in addition, make a
profit for each gap inserted of the length of the gap times the gap
extension penalty. Default gap creation penalty values and gap
extension penalty values in Version 10 of the Wisconsin Genetics
Software Package.RTM. for protein sequences are 8 and 2,
respectively. For nucleotide sequences the default gap creation
penalty is 50 while the default gap extension penalty is 3. The gap
creation and gap extension penalties can be expressed as an integer
selected from the group of integers consisting of from 0 to 100.
Thus, for example, the gap creation and gap extension penalties can
each independently be: 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20,
30, 40, 50, 60 or greater.
[0061] GAP presents one member of the family of best alignments.
There may be many members of this family, but no other member has a
better quality. GAP displays four figures of merit for alignments:
Quality, Ratio, Identity and Similarity. The Quality is the metric
maximized in order to align the sequences. Ratio is the quality
divided by the number of bases in the shorter segment. Percent
Identity is the percent of the symbols that actually match. Percent
Similarity is the percent of the symbols that are similar. Symbols
that are across from gaps are ignored. A similarity is scored when
the scoring matrix value for a pair of symbols is greater than or
equal to 0.50, the similarity threshold. The scoring matrix used in
Version 10 of the Wisconsin Genetics Software Package.RTM. is
BLOSUM62 (see, Henikoff and Henikoff, (1989) Natl. Acad. Sci. USA
89:10915).
[0062] Multiple alignment of the sequences can be performed using
the CLUSTAL method of alignment (Higgins and Sharp, (1989) CABIOS.
5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH
PENALTY=10). Default parameters for pairwise alignments using the
CLUSTAL method are KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS
SAVED=5.
[0063] (c) As used herein, "sequence identity" or "identity" in the
context of two nucleic acid or polypeptide sequences includes
reference to the residues in the two sequences which are the same
when aligned for maximum correspondence over a specified comparison
window. When percentage of sequence identity is used in reference
to proteins it is recognized that residue positions which are not
identical often differ by conservative amino acid substitutions,
where amino acid residues are substituted for other amino acid
residues with similar chemical properties (e.g., charge or
hydrophobicity) and therefore do not change the functional
properties of the molecule. Where sequences differ in conservative
substitutions, the percent sequence identity may be adjusted
upwards to correct for the conservative nature of the substitution.
Sequences which differ by such conservative substitutions are said
to have "sequence similarity" or "similarity". Means for making
this adjustment are well-known to those of skill in the art.
Typically this involves scoring a conservative substitution as a
partial rather than a full mismatch, thereby increasing the
percentage sequence identity. Thus, for example, where an identical
amino acid is given a score of 1 and a non-conservative
substitution is given a score of zero, a conservative substitution
is given a score between zero and 1. The scoring of conservative
substitutions is calculated, e.g., according to the algorithm of
Meyers and Miller, (1988) Computer Applic. Biol. Sci. 4:11-17 e.g.,
as implemented in the program PC/GENE (Intelligenetics, Mountain
View, Calif., USA).
[0064] (d) As used herein, "percentage of sequence identity" means
the value determined by comparing two optimally aligned sequences
over a comparison window, wherein the portion of the polynucleotide
sequence in the comparison window may comprise additions or
deletions (i.e., gaps) as compared to the reference sequence (which
does not comprise additions or deletions) for optimal alignment of
the two sequences. The percentage is calculated by determining the
number of positions at which the identical nucleic acid base or
amino acid residue occurs in both sequences to yield the number of
matched positions, dividing the number of matched positions by the
total number of positions in the window of comparison and
multiplying the result by 100 to yield the percentage of sequence
identity.
Utilities
[0065] The present invention provides, among other things,
compositions and methods for modulating (i.e., increasing or
decreasing) the level of polynucleotides and polypeptides of the
present invention in plants. In particular, the polynucleotides and
polypeptides of the present invention can be expressed temporally
or spatially, e.g., at developmental stages, in tissues and/or in
quantities, which are uncharacteristic of non-recombinantly
engineered plants.
[0066] The present invention also provides isolated nucleic acids
comprising polynucleotides of sufficient length and complementarity
to a polynucleotide of the present invention to use as probes or
amplification primers in the detection, quantitation or isolation
of gene transcripts. For example, isolated nucleic acids of the
present invention can be used as probes in detecting deficiencies
in the level of mRNA in screenings for desired transgenic plants,
for detecting mutations in the gene (e.g., substitutions, deletions
or additions), for monitoring upregulation of expression or changes
in enzyme activity in screening assays of compounds, for detection
of any number of allelic variants (polymorphisms), orthologs or
paralogs of the gene or for site directed mutagenesis in eukaryotic
cells (see, e.g., U.S. Pat. No. 5,565,350). The isolated nucleic
acids of the present invention can also be used for recombinant
expression of their encoded polypeptides or for use as immunogens
in the preparation and/or screening of antibodies. The isolated
nucleic acids of the present invention can also be employed for use
in sense or antisense suppression of one or more genes of the
present invention in a host cell, tissue or plant. Attachment of
chemical agents which bind, intercalate, cleave and/or crosslink to
the isolated nucleic acids of the present invention can also be
used to modulate transcription or translation.
[0067] The present invention also provides isolated proteins
comprising a polypeptide of the present invention (e.g.,
preproenzyme, proenzyme or enzymes). The present invention also
provides proteins comprising at least one epitope from a
polypeptide of the present invention. The proteins of the present
invention can be employed in assays for enzyme agonists or
antagonists of enzyme function or for use as immunogens or antigens
to obtain antibodies specifically immunoreactive with a protein of
the present invention. Such antibodies can be used in assays for
expression levels, for identifying and/or isolating nucleic acids
of the present invention from expression libraries, for
identification of homologous polypeptides from other species or for
purification of polypeptides of the present invention.
[0068] The isolated nucleic acids and polypeptides of the present
invention can be used over a broad range of plant types,
particularly monocots such as the species of the family Gramineae
including Hordeum, Secale, Oryza, Triticum, Sorghum (e.g., S.
bicolor) and Zea (e.g., Z. mays) and dicots such as Glycine.
[0069] The isolated nucleic acid and proteins of the present
invention can also be used in species from the genera: Cucurbita,
Rosa, Vitis, Juglans, Fragaria, Lotus, Medicago, Onobrychis,
Trifolium, Trigonella, Vigna, Citrus, Linum, Geranium, Manihot,
Daucus, Arabidopsis, Brassica, Raphanus, Sinapis, Atropa, Capsicum,
Datura, Hyoscyamus, Lycopersicon, Nicotiana, Solanum, Petunia,
Digitalis, Majorana, Ciahorium, Helianthus, Lactuca, Bromus,
Asparagus, Antirrhinum, Heterocallis, Nemesis, Pelargonium,
Panieum, Pennisetum, Ranunculus, Senecio, Salpiglossis, Cucumis,
Browallia, Pisum, Phaseolus, Lolium and Avena.
Nucleic Acids
[0070] The present invention provides, among other things, isolated
nucleic acids of RNA, DNA and analogs and/or chimeras thereof,
comprising a polynucleotide of the present invention.
[0071] A polynucleotide of the present invention is inclusive of
those in Table 1 and:
[0072] (a) an isolated polynucleotide encoding a polypeptide of the
present invention such as those referenced in Table 1, including
exemplary polynucleotides of the present invention;
[0073] (b) an isolated polynucleotide which is the product of
amplification from a plant nucleic acid library using primer pairs
which selectively hybridize under stringent conditions to loci
within a polynucleotide of the present invention;
[0074] (c) an isolated polynucleotide which selectively hybridizes
to a polynucleotide of (a) or (b);
[0075] (d) an isolated polynucleotide having a specified sequence
identity with polynucleotides of (a), (b) or (c);
[0076] (e) an isolated polynucleotide encoding a protein having a
specified number of contiguous amino acids from a prototype
polypeptide, wherein the protein is specifically recognized by
antisera elicited by presentation of the protein and wherein the
protein does not detectably immunoreact to antisera which has been
fully immunosorbed with the protein;
[0077] (f) complementary sequences of polynucleotides of (a), (b),
(c), (d) or (e);
[0078] (g) an isolated polynucleotide comprising at least a
specific number of contiguous nucleotides from a polynucleotide of
(a), (b), (c), (d), (e) or (f);
[0079] (h) an isolated polynucleotide from a full-length enriched
cDNA library having the physico-chemical property of selectively
hybridizing to a polynucleotide of (a), (b), (c), (d), (e), (f) or
(g);
[0080] (i) an isolated polynucleotide made by the process of: 1)
providing a full-length enriched nucleic acid library, 2)
selectively hybridizing the polynucleotide to a polynucleotide of
(a), (b), (c), (d), (e), (f), (g) or (h), thereby isolating the
polynucleotide from the nucleic acid library.
A. Polynucleotides Encoding a Polypeptide of the Present
Invention
[0081] As indicated in (a), above, the present invention provides
isolated nucleic acids comprising a polynucleotide of the present
invention, wherein the polynucleotide encodes a polypeptide of the
present invention. Every nucleic acid sequence herein that encodes
a polypeptide also, by reference to the genetic code, describes
every possible silent variation of the nucleic acid. One of
ordinary skill will recognize that each codon in a nucleic acid
(except AUG, which is ordinarily the only codon for methionine and
UGG, which is ordinarily the only codon for tryptophan) can be
modified to yield a functionally identical molecule. Thus, each
silent variation of a nucleic acid which encodes a polypeptide of
the present invention is implicit in each described polypeptide
sequence and is within the scope of the present invention.
Accordingly, the present invention includes polynucleotides of the
present invention and polynucleotides encoding a polypeptide of the
present invention.
B. Polynucleotides Amplified from a Plant Nucleic Acid Library
[0082] As indicated in (b), above, the present invention provides
an isolated nucleic acid comprising a polynucleotide of the present
invention, wherein the polynucleotides are amplified, under nucleic
acid amplification conditions, from a plant nucleic acid library.
Nucleic acid amplification conditions for each of the variety of
amplification methods are well known to those of ordinary skill in
the art. The plant nucleic acid library can be constructed from a
monocot such as a cereal crop. Exemplary cereals include maize,
sorghum, alfalfa, canola, wheat or rice. The plant nucleic acid
library can also be constructed from a dicot such as soybean. Zea
mays lines B73, PHRE1, A632, BMS-P2#10, W23 and Mo17 are known and
publicly available. Other publicly known and available maize lines
can be obtained from the Maize Genetics Cooperation (Urbana, Ill.).
Wheat lines are available from the Wheat Genetics Resource Center
(Manhattan, Kans.).
[0083] The nucleic acid library may be a cDNA library, a genomic
library or a library generally constructed from nuclear transcripts
at any stage of intron processing. cDNA libraries can be normalized
to increase the representation of relatively rare cDNAs. In
optional embodiments, the cDNA library is constructed using an
enriched full-length cDNA synthesis method. Examples of such
methods include Oligo-Capping (Maruyama and Sugano, (1994) Gene
138:171-174,), Biotinylated CAP Trapper (Carninci, et al., (1996)
Genomics 37:327-336) and CAP Retention Procedure (Edery, et al.,
(1995) Molecular and Cellular Biology 15:3363-3371). Rapidly
growing tissues or rapidly dividing cells are preferred for use as
an mRNA source for construction of a cDNA library. Growth stages of
maize are described in "How a Corn Plant Develops," Special Report
Number 48, Iowa State University of Science and Technology
Cooperative Extension Service, Ames, Iowa, Reprinted February
1993.
[0084] A polynucleotide of this embodiment (or subsequences
thereof) can be obtained, for example, by using amplification
primers which are selectively hybridized and primer extended, under
nucleic acid amplification conditions, to at least two sites within
a polynucleotide of the present invention or to two sites within
the nucleic acid which flank and comprise a polynucleotide of the
present invention or to a site within a polynucleotide of the
present invention and a site within the nucleic acid which
comprises it. Methods for obtaining 5' and/or 3' ends of a vector
insert are well known in the art. See, e.g., RACE (Rapid
Amplification of Complementary Ends) as described in Frohman, in
PCR Protocols: A Guide to Methods and Applications, Innis, et al.,
Eds. (Academic Press, Inc., San Diego), pp. 28-38 (1990)); see,
also, U.S. Pat. No. 5,470,722 and Current Protocols in Molecular
Biology, Unit 15.6, Ausubel, et al., Eds., Greene Publishing and
Wiley-Interscience, New York (1995); Frohman and Martin, Techniques
1:165 (1989).
[0085] Optionally, the primers are complementary to a subsequence
of the target nucleic acid which they amplify but may have a
sequence identity ranging from about 85% to 99% relative to the
polynucleotide sequence which they are designed to anneal to. As
those skilled in the art will appreciate, the sites to which the
primer pairs will selectively hybridize are chosen such that a
single contiguous nucleic acid can be formed under the desired
nucleic acid amplification conditions. The primer length in
nucleotides is selected from the group of integers consisting of
from at least 15 to 50. Thus, the primers can be at least 15, 18,
20, 25, 30, 40 or 50 nucleotides in length. Those of skill will
recognize that a lengthened primer sequence can be employed to
increase specificity of binding (i.e., annealing) to a target
sequence. A non-annealing sequence at the 5' end of a primer (a
"tail") can be added, for example, to introduce a cloning site at
the terminal ends of the amplicon.
[0086] The amplification products can be translated using
expression systems well known to those of skill in the art. The
resulting translation products can be confirmed as polypeptides of
the present invention by, for example, assaying for the appropriate
catalytic activity (e.g., specific activity and/or substrate
specificity) or verifying the presence of one or more epitopes
which are specific to a polypeptide of the present invention.
Methods for protein synthesis from PCR derived templates are known
in the art and available commercially. See, e.g., Amersham Life
Sciences, Inc, Catalog '97, p. 354.
C. Polynucleotides which Selectively Hybridize to a Polynucleotide
of (A) or (B)
[0087] As indicated in (c), above, the present invention provides
isolated nucleic acids comprising polynucleotides of the present
invention, wherein the polynucleotides selectively hybridize, under
selective hybridization conditions, to a polynucleotide of sections
(A) or (B) as discussed above. Thus, the polynucleotides of this
embodiment can be used for isolating, detecting and/or quantifying
nucleic acids comprising the polynucleotides of (A) or (B). For
example, polynucleotides of the present invention can be used to
identify, isolate or amplify partial or full-length clones in a
deposited library. In some embodiments, the polynucleotides are
genomic or cDNA sequences isolated or otherwise complementary to a
cDNA from a dicot or monocot nucleic acid library. Exemplary
species of monocots and dicots include, but are not limited to:
maize, canola, soybean, cotton, wheat, sorghum, sunflower, alfalfa,
oats, sugar cane, millet, barley and rice. The cDNA library
comprises at least 50% to 95% full-length sequences (for example,
at least 50%, 60%, 70%, 80%, 90% or 95% full-length sequences). The
cDNA libraries can be normalized to increase the representation of
rare sequences. See, e.g., U.S. Pat. No. 5,482,845. Low stringency
hybridization conditions are typically, but not exclusively,
employed with sequences having a reduced sequence identity relative
to complementary sequences. Moderate and high stringency conditions
can optionally be employed for sequences of greater identity. Low
stringency conditions allow selective hybridization of sequences
having about 70% to 80% sequence identity and can be employed to
identify orthologous or paralogous sequences.
D. Polynucleotides Having a Specific Sequence Identity with the
Polynucleotides of (A), (B) or (C)
[0088] As indicated in (d), above, the present invention provides
isolated nucleic acids comprising polynucleotides of the present
invention, wherein the polynucleotides have a specified identity at
the nucleotide level to a polynucleotide as disclosed above in
sections (A), (B) or (C), above. Identity can be calculated using,
for example, the BLAST, CLUSTALW or GAP algorithms under default
conditions. The percentage of identity to a reference sequence is
at least 50% and, rounded upwards to the nearest integer, can be
expressed as an integer selected from the group of integers
consisting of from 50 to 99. Thus, for example, the percentage of
identity to a reference sequence can be at least 60%, 70%, 75%,
80%, 85%, 90% or 95%.
[0089] Optionally, the polynucleotides of this embodiment will
encode a polypeptide that will share an epitope with a polypeptide
encoded by the polynucleotides of sections (A), (B) or (C). Thus,
these polynucleotides encode a first polypeptide which elicits
production of antisera comprising antibodies which are specifically
reactive to a second polypeptide encoded by a polynucleotide of
(A), (B) or (C). However, the first polypeptide does not bind to
antisera raised against itself when the antisera has been fully
immunosorbed with the first polypeptide. Hence, the polynucleotides
of this embodiment can be used to generate antibodies for use in,
for example, the screening of expression libraries for nucleic
acids comprising polynucleotides of (A), (B) or (C), or for
purification of, or in immunoassays for, polypeptides encoded by
the polynucleotides of (A), (B) or (C). The polynucleotides of this
embodiment comprise nucleic acid sequences which can be employed
for selective hybridization to a polynucleotide encoding a
polypeptide of the present invention.
[0090] Screening polypeptides for specific binding to antisera can
be conveniently achieved using peptide display libraries. This
method involves the screening of large collections of peptides for
individual members having the desired function or structure.
Antibody screening of peptide display libraries is well known in
the art. The displayed peptide sequences can be from 3 to 5000 or
more amino acids in length, frequently from 5-100 amino acids long,
and often from about 8 to 15 amino acids long. In addition to
direct chemical synthetic methods for generating peptide libraries,
several recombinant DNA methods have been described. One type
involves the display of a peptide sequence on the surface of a
bacteriophage or cell. Each bacteriophage or cell contains the
nucleotide sequence encoding the particular displayed peptide
sequence. Such methods are described in PCT Patent Publication
Numbers 1991/17271, 1991/18980, 1991/19818 and 1993/08278. Other
systems for generating libraries of peptides have aspects of both
in vitro chemical synthesis and recombinant methods. See, PCT
Patent Publication Numbers 1992/05258, 1992/14843 and 1997/20078.
See also, U.S. Pat. Nos. 5,658,754 and 5,643,768. Peptide display
libraries, vectors and screening kits are commercially available
from such suppliers as Invitrogen (Carlsbad, Calif.).
E. Polynucleotides Encoding a Protein Having a Subsequence from a
Prototype Polypeptide and Cross-Reactive to the Prototype
Polypeptide
[0091] As indicated in (e), above, the present invention provides
isolated nucleic acids comprising polynucleotides of the present
invention, wherein the polynucleotides encode a protein having a
subsequence of contiguous amino acids from a prototype polypeptide
of the present invention such as are provided in (a), above. The
length of contiguous amino acids from the prototype polypeptide is
selected from the group of integers consisting of from at least 10
to the number of amino acids within the prototype sequence. Thus,
for example, the polynucleotide can encode a polypeptide having a
subsequence having at least 10, 15, 20, 25, 30, 35, 40, 45 or 50,
contiguous amino acids from the prototype polypeptide. Further, the
number of such subsequences encoded by a polynucleotide of the
instant embodiment can be any integer selected from the group
consisting of from 1 to 20, such as 2, 3, 4 or 5. The subsequences
can be separated by any integer of nucleotides from 1 to the number
of nucleotides in the sequence such as at least 5, 10, 15, 25, 50,
100 or 200 nucleotides.
[0092] The proteins encoded by polynucleotides of this embodiment,
when presented as an immunogen, elicit the production of polyclonal
antibodies which specifically bind to a prototype polypeptide such
as but not limited to, a polypeptide encoded by the polynucleotide
of (a) or (b), above. Generally, however, a protein encoded by a
polynucleotide of this embodiment does not bind to antisera raised
against the prototype polypeptide when the antisera has been fully
immunosorbed with the prototype polypeptide. Methods of making and
assaying for antibody binding specificity/affinity are well known
in the art. Exemplary immunoassay formats include ELISA,
competitive immunoassays, radioimmunoassays, Western blots,
indirect immunofluorescent assays and the like.
[0093] In a preferred assay method, fully immunosorbed and pooled
antisera which is elicited to the prototype polypeptide can be used
in a competitive binding assay to test the protein. The
concentration of the prototype polypeptide required to inhibit 50%
of the binding of the antisera to the prototype polypeptide is
determined. If the amount of the protein required to inhibit
binding is less than twice the amount of the prototype protein,
then the protein is said to specifically bind to the antisera
elicited to the immunogen. Accordingly, the proteins of the present
invention embrace allelic variants, conservatively modified
variants and minor recombinant modifications to a prototype
polypeptide.
[0094] A polynucleotide of the present invention optionally encodes
a protein having a molecular weight as the non-glycosylated protein
within 20% of the molecular weight of the full-length
non-glycosylated polypeptides of the present invention. Molecular
weight can be readily determined by SDS-PAGE under reducing
conditions. Optionally, the molecular weight is within 15% of a
full length polypeptide of the present invention, more preferably
within 10% or 5%, and most preferably within 3%, 2% or 1% of a full
length polypeptide of the present invention.
[0095] Optionally, the polynucleotides of this embodiment will
encode a protein having a specific enzymatic activity at least 50%,
60%, 80% or 90% of a cellular extract comprising the native,
endogenous full-length polypeptide of the present invention.
Further, the proteins encoded by polynucleotides of this embodiment
will optionally have a substantially similar affinity constant
(K.sub.m) and/or catalytic activity (i.e., the microscopic rate
constant, k.sub.cat) as the native endogenous, full-length protein.
Those of skill in the art will recognize that k.sub.cat/K.sub.m
value determines the specificity for competing substrates and is
often referred to as the specificity constant. Proteins of this
embodiment can have a k.sub.cat/K.sub.m value at least 10% of a
full-length polypeptide of the present invention as determined
using the endogenous substrate of that polypeptide. Optionally, the
k.sub.cat/K.sub.m value will be at least 20%, 30%, 40%, 50% and
most preferably at least 60%, 70%, 80%, 90% or 95% the
k.sub.cat/K.sub.m value of the full-length polypeptide of the
present invention. Determination of k.sub.cat, K.sub.m and
k.sub.cat/K.sub.m can be determined by any number of means well
known to those of skill in the art. For example, the initial rates
(i.e., the first 5% or less of the reaction) can be determined
using rapid mixing and sampling techniques (e.g., continuous-flow,
stopped-flow or rapid quenching techniques), flash photolysis or
relaxation methods (e.g., temperature jumps) in conjunction with
such exemplary methods of measuring as spectrophotometry,
spectrofluorimetry, nuclear magnetic resonance or radioactive
procedures. Kinetic values are conveniently obtained using a
Lineweaver-Burk or Eadie-Hofstee plot.
F. Polynucleotides Complementary to the Polynucleotides of (A)-(E)
As indicated in (f), above, the present invention provides isolated
nucleic acids comprising polynucleotides complementary to the
polynucleotides of paragraphs A-E, above. As those of skill in the
art will recognize, complementary sequences base-pair throughout
the entirety of their length with the polynucleotides of sections
(A)-(E) (i.e., have 100% sequence identity over their entire
length). Complementary bases associate through hydrogen bonding in
double stranded nucleic acids. For example, the following base
pairs are complementary: guanine and cytosine; adenine and thymine
and adenine and uracil. G. Polynucleotides which are Subsequences
of the Polynucleotides of (A)-(F)
[0096] As indicated in (g), above, the present invention provides
isolated nucleic acids comprising polynucleotides which comprise at
least 15 contiguous bases from the polynucleotides of sections (A)
through (F) as discussed above. The length of the polynucleotide is
given as an integer selected from the group consisting of from at
least 15 to the length of the nucleic acid sequence from which the
polynucleotide is a subsequence of. Thus, for example,
polynucleotides of the present invention are inclusive of
polynucleotides comprising at least 15, 20, 25, 30, 40, 50, 60, 75
or 100 contiguous nucleotides in length from the polynucleotides of
(A)-(F). Optionally, the number of such subsequences encoded by a
polynucleotide of the instant embodiment can be any integer
selected from the group consisting of from 1 to 20, such as 2, 3, 4
or 5. The subsequences can be separated by any integer of
nucleotides from 1 to the number of nucleotides in the sequence
such as at least 5, 10, 15, 25, 50, 100 or 200 nucleotides.
[0097] Subsequences can be made by in vitro synthetic, in vitro
biosynthetic or in vivo recombinant methods. In optional
embodiments, subsequences can be made by nucleic acid
amplification. For example, nucleic acid primers will be
constructed to selectively hybridize to a sequence (or its
complement) within, or co-extensive with, the coding region.
[0098] The subsequences of the present invention can comprise
structural characteristics of the sequence from which it is
derived. Alternatively, the subsequences can lack certain
structural characteristics of the larger sequence from which it is
derived such as a poly (A) tail. Optionally, a subsequence from a
polynucleotide encoding a polypeptide having at least one epitope
in common with a prototype polypeptide sequence as provided in (a),
above, may encode an epitope in common with the prototype sequence.
Alternatively, the subsequence may not encode an epitope in common
with the prototype sequence but can be used to isolate the larger
sequence by, for example, nucleic acid hybridization with the
sequence from which it's derived. Subsequences can be used to
modulate or detect gene expression by introducing into the
subsequences compounds which bind, intercalate, cleave and/or
crosslink to nucleic acids. Exemplary compounds include acridine,
psoralen, phenanthroline, naphthoquinone, daunomycin or
chloroethylaminoaryl conjugates.
H. Polynucleotides from a Full-Length Enriched cDNA Library Having
the Physico-Chemical Property of Selectively Hybridizing to a
Polynucleotide of (A)-(G)
[0099] As indicated in (h), above, the present invention provides
an isolated polynucleotide from a full-length enriched cDNA library
having the physico-chemical property of selectively hybridizing to
a polynucleotide of paragraphs (A), (B), (C), (D), (E), (F) or (G)
as discussed above. Methods of constructing full-length enriched
cDNA libraries are known in the art and discussed briefly below.
The cDNA library comprises at least 50% to 95% full-length
sequences (for example, at least 50%, 60%, 70%, 80%, 90% or 95%
full-length sequences). The cDNA library can be constructed from a
variety of tissues from a monocot or dicot at a variety of
developmental stages. Exemplary species include maize, wheat, rice,
canola, soybean, cotton, sorghum, sunflower, alfalfa, oats, sugar
cane, millet, barley and rice. Methods of selectively hybridizing,
under selective hybridization conditions, a polynucleotide from a
full-length enriched library to a polynucleotide of the present
invention are known to those of ordinary skill in the art. Any
number of stringency conditions can be employed to allow for
selective hybridization. In optional embodiments, the stringency
allows for selective hybridization of sequences having at least
70%, 75%, 80%, 85%, 90%, 95% or 98% sequence identity over the
length of the hybridized region. Full-length enriched cDNA
libraries can be normalized to increase the representation of rare
sequences.
I. Polynucleotide Products Made by a cDNA Isolation Process
[0100] As indicated in (I), above, the present invention provides
an isolated polynucleotide made by the process of: 1) providing a
full-length enriched nucleic acid library, 2) selectively
hybridizing the polynucleotide to a polynucleotide of paragraphs
(A), (B), (C), (D), (E), (F), (G) or (H) as discussed above, and
thereby isolating the polynucleotide from the nucleic acid library.
Full-length enriched nucleic acid libraries are constructed as
discussed in paragraph (G) and below. Selective hybridization
conditions are as discussed in paragraph (G). Nucleic acid
purification procedures are well known in the art. Purification can
be conveniently accomplished using solid-phase methods; such
methods are well known to those of skill in the art and kits are
available from commercial suppliers such as Advanced
Biotechnologies (Surrey, UK). For example, a polynucleotide of
paragraphs (A)-(H) can be immobilized to a solid support such as a
membrane, bead, or particle. See, e.g., U.S. Pat. No. 5,667,976.
The polynucleotide product of the present process is selectively
hybridized to an immobilized polynucleotide and the solid support
is subsequently isolated from non-hybridized polynucleotides by
methods including, but not limited to, centrifugation, magnetic
separation, filtration, electrophoresis and the like.
Construction of Nucleic Acids
[0101] The isolated nucleic acids of the present invention can be
made using (a) standard recombinant methods, (b) synthetic
techniques or combinations thereof. In some embodiments, the
polynucleotides of the present invention will be cloned, amplified
or otherwise constructed from a monocot such as maize, rice or
wheat or a dicot such as soybean.
[0102] The nucleic acids may conveniently comprise sequences in
addition to a polynucleotide of the present invention. For example,
a multi-cloning site comprising one or more endonuclease
restriction sites may be inserted into the nucleic acid to aid in
isolation of the polynucleotide. Also, translatable sequences may
be inserted to aid in the isolation of the translated
polynucleotide of the present invention. For example, a
hexa-histidine marker sequence provides a convenient means to
purify the proteins of the present invention. A polynucleotide of
the present invention can be attached to a vector, adapter or
linker for cloning and/or expression of a polynucleotide of the
present invention. Additional sequences may be added to such
cloning and/or expression sequences to optimize their function in
cloning and/or expression, to aid in isolation of the
polynucleotide, or to improve the introduction of the
polynucleotide into a cell. Typically, the length of a nucleic acid
of the present invention less the length of its polynucleotide of
the present invention is less than 20 kilobase pairs, often less
than 15 kb and frequently less than 10 kb. Use of cloning vectors,
expression vectors, adapters, and linkers is well known and
extensively described in the art. For a description of various
nucleic acids see, for example, Stratagene Cloning Systems,
Catalogs 1999 (La Jolla, Calif.) and Amersham Life Sciences, Inc,
Catalog '99 (Arlington Heights, Ill.).
A. Recombinant Methods for Constructing Nucleic Acids
[0103] The isolated nucleic acid compositions of this invention,
such as RNA, cDNA, genomic DNA or a hybrid thereof, can be obtained
from plant biological sources using any number of cloning
methodologies known to those of skill in the art. In some
embodiments, oligonucleotide probes which selectively hybridize,
under stringent conditions, to the polynucleotides of the present
invention are used to identify the desired sequence in a cDNA or
genomic DNA library. Isolation of RNA, and construction of cDNA and
genomic libraries is well known to those of ordinary skill in the
art. See, e.g., Plant Molecular Biology: A Laboratory Manual,
Clark, Ed., Springer-Verlag, Berlin (1997); and, Current Protocols
in Molecular Biology, Ausubel, et al., Eds., Greene Publishing and
Wiley-Interscience, New York (1995).
A1. Full-Length Enriched cDNA Libraries
[0104] A number of cDNA synthesis protocols have been described
which provide enriched full-length cDNA libraries. Enriched
full-length cDNA libraries are constructed to comprise at least
600%, and more preferably at least 70%, 80%, 90% or 95% full-length
inserts amongst clones containing inserts. The length of insert in
such libraries can be at least 2, 3, 4, 5, 6, 7, 8, 9, 10 or more
kilobase pairs. Vectors to accommodate inserts of these sizes are
known in the art and available commercially. See, e.g.,
Stratagene's lambda ZAP Express (cDNA cloning vector with 0 to 12
kb cloning capacity). An exemplary method of constructing a greater
than 95% pure full-length cDNA library is described by Carninci, et
al., (1996) Genomics, 37:327-336. Other methods for producing
full-length libraries are known in the art. See, e.g., Edery, et
al., (1995) Mol. Cell Biol. 15(6):3363-3371 and PCT Application
Number WO 1996/34981.
A2. Normalized or Subtracted cDNA Libraries
[0105] A non-normalized cDNA library represents the mRNA population
of the tissue it was made from. Since unique clones are
out-numbered by clones derived from highly expressed genes their
isolation can be laborious. Normalization of a cDNA library is the
process of creating a library in which each clone is more equally
represented. Construction of normalized libraries is described in
Ko, (1990) Nucl. Acids. Res. 18(19):5705-5711; Patanjali, et al.,
(1991) Proc. Natl. Acad. U.S.A. 88:1943-1947; U.S. Pat. Nos.
5,482,685, 5,482,845 and 5,637,685. In an exemplary method
described by Soares, et al., normalization resulted in reduction of
the abundance of clones from a range of four orders of magnitude to
a narrow range of only 1 order of magnitude. Proc. Natl. Acad. Sci.
USA, 91:9228-9232 (1994).
[0106] Subtracted cDNA libraries are another means to increase the
proportion of less abundant cDNA species. In this procedure, cDNA
prepared from one pool of mRNA is depleted of sequences present in
a second pool of mRNA by hybridization. The cDNA:mRNA hybrids are
removed and the remaining un-hybridized cDNA pool is enriched for
sequences unique to that pool. See, Foote, et al., in, Plant
Molecular Biology: A Laboratory Manual, Clark, Ed.,
Springer-Verlag, Berlin (1997); Kho and Zarbl, (1991) Technique
3(2):58-63; Sive and St. John, (1988) Nucl. Acids Res.,
16(22):10937; Current Protocols in Molecular Biology, Ausubel, et
al., Eds., Greene Publishing and Wiley-Interscience, New York
(1995) and Swaroop, et al., (1991) Nucl. Acids Res., 19(8):1954.
cDNA subtraction kits are commercially available. See, e.g.,
PCR-Select (Clontech, Palo Alto, Calif.).
[0107] To construct genomic libraries, large segments of genomic
DNA are generated by fragmentation, e.g., using restriction
endonucleases, and are ligated with vector DNA to form concatemers
that can be packaged into the appropriate vector. Methodologies to
accomplish these ends and sequencing methods to verify the sequence
of nucleic acids are well known in the art. Examples of appropriate
molecular biological techniques and instructions sufficient to
direct persons of skill through many construction, cloning and
screening methodologies are found in Sambrook, et al., Molecular
Cloning A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory
Vols. 1-3 (1989), Methods in Enzymology, Vol. 152: Guide to
Molecular Cloning Techniques, Berger and Kimmel, Eds., San Diego:
Academic Press, Inc. (1987), Current Protocols in Molecular
Biology, Ausubel, et al., Eds., Greene Publishing and
Wiley-Interscience, New York (1995); Plant Molecular Biology: A
Laboratory Manual, Clark, Ed., Springer-Verlag, Berlin (1997). Kits
for construction of genomic libraries are also commercially
available.
[0108] The cDNA or genomic library can be screened using a probe
based upon the sequence of a polynucleotide of the present
invention such as those disclosed herein. Probes may be used to
hybridize with genomic DNA or cDNA sequences to isolate homologous
genes in the same or different plant species. Those of skill in the
art will appreciate that various degrees of stringency of
hybridization can be employed in the assay and either the
hybridization or the wash medium can be stringent.
[0109] The nucleic acids of interest can also be amplified from
nucleic acid samples using amplification techniques. For instance,
polymerase chain reaction (PCR) technology can be used to amplify
the sequences of polynucleotides of the present invention and
related genes directly from genomic DNA or cDNA libraries. PCR and
other in vitro amplification methods may also be useful, for
example, to clone nucleic acid sequences that code for proteins to
be expressed, to make nucleic acids to use as probes for detecting
the presence of the desired mRNA in samples, for nucleic acid
sequencing or for other purposes. The T4 gene 32 protein
(Boehringer Mannheim) can be used to improve yield of long PCR
products.
[0110] PCR-based screening methods have been described. Wilfinger,
et al., describe a PCR-based method in which the longest cDNA is
identified in the first step so that incomplete clones can be
eliminated from study. BioTechniques, 22(3):481-486 (1997). Such
methods are particularly effective in combination with a
full-length cDNA construction methodology, above.
B. Synthetic Methods for Constructing Nucleic Acids
[0111] The isolated nucleic acids of the present invention can also
be prepared by direct chemical synthesis by methods such as the
phosphotriester method of Narang, et al., (1979) Meth. Enzymol. 68:
90-99; the phosphodiester method of Brown, et al., (1979) Meth.
Enzymol. 68:109-151; the diethylphosphoramidite method of Beaucage,
et al., (1981) Tetra. Lett. 22:1859-1862; the solid phase
phosphoramidite triester method described by Beaucage and
Caruthers, (1981) Tetra. Letts. 22(20):1859-1862, e.g., using an
automated synthesizer, e.g., as described in Needham-VanDevanter,
et al., (1984) Nucleic Acids Res., 12:6159-6168 and the solid
support method of U.S. Pat. No. 4,458,066. Chemical synthesis
generally produces a single stranded oligonucleotide. This may be
converted into double stranded DNA by hybridization with a
complementary sequence or by polymerization with a DNA polymerase
using the single strand as a template. One of skill will recognize
that while chemical synthesis of DNA is best employed for sequences
of about 100 bases or less, longer sequences may be obtained by the
ligation of shorter sequences.
Recombinant Expression Cassettes
[0112] The present invention further provides recombinant
expression cassettes comprising a nucleic acid of the present
invention. A nucleic acid sequence coding for the desired
polypeptide of the present invention, for example a cDNA or a
genomic sequence encoding a full length polypeptide of the present
invention, can be used to construct a recombinant expression
cassette which can be introduced into the desired host cell. A
recombinant expression cassette will typically comprise a
polynucleotide of the present invention operably linked to
transcriptional initiation regulatory sequences which will direct
the transcription of the polynucleotide in the intended host cell,
such as tissues of a transformed plant.
[0113] For example, plant expression vectors may include (1) a
cloned plant gene under the transcriptional control of 5' and 3'
regulatory sequences and (2) a dominant selectable marker. Such
plant expression vectors may also contain, if desired, a promoter
regulatory region (e.g., one conferring inducible or constitutive,
environmentally- or developmentally-regulated, or cell- or
tissue-specific/selective expression), a transcription initiation
start site, a ribosome binding site, an RNA processing signal, a
transcription termination site and/or a polyadenylation signal.
[0114] A plant promoter fragment can be employed which will direct
expression of a polynucleotide of the present invention in all
tissues of a regenerated plant. Such promoters are referred to
herein as "constitutive" promoters and are active under most
environmental conditions and states of development or cell
differentiation. Examples of constitutive promoters include the
cauliflower mosaic virus (CaMV) 35S transcription initiation
region, the 1'- or 2'-promoter derived from T-DNA of Agrobacterium
tumefaciens, the ubiquitin 1 promoter, the Smas promoter, the
cinnamyl alcohol dehydrogenase promoter (U.S. Pat. No. 5,683,439),
the Nos promoter, the pEmu promoter, the rubisco promoter and the
GRP1-8 promoter.
[0115] Alternatively, the plant promoter can direct expression of a
polynucleotide of the present invention in a specific tissue or may
be otherwise under more precise environmental or developmental
control. Such promoters are referred to here as "inducible"
promoters. Environmental conditions that may effect transcription
by inducible promoters include pathogen attack, anaerobic
conditions or the presence of light. Examples of inducible
promoters are the Adh1 promoter which is inducible by hypoxia or
cold stress, the Hsp70 promoter which is inducible by heat stress
and the PPDK promoter which is inducible by light.
[0116] Examples of promoters under developmental control include
promoters that initiate transcription only, or preferentially, in
certain tissues, such as leaves, roots, fruit, seeds or flowers.
Exemplary promoters include the anther-specific promoter 5126 (U.S.
Pat. Nos. 5,689,049 and 5,689,051), glb-1 promoter and gamma-zein
promoter. Also see, for example, U.S. Patent Application Ser. Nos.
60/155,859 and 60/163,114. The operation of a promoter may also
vary depending on its location in the genome. Thus, an inducible
promoter may become fully or partially constitutive in certain
locations.
[0117] Both heterologous and non-heterologous (i.e., endogenous)
promoters can be employed to direct expression of the nucleic acids
of the present invention. These promoters can also be used, for
example, in recombinant expression cassettes to drive expression of
antisense nucleic acids to reduce, increase or alter concentration
and/or composition of the proteins of the present invention in a
desired tissue. Thus, in some embodiments, the nucleic acid
construct will comprise a promoter, functional in a plant cell,
operably linked to a polynucleotide of the present invention.
Promoters useful in these embodiments include the endogenous
promoters driving expression of a polypeptide of the present
invention.
[0118] In some embodiments, isolated nucleic acids which serve as
promoter or enhancer elements can be introduced in the appropriate
position (generally upstream) of a non-heterologous form of a
polynucleotide of the present invention so as to up or down
regulate expression of a polynucleotide of the present invention.
For example, endogenous promoters can be altered in vivo by
mutation, deletion and/or substitution (see, Kmiec, U.S. Pat. No.
5,565,350; Zarling, et al., PCT/US93/03868) or isolated promoters
can be introduced into a plant cell in the proper orientation and
distance from a cognate gene of a polynucleotide of the present
invention so as to control the expression of the gene. Gene
expression can be modulated under conditions suitable for plant
growth so as to alter the total concentration and/or alter the
composition of the polypeptides of the present invention in plant
cell. Thus, the present invention provides compositions, and
methods for making, heterologous promoters and/or enhancers
operably linked to a native, endogenous (i.e., non-heterologous)
form of a polynucleotide of the present invention.
[0119] If polypeptide expression is desired, it is generally
desirable to include a polyadenylation region at the 3'-end of a
polynucleotide coding region. The polyadenylation region can be
derived from the natural gene, from a variety of other plant genes
or from T-DNA. The 3' end sequence to be added can be derived from,
for example, the nopaline synthase or octopine synthase genes or
alternatively from another plant gene or less preferably from any
other eukaryotic gene.
[0120] An intron sequence can be added to the 5' untranslated
region or the coding sequence of the partial coding sequence to
increase the amount of the mature message that accumulates in the
cytosol. Inclusion of a spliceable intron in the transcription unit
in both plant and animal expression constructs has been shown to
increase gene expression at both the mRNA and protein levels up to
1000-fold. Buchman and Berg, (1988) Mol. Cell Biol. 8:4395-4405;
Callis, et al., (1987) Genes Dev. 1:1183-1200. Such intron
enhancement of gene expression is typically greatest when placed
near the 5' end of the transcription unit. Use of maize introns
Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the
art. See generally, The Maize Handbook, Chapter 116, Freeling and
Walbot, Eds., Springer, New York (1994). The vector comprising the
sequences from a polynucleotide of the present invention will
typically comprise a marker gene which confers a selectable
phenotype on plant cells. Typical vectors useful for expression of
genes in higher plants are well known in the art and include
vectors derived from the tumor-inducing (Ti) plasmid of
Agrobacterium tumefaciens described by Rogers, et al., (1987) Meth.
in Enzymol. 153:253-277.
[0121] A polynucleotide of the present invention can be expressed
in either sense or anti-sense orientation as desired. It will be
appreciated that control of gene expression in either sense or
anti-sense orientation can have a direct impact on the observable
plant characteristics. Antisense technology can be conveniently
used to inhibit gene expression in plants. To accomplish this, a
nucleic acid segment from the desired gene is cloned and operably
linked to a promoter such that the anti-sense strand of RNA will be
transcribed. The construct is then transformed into plants and the
antisense strand of RNA is produced. In plant cells, it has been
shown that antisense RNA inhibits gene expression by preventing the
accumulation of mRNA which encodes the enzyme of interest, see,
e.g., Sheehy, et al., (1988) Proc. Nat'l. Acad. Sci. (USA)
85:8805-8809 and Hiatt, et al., U.S. Pat. No. 4,801,340.
[0122] Another method of suppression is sense suppression (i.e.,
co-supression). Introduction of nucleic acid configured in the
sense orientation has been shown to be an effective means by which
to block the transcription of target genes. For an example of the
use of this method to modulate expression of endogenous genes see,
Napoli, et al., (1990) The Plant Cell 2:279-289 and U.S. Pat. No.
5,034,323.
[0123] Catalytic RNA molecules or ribozymes can also be used to
inhibit expression of plant genes. It is possible to design
ribozymes that specifically pair with virtually any target RNA and
cleave the phosphodiester backbone at a specific location, thereby
functionally inactivating the target RNA. In carrying out this
cleavage, the ribozyme is not itself altered, and is thus capable
of recycling and cleaving other molecules, making it a true enzyme.
The inclusion of ribozyme sequences within antisense RNAs confers
RNA-cleaving activity upon them, thereby increasing the activity of
the constructs. The design and use of target RNA-specific ribozymes
is described in Haseloff, et al., (1988) Nature 334:585-591.
[0124] A variety of cross-linking agents, alkylating agents and
radical generating species as pendant groups on polynucleotides of
the present invention can be used to bind, label, detect and/or
cleave nucleic acids. For example, Vlassov, et al., (1986) Nucleic
Acids Res 14:4065-4076, describe covalent bonding of a
single-stranded DNA fragment with alkylating derivatives of
nucleotides complementary to target sequences. A report of similar
work by the same group is that by Knorre, et al., (1985) Biochimie
67:785-789. Iverson and Dervan also showed sequence-specific
cleavage of single-stranded DNA mediated by incorporation of a
modified nucleotide which was capable of activating cleavage (J Am
Chem Soc (1987) 109:1241-1243). Meyer, et al., (1989) J Am Chem Soc
111:8517-8519, effect covalent crosslinking to a target nucleotide
using an alkylating agent complementary to the single-stranded
target nucleotide sequence. A photoactivated crosslinking to
single-stranded oligonucleotides mediated by psoralen was disclosed
by Lee, et al., (1988) Biochemistry 27:3197-3203. Use of
crosslinking in triple-helix forming probes was also disclosed by
Home, et al., (1990) J Am Chem Soc 112:2435-2437. Use of
N4,N4-ethanocytosine as an alkylating agent to crosslink to
single-stranded oligonucleotides has also been described by Webb
and Matteucci, (1986) J Am Chem Soc 108:2764-2765; Nucleic Acids
Res (1986) 14:7661-7674; Feteritz, et al., (1991) J. Am. Chem. Soc.
113:4000. Various compounds to bind, detect, label and/or cleave
nucleic acids are known in the art. See, for example, U.S. Pat.
Nos. 5,543,507; 5,672,593; 5,484,908; 5,256,648 and 5,681,941.
Proteins
[0125] The isolated proteins of the present invention comprise a
polypeptide having at least 10 amino acids from a polypeptide of
the present invention (or conservative variants thereof) such as
those encoded by any one of the polynucleotides of the present
invention as discussed more fully above (e.g., Table 1). The
proteins of the present invention or variants thereof can comprise
any number of contiguous amino acid residues from a polypeptide of
the present invention, wherein that number is selected from the
group of integers consisting of from 10 to the number of residues
in a full-length polypeptide of the present invention. Optionally,
this subsequence of contiguous amino acids is at least 15, 20, 25,
30, 35 or 40 amino acids in length, often at least 50, 60, 70, 80
or 90 amino acids in length. Further, the number of such
subsequences can be any integer selected from the group consisting
of from 1 to 20, such as 2, 3, 4 or 5.
[0126] The present invention further provides a protein comprising
a polypeptide having a specified sequence identity/similarity with
a polypeptide of the present invention. The percentage of sequence
identity/similarity is an integer selected from the group
consisting of from 50 to 99. Exemplary sequence identity/similarity
values include 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% and 95%.
Sequence identity can be determined using, for example, the GAP,
CLUSTALW or BLAST algorithms.
[0127] As those of skill will appreciate, the present invention
includes, but is not limited to, catalytically active polypeptides
of the present invention (i.e., enzymes). Catalytically active
polypeptides have a specific activity of at least 20%, 30% or 40%
and preferably at least 50%, 60% or 70% and most preferably at
least 80%, 90% or 95% that of the native (non-synthetic),
endogenous polypeptide. Further, the substrate specificity
(k.sub.cat/K.sub.m) is optionally substantially similar to the
native (non-synthetic), endogenous polypeptide. Typically, the
K.sub.m will be at least 30%, 40%, or 50%, that of the native
(non-synthetic), endogenous polypeptide; and more preferably at
least 60%, 70%, 80% or 90%. Methods of assaying and quantifying
measures of enzymatic activity and substrate specificity
(k.sub.cat/K.sub.m) are well known to those of skill in the
art.
[0128] Generally, the proteins of the present invention will, when
presented as an immunogen, elicit production of an antibody
specifically reactive to a polypeptide of the present invention.
Further, the proteins of the present invention will not bind to
antisera raised against a polypeptide of the present invention
which has been fully immunosorbed with the same polypeptide.
Immunoassays for determining binding are well known to those of
skill in the art. A preferred immunoassay is a competitive
immunoassay. Thus, the proteins of the present invention can be
employed as immunogens for constructing antibodies immunoreactive
to a protein of the present invention for such exemplary utilities
as immunoassays or protein purification techniques.
Expression of Proteins in Host Cells
[0129] Using the nucleic acids of the present invention, one may
express a protein of the present invention in a recombinantly
engineered cell such as bacteria, yeast, insect, mammalian or
preferably plant cells. The cells produce the protein in a
non-natural condition (e.g., in quantity, composition, location
and/or time), because they have been genetically altered through
human intervention to do so.
[0130] It is expected that those of skill in the art are
knowledgeable in the numerous expression systems available for
expression of a nucleic acid encoding a protein of the present
invention. No attempt to describe in detail the various methods
known for the expression of proteins in prokaryotes or eukaryotes
will be made.
[0131] In brief summary, the expression of isolated nucleic acids
encoding a protein of the present invention will typically be
achieved by operably linking, for example, the DNA or cDNA to a
promoter (which is either constitutive or regulatable), followed by
incorporation into an expression vector. The vectors can be
suitable for replication and integration in either prokaryotes or
eukaryotes. Typical expression vectors contain transcription and
translation terminators, initiation sequences and promoters useful
for regulation of the expression of the DNA encoding a protein of
the present invention. To obtain high level expression of a cloned
gene, it is desirable to construct expression vectors which
contain, at the minimum, a strong promoter to direct transcription,
a ribosome binding site for translational initiation and a
transcription/translation terminator. One of skill would recognize
that modifications can be made to a protein of the present
invention without diminishing its biological activity. Some
modifications may be made to facilitate the cloning, expression, or
incorporation of the targeting molecule into a fusion protein. Such
modifications are well known to those of skill in the art and
include, for example, a methionine added at the amino terminus to
provide an initiation site or additional amino acids (e.g., poly
His) placed on either terminus to create conveniently located
purification sequences. Restriction sites or termination codons can
also be introduced.
Synthesis of Proteins
[0132] The proteins of the present invention can be constructed
using non-cellular synthetic methods. Solid phase synthesis of
proteins of less than about 50 amino acids in length may be
accomplished by attaching the C-terminal amino acid of the sequence
to an insoluble support followed by sequential addition of the
remaining amino acids in the sequence. Techniques for solid phase
synthesis are described by Barany and Merrifield, Solid-Phase
Peptide Synthesis, pp. 3-284 in The Peptides: Analysis, Synthesis,
Biology Vol. 2: Special Methods in Peptide Synthesis, Part A.;
Merrifield, et al., (1963) J. Am. Chem. Soc. 85:2149-2156 and
Stewart, et al., Solid Phase Peptide Synthesis, 2nd ed., Pierce
Chem. Co., Rockford, Ill. (1984). Proteins of greater length may be
synthesized by condensation of the amino and carboxy termini of
shorter fragments. Methods of forming peptide bonds by activation
of a carboxy terminal end (e.g., by the use of the coupling reagent
N,N'-dicycylohexylcarbodiimide) are known to those of skill.
Purification of Proteins
[0133] The proteins of the present invention may be purified by
standard techniques well known to those of skill in the art.
Recombinantly produced proteins of the present invention can be
directly expressed or expressed as a fusion protein. The
recombinant protein is purified by a combination of cell lysis
(e.g., sonication, French press) and affinity chromatography. For
fusion products, subsequent digestion of the fusion protein with an
appropriate proteolytic enzyme releases the desired recombinant
protein.
[0134] The proteins of this invention, recombinant or synthetic,
may be purified to substantial purity by standard techniques well
known in the art, including detergent solubilization, selective
precipitation with such substances as ammonium sulfate, column
chromatography, immunopurification methods and others. See, for
instance, Scopes, Protein Purification: Principles and Practice,
Springer-Verlag: New York (1982); Deutscher, Guide to Protein
Purification, Academic Press (1990). For example, antibodies may be
raised to the proteins as described herein. Purification from E.
coli can be achieved following procedures described in U.S. Pat.
No. 4,511,503. The protein may then be isolated from cells
expressing the protein and further purified by standard protein
chemistry techniques as described herein. Detection of the
expressed protein is achieved by methods known in the art and
include, for example, radioimmunoassays, Western blotting
techniques or immunoprecipitation.
Introduction of Nucleic Acids into Host Cells
[0135] The method of introducing a nucleic acid of the present
invention into a host cell is not critical to the instant
invention. Transformation or transfection methods are conveniently
used. Accordingly, a wide variety of methods have been developed to
insert a DNA sequence into the genome of a host cell to obtain the
transcription and/or translation of the sequence to effect
phenotypic changes in the organism. Thus, any method which provides
for effective introduction of a nucleic acid may be employed.
A. Plant Transformation
[0136] A nucleic acid comprising a polynucleotide of the present
invention is optionally introduced into a plant. Generally, the
polynucleotide will first be incorporated into a recombinant
expression cassette or vector. Isolated nucleic acid acids of the
present invention can be introduced into plants according to
techniques known in the art. Techniques for transforming a wide
variety of higher plant species are well known and described in the
technical, scientific, and patent literature. See, for example,
Weising, et al., (1988) Ann. Rev. Genet. 22:421-477. For example,
the DNA construct may be introduced directly into the genomic DNA
of the plant cell using techniques such as electroporation,
polyethylene glycol (PEG) poration, particle bombardment, silicon
fiber delivery or microinjection of plant cell protoplasts or
embryogenic callus. See, e.g., Tomes, et al., Direct DNA Transfer
into Intact Plant Cells Via Microprojectile Bombardment. pp.
197-213 in Plant Cell, Tissue and Organ Culture, Fundamental
Methods. eds. Gamborg and Phillips. Springer-Verlag Berlin
Heidelberg New York, 1995; see, U.S. Pat. No. 5,990,387. The
introduction of DNA constructs using PEG precipitation is described
in Paszkowski, et al., (1984) Embo J. 3:2717-2722. Electroporation
techniques are described in Fromm, et al., (1985) Proc. Natl. Acad.
Sci. (USA) 82:5824. Ballistic transformation techniques are
described in Klein, et al., (1987) Nature 327:70-73.
[0137] Agrobacterium tumefaciens-mediated transformation techniques
are well described in the scientific literature. See, for example,
Horsch, et al., (1984) Science 233:496-498; Fraley, et al., (1983)
Proc. Natl. Acad. Sci. (USA) 80:4803 and Plant Molecular Biology: A
Laboratory Manual, Chapter 8, Clark, Ed., Springer-Verlag, Berlin
(1997). The DNA constructs may be combined with suitable T-DNA
flanking regions and introduced into a conventional Agrobacterium
tumefaciens host vector. The virulence functions of the
Agrobacterium tumefaciens host will direct the insertion of the
construct and adjacent marker into the plant cell DNA when the cell
is infected by the bacteria. See, U.S. Pat. No. 5,591,616. Although
Agrobacterium is useful primarily in dicots, certain monocots can
be transformed by Agrobacterium. For instance, Agrobacterium
transformation of maize is described in U.S. Pat. No.
5,550,318.
[0138] Other methods of transfection or transformation include (1)
Agrobacterium rhizogenes-mediated transformation (see, e.g.,
Lichtenstein and Fuller In: Genetic Engineering, vol. 6, Rigby,
Ed., London, Academic Press, 1987; and Lichtenstein, and Draper,
In: DNA Cloning, Vol. II, Glover, Ed., Oxford, IRI Press, 1985),
PCT Application Number PCT/US87/02512 (WO 1988/02405 published Apr.
7, 1988) describes the use of A. rhizogenes strain A4 and its Ri
plasmid along with A. tumefaciens vectors pARC8 or pARC16 (2)
liposome-mediated DNA uptake (see, e.g., Freeman, et al., (1984)
Plant Cell Physiol. 25:1353), (3) the vortexing method (see, e.g.,
Kindle, (1990) Proc. Natl. Acad. Sci., (USA) 87:1228).
[0139] DNA can also be introduced into plants by direct DNA
transfer into pollen as described by Zhou, et al., (1983) Methods
in Enzymology 101:433; Hess, (1987) Intern Rev. Cytol. 107:367;
Luo, et al., (1988) Plant Mol. Biol. Reporter 6:165. Expression of
polypeptide coding genes can be obtained by injection of the DNA
into reproductive organs of a plant as described by Pena, et al.,
(1987) Nature, 325.274. DNA can also be injected directly into the
cells of immature embryos and the rehydration of desiccated embryos
as described by Neuhaus, et al., (1987) Theor. Appl. Genet., 75:30
and Benbrook, et al., in Proceedings Bio Expo 1986, Butterworth,
Stoneham, Mass., pp. 27-54 (1986). A variety of plant viruses that
can be employed as vectors are known in the art and include
cauliflower mosaic virus (CaMV), geminivirus, brome mosaic virus
and tobacco mosaic virus.
B. Transfection of Prokaryotes, Lower Eukaryotes, and Animal
Cells
[0140] Animal and lower eukaryotic (e.g., yeast) host cells are
competent or rendered competent for transfection by various means.
There are several well-known methods of introducing DNA into animal
cells. These include: calcium phosphate precipitation, fusion of
the recipient cells with bacterial protoplasts containing the DNA,
treatment of the recipient cells with liposomes containing the DNA,
DEAE dextran, electroporation, biolistics and micro-injection of
the DNA directly into the cells. The transfected cells are cultured
by means well known in the art. Kuchler, Biochemical Methods in
Cell Culture and Virology, Dowden, Hutchinson and Ross, Inc.
(1977).
Transgenic Plant Regeneration
[0141] Plant cells which directly result or are derived from the
nucleic acid introduction techniques can be cultured to regenerate
a whole plant which possesses the introduced genotype. Such
regeneration techniques often rely on manipulation of certain
phytohormones in a tissue culture growth medium. Plants cells can
be regenerated, e.g., from single cells, callus tissue or leaf
discs according to standard plant tissue culture techniques. It is
well known in the art that various cells, tissues, and organs from
almost any plant can be successfully cultured to regenerate an
entire plant. Plant regeneration from cultured protoplasts is
described in Evans, et al., Protoplasts Isolation and Culture,
Handbook of Plant Cell Culture, Macmillan Publishing Company, New
York, pp. 124-176 (1983) and Binding, Regeneration of Plants, Plant
Protoplasts, CRC Press, Boca Raton, pp. 21-73 (1985).
[0142] The regeneration of plants from either single plant
protoplasts or various explants is well known in the art. See, for
example, Methods for Plant Molecular Biology, Weissbach and
Weissbach, eds., Academic Press, Inc., San Diego, Calif. (1988).
This regeneration and growth process includes the steps of
selection of transformant cells and shoots, rooting the
transformant shoots and growth of the plantlets in soil. For maize
cell culture and regeneration see generally, The Maize Handbook,
Freeling and Walbot, Eds., Springer, New York (1994); Corn and Corn
Improvement, 3.sup.rd edition, Sprague and Dudley Eds., American
Society of Agronomy, Madison, Wis. (1988). For transformation and
regeneration of maize see, Gordon-Kamm, et al., (1990) The Plant
Cell 2:603-618.
[0143] The regeneration of plants containing the polynucleotide of
the present invention and introduced by Agrobacterium from leaf
explants can be achieved as described by Horsch, et al., (1985)
Science, 227:1229-1231. In this procedure, transformants are grown
in the presence of a selection agent and in a medium that induces
the regeneration of shoots in the plant species being transformed
as described by Fraley, et al., (1983) Proc. Natl. Acad. Sci.
(U.S.A.) 80:4803. This procedure typically produces shoots within
two to four weeks and these transformant shoots are then
transferred to an appropriate root-inducing medium containing the
selective agent and an antibiotic to prevent bacterial growth.
Transgenic plants of the present invention may be fertile or
sterile.
[0144] One of skill will recognize that after the recombinant
expression cassette is stably incorporated in transgenic plants and
confirmed to be operable, it can be introduced into other plants by
sexual crossing. Any of a number of standard breeding techniques
can be used, depending upon the species to be crossed. In
vegetatively propagated crops, mature transgenic plants can be
propagated by the taking of cuttings or by tissue culture
techniques to produce multiple identical plants. Selection of
desirable transgenics is made and new varieties are obtained and
propagated vegetatively for commercial use. In seed propagated
crops, mature transgenic plants can be self-crossed to produce a
homozygous inbred plant. The inbred plant produces seed containing
the newly introduced heterologous nucleic acid. These seeds can be
grown to produce plants that would produce the selected phenotype.
Parts obtained from the regenerated plant, such as flowers, seeds,
leaves, branches, fruit and the like are included in the invention,
provided that these parts comprise cells comprising the isolated
nucleic acid of the present invention. Progeny and variants, and
mutants of the regenerated plants are also included within the
scope of the invention, provided that these parts comprise the
introduced nucleic acid sequences.
[0145] Transgenic plants expressing a polynucleotide of the present
invention can be screened for transmission of the nucleic acid of
the present invention by, for example, standard immunoblot and DNA
detection techniques. Expression at the RNA level can be determined
initially to identify and quantitate expression-positive plants.
Standard techniques for RNA analysis can be employed and include
PCR amplification assays using oligonucleotide primers designed to
amplify only the heterologous RNA templates and solution
hybridization assays using heterologous nucleic acid-specific
probes. The RNA-positive plants can then analyzed for protein
expression by Western immunoblot analysis using the specifically
reactive antibodies of the present invention. In addition, in situ
hybridization and immunocytochemistry according to standard
protocols can be done using heterologous nucleic acid specific
polynucleotide probes and antibodies, respectively, to localize
sites of expression within transgenic tissue. Generally, a number
of transgenic lines are usually screened for the incorporated
nucleic acid to identify and select plants with the most
appropriate expression profiles.
[0146] A preferred embodiment is a transgenic plant that is
homozygous for the added heterologous nucleic acid; i.e., a
transgenic plant that contains two added nucleic acid sequences,
one gene at the same locus on each chromosome of a chromosome pair.
A homozygous transgenic plant can be obtained by sexually mating
(selfing) a heterozygous transgenic plant that contains a single
added heterologous nucleic acid, germinating some of the seed
produced and analyzing the resulting plants produced for altered
expression of a polynucleotide of the present invention relative to
a control plant (i.e., native, non-transgenic). Back-crossing to a
parental plant and out-crossing with a non-transgenic plant are
also contemplated.
Modulating Polypeptide Levels and/or Composition
[0147] The present invention further provides a method for
modulating (i.e., increasing or decreasing) the concentration or
ratio of the polypeptides of the present invention in a plant or
part thereof. Modulation can be effected by increasing or
decreasing the concentration and/or the ratio of the polypeptides
of the present invention in a plant. The method comprises
introducing into a plant cell a recombinant expression cassette
comprising a polynucleotide of the present invention as described
above to obtain a transgenic plant cell, culturing the transgenic
plant cell under transgenic plant cell growing conditions and
inducing or repressing expression of a polynucleotide of the
present invention in the transgenic plant for a time sufficient to
modulate concentration and/or the ratios of the polypeptides in the
transgenic plant or plant part.
[0148] In some embodiments, the concentration and/or ratios of
polypeptides of the present invention in a plant may be modulated
by altering, in vivo or in vitro, the promoter of a gene to up- or
down-regulate gene expression. In some embodiments, the coding
regions of native genes of the present invention can be altered via
substitution, addition, insertion or deletion to decrease activity
of the encoded enzyme. (See, e.g., Kmiec, U.S. Pat. No. 5,565,350;
Zarling, et al., PCT/US93/03868.) And in some embodiments, an
isolated nucleic acid (e.g., a vector) comprising a promoter
sequence is transfected into a plant cell. Subsequently, a plant
cell comprising the promoter operably linked to a polynucleotide of
the present invention is selected for by means known to those of
skill in the art such as, but not limited to, Southern blot, DNA
sequencing or PCR analysis using primers specific to the promoter
and to the gene and detecting amplicons produced therefrom. A plant
or plant part altered or modified by the foregoing embodiments is
grown under plant forming conditions for a time sufficient to
modulate the concentration and/or ratios of polypeptides of the
present invention in the plant. Plant forming conditions are well
known in the art and discussed briefly, supra.
[0149] In general, concentration or the ratios of the polypeptides
is increased or decreased by at least 5%, 10%, 20%, 30%, 40%, 50%,
60%, 70%, 80% or 90% relative to a native control plant, plant part
or cell lacking the aforementioned recombinant expression cassette.
Modulation in the present invention may occur during and/or
subsequent to growth of the plant to the desired stage of
development. Modulating nucleic acid expression temporally and/or
in particular tissues can be controlled by employing the
appropriate promoter operably linked to a polynucleotide of the
present invention in, for example, sense or antisense orientation
as discussed in greater detail, supra. Induction of expression of a
polynucleotide of the present invention can also be controlled by
exogenous administration of an effective amount of inducing
compound. Inducible promoters and inducing compounds which activate
expression from these promoters are well known in the art. In
preferred embodiments, the polypeptides of the present invention
are modulated in monocots, particularly maize.
UTRs and Codon Preference
[0150] In general, translational efficiency has been found to be
regulated by specific sequence elements in the 5' non-coding or
untranslated region (5' UTR) of the RNA. Positive sequence motifs
include translational initiation consensus sequences (Kozak, (1987)
Nucleic Acids Res. 15:8125) and the 7-methylguanosine cap structure
(Drummond, et al., (1985) Nucleic Acids Res. 13:7375). Negative
elements include stable intramolecular 5' UTR stem-loop structures
(Muesing, et al., (1987) Cell 48:691) and AUG sequences or short
open reading frames preceded by an appropriate AUG in the 5' UTR
(Kozak, supra, Rao, et al., (1988) Mol. and Cell. Biol. 8:284).
Accordingly, the present invention provides 5' and/or 3'
untranslated regions for modulation of translation of heterologous
coding sequences.
[0151] Further, the polypeptide-encoding segments of the
polynucleotides of the present invention can be modified to alter
codon usage. Altered codon usage can be employed to alter
translational efficiency and/or to optimize the coding sequence for
expression in a desired host such as to optimize the codon usage in
a heterologous sequence for expression in maize. Codon usage in the
coding regions of the polynucleotides of the present invention can
be analyzed statistically using commercially available software
packages such as "Codon Preference" available from the University
of Wisconsin Genetics Computer Group (see, Devereaux, et al.,
(1984) Nucleic Acids Res. 12:387-395) or MacVector 4.1 (Eastman
Kodak Co., New Haven, Conn.). Thus, the present invention provides
a codon usage frequency characteristic of the coding region of at
least one of the polynucleotides of the present invention. The
number of polynucleotides that can be used to determine a codon
usage frequency can be any integer from 1 to the number of
polynucleotides of the present invention as provided herein.
Optionally, the polynucleotides will be full-length sequences. An
exemplary number of sequences for statistical analysis can be at
least 1, 5, 10, 20, 50 or 100.
Sequence Shuffling
[0152] The present invention provides methods for sequence
shuffling using polynucleotides of the present invention, and
compositions resulting therefrom. Sequence shuffling is described
in PCT Publication Number WO 1997/20078. See also, Zhang, et al.,
(1997) Proc. Natl. Acad. Sci. USA 94:4504-4509. Generally, sequence
shuffling provides a means for generating libraries of
polynucleotides having a desired characteristic which can be
selected or screened for. Libraries of recombinant polynucleotides
are generated from a population of related sequence polynucleotides
which comprise sequence regions which have substantial sequence
identity and can be homologously recombined in vitro or in vivo.
The population of sequence-recombined polynucleotides comprises a
subpopulation of polynucleotides which possess desired or
advantageous characteristics and which can be selected by a
suitable selection or screening method. The characteristics can be
any property or attribute capable of being selected for or detected
in a screening system and may include properties of: an encoded
protein, a transcriptional element, a sequence controlling
transcription, RNA processing, RNA stability, chromatin
conformation, translation or other expression property of a gene or
transgene, a replicative element, a protein-binding element or the
like, such as any feature which confers a selectable or detectable
property. In some embodiments, the selected characteristic will be
a decreased K.sub.m and/or increased K.sub.cat over the wild-type
protein as provided herein. In other embodiments, a protein or
polynucleotide generated from sequence shuffling will have a ligand
binding affinity greater than the non-shuffled wild-type
polynucleotide. The increase in such properties can be at least
110%, 120%, 130%, 140% or at least 150% of the wild-type value.
Generic and Consensus Sequences
[0153] Polynucleotides and polypeptides of the present invention
further include those having: (a) a generic sequence of at least
two homologous polynucleotides or polypeptides, respectively, of
the present invention and (b) a consensus sequence of at least
three homologous polynucleotides or polypeptides, respectively, of
the present invention. The generic sequence of the present
invention comprises each species of polypeptide or polynucleotide
embraced by the generic polypeptide or polynucleotide sequence,
respectively. The individual species encompassed by a
polynucleotide having an amino acid or nucleic acid consensus
sequence can be used to generate antibodies or produce nucleic acid
probes or primers to screen for homologs in other species, genera,
families, orders, classes, phyla or kingdoms. For example, a
polynucleotide having a consensus sequence from a gene family of
Zea mays can be used to generate antibody or nucleic acid probes or
primers to other Gramineae species such as wheat, rice or sorghum.
Alternatively, a polynucleotide having a consensus sequence
generated from orthologous genes can be used to identify or isolate
orthologs of other taxa. Typically, a polynucleotide having a
consensus sequence will be at least 9, 10, 15, 20, 25, 30 or 40
amino acids in length, or 20, 30, 40, 50, 100 or 150 nucleotides in
length. As those of skill in the art are aware, a conservative
amino acid substitution can be used for amino acids which differ
amongst aligned sequence but are from the same conservative
substitution group as discussed above. Optionally, no more than 1
or 2 conservative amino acids are substituted for each 10 amino
acid length of consensus sequence.
[0154] Similar sequences used for generation of a consensus or
generic sequence include any number and combination of allelic
variants of the same gene, orthologous or paralogous sequences as
provided herein. Optionally, similar sequences used in generating a
consensus or generic sequence are identified using the BLAST
algorithm's smallest sum probability (P(N)). Various suppliers of
sequence-analysis software are listed in chapter 7 of Current
Protocols in Molecular Biology, Ausubel et al., Eds., Current
Protocols, a joint venture between Greene Publishing Associates,
Inc. and John Wiley & Sons, Inc. (Supplement 30). A
polynucleotide sequence is considered similar to a reference
sequence if the smallest sum probability in a comparison of the
test nucleic acid to the reference nucleic acid is less than about
0.1, more preferably less than about 0.01, or 0.001 and most
preferably less than about 0.0001 or 0.00001. Similar
polynucleotides can be aligned and a consensus or generic sequence
generated using multiple sequence alignment software available from
a number of commercial suppliers such as the Genetics Computer
Group's (Madison, Wis.) PILEUP software, Vector NTI's (North
Bethesda, Md.) ALIGNX, or Genecode's (Ann Arbor, Mich.) SEQUENCHER.
Conveniently, default parameters of such software can be used to
generate consensus or generic sequences.
Machine Applications
[0155] The present invention provides machines, data structures,
and processes for modeling or analyzing the polynucleotides and
polypeptides of the present invention.
A. Machines: Data, Data Structures, Processes and Functions
[0156] The present invention provides a machine having a memory
comprising: 1) data representing a sequence of a polynucleotide or
polypeptide of the present invention, 2) a data structure which
reflects the underlying organization and structure of the data and
facilitates program access to data elements corresponding to
logical sub-components of the sequence, 3) processes for effecting
the use, analysis, or modeling of the sequence, and 4) optionally,
a function or utility for the polynucleotide or polypeptide. Thus,
the present invention provides a memory for storing data that can
be accessed by a computer programmed to implement a process for
affecting the use, analyses or modeling of a sequence of a
polynucleotide, with the memory comprising data representing the
sequence of a polynucleotide of the present invention.
[0157] The machine of the present invention is typically a digital
computer. The term "computer" includes one or several desktop or
portable computers, computer workstations, servers (including
intranet or internet servers), mainframes and any integrated system
comprising any of the above irrespective of whether the processing,
memory, input or output of the computer is remote or local, as well
as any networking interconnecting the modules of the computer. The
term "computer" is exclusive of computers of the United States
Patent and Trademark Office or the European Patent Office when data
representing the sequence of polypeptides or polynucleotides of the
present invention is used for patentability searches.
[0158] The present invention contemplates providing as data a
sequence of a polynucleotide of the present invention embodied in a
computer readable medium. As those of skill in the art will be
aware, the form of memory of a machine of the present invention or
the particular embodiment of the computer readable medium, are not
critical elements of the invention and can take a variety of forms.
The memory of such a machine includes, but is not limited to, ROM
or RAM or computer readable media such as, but not limited to,
magnetic media such as computer disks or hard drives or media such
as CD-ROMs, DVDs and the like.
[0159] The present invention further contemplates providing a data
structure that is also contained in memory. The data structure may
be defined by the computer programs that define the processes (see
below) or it may be defined by the programming of separate data
storage and retrieval programs subroutines or systems. Thus, the
present invention provides a memory for storing a data structure
that can be accessed by a computer programmed to implement a
process for affecting the use, analysis or modeling of a sequence
of a polynucleotide. The memory comprises data representing a
polynucleotide having the sequence of a polynucleotide of the
present invention. The data is stored within memory. Further, a
data structure, stored within memory, is associated with the data
reflecting the underlying organization and structure of the data to
facilitate program access to data elements corresponding to logical
sub-components of the sequence. The data structure enables the
polynucleotide to be identified and manipulated by such
programs.
[0160] In a further embodiment, the present invention provides a
data structure that contains data representing a sequence of a
polynucleotide of the present invention stored within a computer
readable medium. The data structure is organized to reflect the
logical structuring of the sequence, so that the sequence is easily
analyzed by software programs capable of accessing the data
structure. In particular, the data structures of the present
invention organize the reference sequences of the present invention
in a manner which allows software tools to perform a wide variety
of analyses using logical elements and sub-elements of each
sequence.
[0161] An example of such a data structure resembles a layered hash
table, where in one dimension the base content of the sequence is
represented by a string of elements A, T, C, G and N. The direction
from the 5' end to the 3' end is reflected by the order from the
position 0 to the position of the length of the string minus one.
Such a string, corresponding to a nucleotide sequence of interest,
has a certain number of substrings, each of which is delimited by
the string position of its 5' end and the string position of its 3'
end within the parent string. In a second dimension, each substring
is associated with or pointed to one or multiple attribute fields.
Such attribute fields contain annotations to the region on the
nucleotide sequence represented by the substring.
[0162] For example, a sequence under investigation is 520 bases
long and represented by a string named SeqTarget. There is a minor
groove in the 5' upstream non-coding region from position 12 to 38,
which is identified as a binding site for an enhancer protein HM-A,
which in turn will increase the transcription of the gene
represented by SeqTarget. Here, the substring is represented as
(12, 38) and has the following attributes: [upstream uncoded],
[minor groove], [HM-A binding] and [increase transcription upon
binding by HM-A]. Similarly, other types of information can be
stored and structured in this manner, such as information related
to the whole sequence, e.g., whether the sequence is a full length
viral gene, a mammalian house keeping gene or an EST from clone X,
information related to the 3' down stream non-coding region, e.g.,
hair pin structure and information related to various domains of
the coding region, e.g., Zinc finger.
[0163] This data structure is an open structure and is robust
enough to accommodate newly generated data and acquired knowledge.
Such a structure is also a flexible structure. It can be trimmed
down to a 1-D string to facilitate data mining and analysis steps,
such as clustering, repeat-masking, and HMM analysis. Meanwhile,
such a data structure also can extend the associated attributes
into multiple dimensions. Pointers can be established among the
dimensioned attributes when needed to facilitate data management
and processing in a comprehensive genomics knowledgebase.
Furthermore, such a data structure is object-oriented. Polymorphism
can be represented by a family or class of sequence objects, each
of which has an internal structure as discussed above. The common
traits are abstracted and assigned to the parent object, whereas
each child object represents a specific variant of the family or
class. Such a data structure allows data to be efficiently
retrieved, updated and integrated by the software applications
associated with the sequence database and/or knowledgebase.
[0164] The present invention contemplates providing processes for
effecting analysis and modeling, which are described in the
following section.
[0165] Optionally, the present invention further contemplates that
the machine of the present invention will embody in some manner a
utility or function for the polynucleotide or polypeptide of the
present invention. The function or utility of the polynucleotide or
polypeptide can be a function or utility for the sequence data, per
se, or of the tangible material. Exemplary function or utilities
include the name (per International Union of Biochemistry and
Molecular Biology rules of nomenclature) or function of the enzyme
or protein represented by the polynucleotide or polypeptide of the
present invention; the metabolic pathway of the protein represented
by the polynucleotide or polypeptide of the present invention; the
substrate or product or structural role of the protein represented
by the polynucleotide or polypeptide of the present invention or
the phenotype (e.g., an agronomic or pharmacological trait)
affected by modulating expression or activity of the protein
represented by the polynucleotide or polypeptide of the present
invention.
B. Computer Analysis and Modeling
[0166] The present invention provides a process of modeling and
analyzing data representative of a polynucleotide or polypeptide
sequence of the present invention. The process comprises entering
sequence data of a polynucleotide or polypeptide of the present
invention into a machine having a hardware or software sequence
modeling and analysis system, developing data structures to
facilitate access to the sequence data, manipulating the data to
model or analyze the structure or activity of the polynucleotide or
polypeptide and displaying the results of the modeling or analysis.
Thus, the present invention provides a process for affecting the
use, analysis or modeling of a polynucleotide sequence or its
derived peptide sequence through use of a computer having a memory.
The process comprises: 1) placing into the memory data representing
a polynucleotide having the sequence of a polynucleotide of the
present invention, developing within the memory a data structure
associated with the data and reflecting the underlying organization
and structure of the data to facilitate program access to data
elements corresponding to logical sub-components of the sequence,
2) programming the computer with a program containing instructions
sufficient to implement the process for effecting the use, analysis
or modeling of the polynucleotide sequence or the peptide sequence
and 3) executing the program on the computer while granting the
program access to the data and to the data structure within the
memory.
[0167] A variety of modeling and analytic tools are well known in
the art and available commercially. Included amongst the
modeling/analysis tools are methods to: 1) recognize overlapping
sequences (e.g., from a sequencing project) with a polynucleotide
of the present invention and create an alignment called a "contig";
2) identify restriction enzyme sites of a polynucleotide of the
present invention; 3) identify the products of a T1 ribonuclease
digestion of a polynucleotide of the present invention; 4) identify
PCR primers with minimal self-complementarity; 5) compute pairwise
distances between sequences in an alignment, reconstruct
phylogentic trees using distance methods and calculate the degree
of divergence of two protein coding regions; 6) identify patterns
such as coding regions, terminators, repeats and other consensus
patterns in polynucleotides of the present invention; 7) identify
RNA secondary structure; 8) identify sequence motifs, isoelectric
point, secondary structure, hydrophobicity and antigenicity in
polypeptides of the present invention; 9) translate polynucleotides
of the present invention and backtranslate polypeptides of the
present invention and 10) compare two protein or nucleic acid
sequences and identifying points of similarity or dissimilarity
between them.
[0168] The processes for effecting analysis and modeling can be
produced independently or obtained from commercial suppliers.
Exemplary analysis and modeling tools are provided in products such
as InforMax's (Bethesda, Md.) Vector NTI Suite (Version 5.5),
Intelligenetics' (Mountain View, Calif.) PC/Gene program and
Genetics Computer Group's (Madison, Wis.) Wisconsin Package.RTM.
(Version 10.0); these tools, and the functions they perform, (as
provided and disclosed by the programs and accompanying literature)
are incorporated herein by reference and are described in more
detail in section C which follows.
[0169] Thus, in a further embodiment, the present invention
provides a machine-readable media containing a computer program and
data, comprising a program stored on the media containing
instructions sufficient to implement a process for affecting the
use, analysis or modeling of a representation of a polynucleotide
or peptide sequence. The data stored on the media represents a
sequence of a polynucleotide having the sequence of a
polynucleotide of the present invention. The media also includes a
data structure reflecting the underlying organization and structure
of the data to facilitate program access to data elements
corresponding to logical sub-components of the sequence, the data
structure being inherent in the program and in the way in which the
program organizes and accesses the data.
C. Homology Searches
[0170] As an example of such a comparative analysis, the present
invention provides a process of identifying a candidate homologue
(i.e., an ortholog or paralog) of a polynucleotide or polypeptide
of the present invention. The process comprises entering sequence
data of a polynucleotide or polypeptide of the present invention
into a machine having a hardware or software sequence analysis
system, developing data structures to facilitate access to the
sequence data, manipulating the data to analyze the structure the
polynucleotide or polypeptide and displaying the results of the
analysis. A candidate homologue has statistically significant
probability of having the same biological function (e.g., catalyzes
the same reaction, binds to homologous proteins/nucleic acids, has
a similar structural role) as the reference sequence to which it is
compared. Accordingly, the polynucleotides and polypeptides of the
present invention have utility in identifying homologs in animals
or other plant species, particularly those in the family Gramineae
such as, but not limited to, sorghum, wheat or rice.
[0171] The process of the present invention comprises obtaining
data representing a polynucleotide or polypeptide test sequence.
Test sequences can be obtained from a nucleic acid of an animal or
plant. Test sequences can be obtained directly or indirectly from
sequence databases including, but not limited to, those such as:
GenBank, EMBL, GenSeq, SWISS-PROT or those available on-line via
the UK Human Genome Mapping Project (HGMP) GenomeWeb. In some
embodiments the test sequence is obtained from a plant species
other than maize whose function is uncertain but will be compared
to the test sequence to determine sequence similarity or sequence
identity. The test sequence data is entered into a machine, such as
a computer, containing: i) data representing a reference sequence
and ii) a hardware or software sequence comparison system to
compare the reference and test sequence for sequence similarity or
identity.
[0172] Exemplary sequence comparison systems are provided for in
sequence analysis software such as those provided by the Genetics
Computer Group (Madison, Wis.) or InforMax (Bethesda, Md.) or
Intelligenetics (Mountain View, Calif.). Optionally, sequence
comparison is established using the BLAST or GAP suite of programs.
Generally, a smallest sum probability value (P(N)) of less than
0.1, or alternatively, less than 0.01, 0.001, 0.0001 or 0.00001
using the BLAST 2.0 suite of algorithms under default parameters
identifies the test sequence as a candidate homologue (i.e., an
allele, ortholog or paralog) of the reference sequence. Those of
skill in the art will recognize that a candidate homologue has an
increased statistical probability of having the same or similar
function as the gene/protein represented by the test sequence.
[0173] The reference sequence can be the sequence of a polypeptide
or a polynucleotide of the present invention. The reference or test
sequence is each optionally at least 25 amino acids or at least 100
nucleotides in length. The length of the reference or test
sequences can be the length of the polynucleotide or polypeptide
described, respectively, above in the sections entitled "Nucleic
Acids" (particularly section (g)) and "Proteins". As those of skill
in the art are aware, the greater the sequence identity/similarity
between a reference sequence of known function and a test sequence,
the greater the probability that the test sequence will have the
same or similar function as the reference sequence. The results of
the comparison between the test and reference sequences are
outputted (e.g., displayed, printed, recorded) via any one of a
number of output devices and/or media (e.g., computer monitor, hard
copy or computer readable medium).
Detection of Nucleic Acids
[0174] The present invention further provides methods for detecting
a polynucleotide of the present invention in a nucleic acid sample
suspected of containing a polynucleotide of the present invention,
such as a plant cell lysate, particularly a lysate of maize. In
some embodiments, a cognate gene of a polynucleotide of the present
invention or portion thereof can be amplified prior to the step of
contacting the nucleic acid sample with a polynucleotide of the
present invention. The nucleic acid sample is contacted with the
polynucleotide to form a hybridization complex. The polynucleotide
hybridizes under stringent conditions to a gene encoding a
polypeptide of the present invention. Formation of the
hybridization complex is used to detect a gene encoding a
polypeptide of the present invention in the nucleic acid sample.
Those of skill will appreciate that an isolated nucleic acid
comprising a polynucleotide of the present invention should lack
cross-hybridizing sequences in common with non-target genes that
would yield a false positive result. Detection of the hybridization
complex can be achieved using any number of well known methods. For
example, the nucleic acid sample, or a portion thereof, may be
assayed by hybridization formats including but not limited to,
solution phase, solid phase, mixed phase or in situ hybridization
assays.
[0175] Detectable labels suitable for use in the present invention
include any composition detectable by spectroscopic, radioisotopic,
photochemical, biochemical, immunochemical, electrical, optical or
chemical means. Useful labels in the present invention include
biotin for staining with labeled streptavidin conjugate, magnetic
beads, fluorescent dyes, radiolabels, enzymes and colorimetric
labels. Other labels include ligands which bind to antibodies
labeled with fluorophores, chemiluminescent agents and enzymes.
Labeling the nucleic acids of the present invention is readily
achieved such as by the use of labeled PCR primers.
[0176] Although the present invention has been described in some
detail by way of illustration and example for purposes of clarity
of understanding, it will be obvious that certain changes and
modifications may be practiced within the scope of the appended
claims.
Example 1
[0177] This example describes the construction of a cDNA
library.
[0178] Total RNA can be isolated from maize tissues with TRIzol
Reagent (Life Technology Inc. Gaithersburg, Md.) using a
modification of the guanidine isothiocyanate/acid-phenol procedure
described by Chomczynski and Sacchi (Chomczynski and Sacchi, (1987)
Anal. Biochem. 162:156). In brief, plant tissue samples is
pulverized in liquid nitrogen before the addition of the TRIzol
Reagent and then further homogenized with a mortar and pestle.
Addition of chloroform followed by centrifugation is conducted for
separation of an aqueous phase and an organic phase. The total RNA
is recovered by precipitation with isopropyl alcohol from the
aqueous phase.
[0179] The selection of poly(A)+ RNA from total RNA can be
performed using PolyATact system (Promega Corporation. Madison,
Wis.). Biotinylated oligo(dT) primers are used to hybridize to the
3' poly(A) tails on mRNA. The hybrids are captured using
streptavidin coupled to paramagnetic particles and a magnetic
separation stand. The mRNA is then washed at high stringency
conditions and eluted by RNase-free deionized water. cDNA synthesis
and construction of unidirectional cDNA libraries can be
accomplished using the SuperScript Plasmid System (Life Technology
Inc. Gaithersburg, Md.). The first strand of cDNA is synthesized by
priming an oligo(dT) primer containing a Not I site. The reaction
is catalyzed by SuperScript Reverse Transcriptase II at 45.degree.
C. The second strand of cDNA is labeled with alpha-.sup.32P-dCTP
and a portion of the reaction analyzed by agarose gel
electrophoresis to determine cDNA sizes. cDNA molecules smaller
than 500 base pairs and unligated adapters are removed by
Sephacryl-S400 chromatography. The selected cDNA molecules are
ligated into pSPORT1 vector in between of Not I and Sal I
sites.
[0180] Alternatively, cDNA libraries can be prepared by any one of
many methods available. For example, the cDNAs may be introduced
into plasmid vectors by first preparing the cDNA libraries in
Uni-ZAP.TM. XR vectors according to the manufacturer's protocol
(Stratagene Cloning Systems, La Jolla, Calif.). The Uni-ZAP.TM. XR
libraries are converted into plasmid libraries according to the
protocol provided by Stratagene. Upon conversion, cDNA inserts will
be contained in the plasmid vector pBluescript. In addition, the
cDNAs may be introduced directly into precut Bluescript II SK(+)
vectors (Stratagene) using T4 DNA ligase (New England Biolabs),
followed by transfection into DH10B cells according to the
manufacturer's protocol (GIBCO BRL Products). Once the cDNA inserts
are in plasmid vectors, plasmid DNAs are prepared from randomly
picked bacterial colonies containing recombinant pBluescript
plasmids or the insert cDNA sequences are amplified via polymerase
chain reaction using primers specific for vector sequences flanking
the inserted cDNA sequences. Amplified insert DNAs or plasmid DNAs
are sequenced in dye-primer sequencing reactions to generate
partial cDNA sequences (expressed sequence tags or "ESTs"; see,
Adams, et al., (1991) Science 252:1651-1656). The resulting ESTs
are analyzed using a Perkin Elmer Model 377 fluorescent
sequencer.
Example 2
[0181] This method describes construction of a full-length enriched
cDNA library.
[0182] An enriched full-length cDNA library can be constructed
using one of two variations of the method of Carninci, et al.,
(1996) Genomics 37:327-336. These variations are based on chemical
introduction of a biotin group into the diol residue of the 5' cap
structure of eukaryotic mRNA to select full-length first strand
cDNA. The selection occurs by trapping the biotin residue at the
cap sites using streptavidin-coated magnetic beads followed by
RNase I treatment to eliminate incompletely synthesized cDNAs.
Second strand cDNA is synthesized using established procedures such
as those provided in Life Technologies' (Rockville, Md.)
"SuperScript Plasmid System for cDNA Synthesis and Plasmid Cloning"
kit. Libraries made by this method have been shown to contain 50%
to 70% full-length cDNAs.
[0183] The first strand synthesis methods are detailed below. An
asterisk denotes that the reagent was obtained from Life
Technologies, Inc.
A. First Strand cDNA Synthesis Method 1 (with Trehalose)
TABLE-US-00003 mRNA (10 ug) 25 .mu.l *Not I primer (5 ug) 10 .mu.l
*5x 1.sup.st strand buffer 43 .mu.l *0.1 m DTT 20 .mu.l *dNTP mix
10 mm 10 .mu.l BSA 10 ug/.mu.l 1 .mu.l Trehalose (saturated) 59.2
.mu.l RNase inhibitor (Promega) 1.8 .mu.l *Superscript II RT 200
u/.mu.l 20 .mu.l 100% glycerol 18 .mu.l Water 7 .mu.l
[0184] The mRNA and Not I primer are mixed and denatured at
65.degree. C. for 10 min. They are then chilled on ice and other
components added to the tube. Incubation is at 45.degree. C. for 2
min. Twenty microliters of RT (reverse transcriptase) is added to
the reaction and start program on the thermocycler (MJ Research,
Waltham, Mass.):
TABLE-US-00004 Step 1 45.degree. C. 10 min Step 2 45.degree. C.
-0.3.degree. C./cycle, 2 seconds/cycle Step 3 go to 2 for 33 cycles
Step 4 35.degree. C. 5 min Step 5 45.degree. C. 5 min Step 6
45.degree. C. 0.2.degree. C./cycle, 1 sec/cycle Step 7 go to 7 for
49 cycles Step 8 55.degree. C. 0.1.degree. C./cycle, 12 sec/cycle
Step 9 go to 8 for 49 cycles Step 10 55.degree. C. 2 min Step 11
60.degree. C. 2 min Step 12 go to 11 for 9 times Step 13 4.degree.
C. forever Step 14 end
B. First Strand cDNA Synthesis Method 2
TABLE-US-00005 mRNA (10 .mu.g) 25 .mu.l water 30 .mu.l *Not I
adapter primer (5 .mu.g) 10 .mu.l 65.degree. C. for 10 min, chill
on ice, then add following reagents, *5x first buffer 20 .mu.l
*0.1M DTT 10 .mu.l *10 mM dNTP mix 5 .mu.l
[0185] Incubate at 45.degree. C. for 2 min, then add 10 .mu.l of
*Superscript II RT (200u/.mu.l), start the following program:
TABLE-US-00006 Step 1 45.degree. C. for 6 sec, -0.1.degree.
C./cycle Step 2 go to 1 for 99 additional cycles Step 3 35.degree.
C. for 5 min Step 4 45.degree. C. for 60 min Step 5 50.degree. C.
for 10 min Step 6 4.degree. C. forever Step 7 end
[0186] After the 1.sup.st strand cDNA synthesis, the DNA is
extracted by phenol according to standard procedures, and then
precipitated in NaOAc and ethanol, and stored in -20.degree. C.
C. Oxidization of the Diol Group of mRNA for Biotin Labeling
[0187] First strand cDNA is spun down and washed once with 70%
EtOH. The pellet resuspended in 23.2 .mu.l of DEPC treated water
and put on ice. Prepare 100 mM of NalO4 freshly and then add the
following reagents:
TABLE-US-00007 mRNA:1.sup.st cDNA (start with 20 .mu.g mRNA) 46.4
.mu.l 100 mM NaIO4 (freshly made) 2.5 .mu.l NaOAc 3M pH 4.5 1.1
.mu.l
[0188] To make 100 mM NalO4, use 21.39 .mu.g of NalO4 for 1 .mu.l
of water.
[0189] Wrap the tube in a foil and incubate on ice for 45 min.
[0190] After the incubation, the reaction is then precipitated
in:
TABLE-US-00008 5M NaCl 10 .mu.l 20% SDS 0.5 .mu.l isopropanol 61
.mu.l
[0191] Incubate on ice for at least 30 min, then spin it down at
max speed at 4.degree. C. for 30 min and wash once with 70% ethanol
and then 80% EtOH.
D. Biotinylation of the mRNA Diol Group
[0192] Resuspend the DNA in 110 .mu.l DEPC treated water, then add
the following reagents:
TABLE-US-00009 20% SDS 5 .mu.l 2M NaOAc pH 6.1 5 .mu.l 10 mm biotin
hydrazide (freshly made) 300 .mu.l
[0193] Wrap in a foil and incubate at room temperature
overnight.
E. RNase I Treatment
[0194] Precipitate DNA in:
TABLE-US-00010 5M NaCl 10 .mu.l 2M NaOAc pH 6.1 75 .mu.l
biotinylated mRNA:cDNA 420 .mu.l 100% EtOH (2.5 Vol) 1262.5
.mu.l
[0195] (Perform this precipitation in two tubes and split the 420
.mu.l of DNA into 210 .mu.l each, add 5 .mu.l of 5M NaCl, 37.5
.mu.l of 2M NaOAc pH 6.1 and 631.25 .mu.l of 100% EtOH).
[0196] Store at -20.degree. C. for at least 30 min. Spin the DNA
down at 4.degree. C. at maximal speed for 30 min. and wash with 80%
EtOH twice, then dissolve DNA in 70 .mu.l RNase free water. Pool
two tubes and end up with 140 .mu.l.
[0197] Add the following reagents:
TABLE-US-00011 RNase One 10 U/.mu.l 40 .mu.l 1.sup.st cDNA:RNA 140
.mu.l 10X buffer 20 .mu.l Incubate at 37.degree. C. for 15 min.
[0198] Add 5 .mu.l of 40 .mu.g/.mu.l yeast tRNA to each sample for
capturing.
F. Full Length 1.sup.st cDNA Capturing
[0199] Blocking the beads with yeast tRNA:
TABLE-US-00012 Beads 1 ml Yeast tRNA 40 .mu.g/.mu.l 5 .mu.l
[0200] Incubate on ice for 30 min with mixing, wash 3 times with 1
ml of 2M NaCl, 50 mmEDTA, pH 8.0.
[0201] Resuspend the beads in 800 .mu.l of 2M NaCl, 50 mm EDTA, pH
8.0, add RNase I treated sample 200 .mu.l, and incubate the
reaction for 30 min at room temperature.
[0202] Capture the beads using the magnetic stand, save the
supernatant, and start following washes:
[0203] 2 washes with 2M NaCl, 50 mm EDTA, pH 8.0, 1 ml each
time,
[0204] 1 wash with 0.4% SDS, 50 .mu.g/ml tRNA,
[0205] 1 wash with 10 mm Tris-Cl pH 7.5, 0.2 mm EDTA, 10 mm NaCl,
20% glycerol,
[0206] 1 wash with 50 .mu.g/m tRNA,
[0207] 1 wash with 1.sup.st cDNA buffer
G. Second Strand cDNA Synthesis
[0208] Resuspend the beads in:
TABLE-US-00013 *5X first buffer 8 .mu.l *0.1 mM DTT 4 .mu.l *10 mm
dNTP mix 8 .mu.l *5X 2nd buffer 60 .mu.l *E. coli Ligase 10 U/.mu.l
2 .mu.l *E. coli DNA polymerase 10 U/.mu.l 8 .mu.l *E. coli RNaseH
2 U/.mu.l 2 .mu.l P32 dCTP 10 .mu.ci/.mu.l 2 .mu.l Or water up to
300 .mu.l 208 .mu.l
[0209] Incubate at 16.degree. C. for 2 hr with mixing the reaction
in every 30 min.
[0210] Add 4 .mu.l of T4 DNA polymerase and incubate for additional
5 min at 16.degree. C.
[0211] Elute 2.sup.nd cDNA from the beads.
[0212] Use a magnetic stand to separate the 2.sup.nd cDNA from the
beads, then resuspend the beads in 200 .mu.l of water, and then
separate again, pool the samples (about 500 .mu.l), Add 200 .mu.l
of water to the beads, then 200 .mu.l of phenol:chloroform, vortex
and spin to separate the sample with phenol.
[0213] Pool the DNA together (about 700 .mu.l) and use phenol to
clean the DNA again, DNA is then precipitated in 2 .mu.g of
glycogen and 0.5 vol of 7.5M NH4OAc and 2 vol of 100% EtOH.
Precipitate overnight. Spin down the pellet and wash with 70% EtOH,
air-dry the pellet.
TABLE-US-00014 DNA 250 .mu.l DNA 200 .mu.l 7.5M NH4OAc 125 .mu.l
7.5M NH4OAc 100 .mu.l 100% EtOH 750 .mu.l 100% EtOH 600 .mu.l
glycogen 1 .mu.g/.mu.l 2 .mu.l glycogen 1 .mu.g/.mu.l 2 .mu.l
H. Sal I Adapter Ligation
[0214] Resuspend the pellet in 26 .mu.l of water and use 1 .mu.l
for TAE gel.
[0215] Set up reaction as following:
TABLE-US-00015 2.sup.nd strand cDNA 25 .mu.l *5X T4 DNA ligase
buffer 10 .mu.l *Sal I adapters 10 .mu.l *T4 DNA ligase 5 .mu.l
[0216] Mix gently, incubate the reaction at 16.degree. C.
overnight.
[0217] Add 2 .mu.l of ligase second day and incubate at room
temperature for 2 hrs (optional).
[0218] Add 50 .mu.l water to the reaction and use 100 .mu.l of
phenol to clean the DNA, 90 .mu.l of the upper phase is transferred
into a new tube and precipitate in:
TABLE-US-00016 Glycogen 1 .mu.g/.mu.l 2 .mu.l Upper phase DNA 90
.mu.l 7.5M NH4OAc 50 .mu.l 100% EtOH 300 .mu.l
precipitate at -20.degree. C. overnight
[0219] Spin down the pellet at 4.degree. C. and wash in 70% EtOH,
dry the pellet.
I. Not I Digestion
TABLE-US-00017 [0220] 2.sup.nd cDNA 41 .mu.l *Reaction 3 buffer 5
.mu.l *Not I 15 u/.mu.l 4 .mu.l
[0221] Mix gently and incubate the reaction at 37.degree. C. for 2
hr.
[0222] Add 50 .mu.l of water and 100 .mu.l of phenol, vortex, and
take 90 .mu.l of the upper phase to a new tube, then add 50 .mu.l
of NH.sub.40Ac and 300 .mu.l of EtOH. Precipitate overnight at
-20.degree. C.
[0223] Cloning, ligation and transformation are performed per the
Superscript cDNA synthesis kit.
Example 3
[0224] This example describes cDNA sequencing and library
subtraction.
[0225] Individual colonies can be picked and DNA prepared either by
PCR with M13 forward primers and M13 reverse primers or by plasmid
isolation. cDNA clones can be sequenced using M13 reverse
primers.
[0226] cDNA libraries are plated out on 22.times.22 cm.sup.2 agar
plate at density of about 3,000 colonies per plate. The plates are
incubated in a 37.degree. C. incubator for 12-24 hours. Colonies
are picked into 384-well plates by a robot colony picker, Q-bot
(GENETIX Limited). These plates are incubated overnight at
37.degree. C. Once sufficient colonies are picked, they are pinned
onto 22.times.22 cm.sup.2 nylon membranes using Q-bot. Each
membrane holds 9,216 or 36,864 colonies. These membranes are placed
onto an agar plate with an appropriate antibiotic. The plates are
incubated at 37.degree. C. overnight.
[0227] After colonies are recovered on the second day, these
filters are placed on filter paper prewetted with denaturing
solution for four minutes, then incubated on top of a boiling water
bath for an additional four minutes. The filters are then placed on
filter paper prewetted with neutralizing solution for four minutes.
After excess solution is removed by placing the filters on dry
filter papers for one minute, the colony side of the filters is
placed into Proteinase K solution, incubated at 37.degree. C. for
40-50 minutes. The filters are placed on dry filter papers to dry
overnight. DNA is then cross-linked to nylon membrane by UV light
treatment
[0228] Colony hybridization is conducted as described by Sambrook,
et al., (in Molecular Cloning: A laboratory Manual, 2.sup.nd
Edition). The following probes can be used in colony hybridization:
[0229] 1. First strand cDNA from the same tissue as the library was
made from to remove the most redundant clones. [0230] 2. 48-192
most redundant cDNA clones from the same library based on previous
sequencing data. [0231] 3. 192 most redundant cDNA clones in the
entire maize sequence database. [0232] 4. A Sal-A20 oligo
nucleotide: TCG ACC CAC GCG TCC GAA AAA AAA AAA AAA AAA AAA, SEQ ID
NO: 31, removes clones containing a poly A tail but no cDNA. [0233]
5. cDNA clones derived from rRNA.
[0234] The image of the autoradiography is scanned into computer
and the signal intensity and cold colony addresses of each colony
is analyzed. Re-arraying of cold-colonies from 384 well plates to
96 well plates is conducted using Q-bot.
Example 4
[0235] This example describes identification of the gene from a
computer homology search.
[0236] Gene identities can be determined by conducting BLAST (Basic
Local Alignment Search Tool; Altschul, et al., (1993) J. Mol. Biol.
215:403-410) searches under default parameters for similarity to
sequences contained in the BLAST "nr" database (comprising all
non-redundant GenBank CDS translations, sequences derived from the
3-dimensional structure Brookhaven Protein Data Bank, the last
major release of the SWISS-PROT protein sequence database, EMBL and
DDBJ databases). The cDNA sequences are analyzed for similarity to
all publicly available DNA sequences contained in the "nr" database
using the BLASTN algorithm. The DNA sequences are translated in all
reading frames and compared for similarity to all publicly
available protein sequences contained in the "nr" database using
the BLASTX algorithm (Gish and States, (1993) Nature Genetics
3:266-272) provided by the NCBI. In some cases, the sequencing data
from two or more clones containing overlapping segments of DNA are
used to construct contiguous DNA sequences.
[0237] Sequence alignments and percent identity calculations can be
performed using the Megalign program of the LASERGENE
bioinformatics computing suite (DNASTAR Inc., Madison, Wis.).
Multiple alignments of the sequences can be performed using the
Clustal method of alignment (Higgins and Sharp, (1989) CABIOS.
5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH
PENALTY=10). Default parameters for pairwise alignments using the
Clustal method are KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS
SAVED=5.
[0238] Other methods of sequence alignment and percent identity
analysis known to those of skill in the art, including those
disclosed herein, can also be employed.
Example 5
[0239] This example describes expression of transgenes in monocot
cells.
[0240] A transgene comprising a cDNA encoding the instant
polypeptides in sense orientation with respect to the maize 27 kD
zein promoter that is located 5' to the cDNA fragment, and the 10
kD zein 3' end that is located 3' to the cDNA fragment, can be
constructed. The cDNA fragment of this gene may be generated by
polymerase chain reaction (PCR) of the cDNA clone using appropriate
oligonucleotide primers. Cloning sites (NcoI or SmaI) can be
incorporated into the oligonucleotides to provide proper
orientation of the DNA fragment when inserted into the digested
vector pML103 as described below. Amplification is then performed
in a standard PCR. The amplified DNA is then digested with
restriction enzymes NcoI and SmaI and fractionated on an agarose
gel. The appropriate band can be isolated from the gel and combined
with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid
pML103 has been deposited under the terms of the Budapest Treaty at
ATCC (American Type Culture Collection, 10801 University Blvd.,
Manassas, Va. 20110-2209) and bears accession number ATCC 97366.
The DNA segment from pML103 contains a 1.05 kb SalI-NcoI promoter
fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SalI
fragment from the 3' end of the maize 10 kD zein gene in the vector
pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at
15.degree. C. overnight, essentially as described (Maniatis). The
ligated DNA may then be used to transform E. coli XL1-Blue
(Epicurian Coli XL-1 Blue; Stratagene). Bacterial transformants can
be screened by restriction enzyme digestion of plasmid DNA and
limited nucleotide sequence analysis using the dideoxy chain
termination method (Sequenase DNA Sequencing Kit; US Biochemical).
The resulting plasmid construct would comprise a transgene
encoding, in the 5' to 3' direction, the maize 27 kD zein promoter,
a cDNA fragment encoding the instant polypeptides and the 10 kD
zein 3' region.
[0241] The transgene described above can then be introduced into
maize cells by the following procedure. Immature maize embryos can
be dissected from developing caryopses derived from crosses of the
inbred maize lines H99 and LH132. The embryos are isolated 10 to 11
days after pollination when they are 1.0 to 1.5 mm long. The
embryos are then placed with the axis-side facing down and in
contact with agarose-solidified N6 medium (Chu, et al., (1975) Sci.
Sin. Peking 18:659-668). The embryos are kept in the dark at
27.degree. C. Friable embryogenic callus consisting of
undifferentiated masses of cells with somatic proembryoids and
embryoids borne on suspensor structures proliferates from the
scutellum of these immature embryos. The embryogenic callus
isolated from the primary explant can be cultured on N6 medium and
sub-cultured on this medium every 2 to 3 weeks.
[0242] The plasmid, p35S/Ac (Hoechst Ag, Frankfurt, Germany) or
equivalent may be used in transformation experiments in order to
provide for a selectable marker. This plasmid contains the Pat gene
(see, EP Patent Publication Number 0 242 236) which encodes
phosphinothricin acetyl transferase (PAT). The enzyme PAT confers
resistance to herbicidal glutamine synthetase inhibitors such as
phosphinothricin. The pat gene in p35S/Ac is under the control of
the 35S promoter from Cauliflower Mosaic Virus (Odell, et al.,
(1985) Nature 313:810-812) and the 3' region of the nopaline
synthase gene from the T-DNA of the Ti plasmid of Agrobacterium
tumefaciens.
[0243] The particle bombardment method (Klein, et al., (1987)
Nature 327:70-73) may be used to transfer genes to the callus
culture cells. According to this method, gold particles (1 .mu.m in
diameter) are coated with DNA using the following technique. Ten
.mu.g of plasmid DNAs are added to 50 .mu.L of a suspension of gold
particles (60 mg per mL). Calcium chloride (50 .mu.L of a 2.5 M
solution) and spermidine free base (20 .mu.L of a 1.0 M solution)
are added to the particles. The suspension is vortexed during the
addition of these solutions. After 10 minutes, the tubes are
briefly centrifuged (5 sec at 15,000 rpm) and the supernatant
removed. The particles are resuspended in 200 .mu.L of absolute
ethanol, centrifuged again and the supernatant removed. The ethanol
rinse is performed again and the particles resuspended in a final
volume of 30 .mu.L of ethanol. An aliquot (5 .mu.L) of the
DNA-coated gold particles can be placed in the center of a Kapton
flying disc (Bio-Rad Labs). The particles are then accelerated into
the maize tissue with a Biolistic PDS-1000/He (Bio-Rad Instruments,
Hercules Calif.), using a helium pressure of 1000 psi, a gap
distance of 0.5 cm and a flying distance of 1.0 cm.
[0244] For bombardment, the embryogenic tissue is placed on filter
paper over agarose-solidified N6 medium. The tissue is arranged as
a thin lawn and covers a circular area of about 5 cm in diameter.
The petri dish containing the tissue can be placed in the chamber
of the PDS-1000/He approximately 8 cm from the stopping screen. The
air in the chamber is then evacuated to a vacuum of 28 inches of
Hg. The macrocarrier is accelerated with a helium shock wave using
a rupture membrane that bursts when the He pressure in the shock
tube reaches 1000 psi.
[0245] Seven days after bombardment the tissue can be transferred
to N6 medium that contains gluphosinate (2 mg per liter) and lacks
casein or proline. The tissue continues to grow slowly on this
medium. After an additional 2 weeks the tissue can be transferred
to fresh N6 medium containing gluphosinate. After 6 weeks, areas of
about 1 cm in diameter of actively growing callus can be identified
on some of the plates containing the glufosinate-supplemented
medium. These calli may continue to grow when sub-cultured on the
selective medium.
[0246] Plants can be regenerated from the transgenic callus by
first transferring clusters of tissue to N6 medium supplemented
with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be
transferred to regeneration medium (Fromm, et al., (1990)
Bio/Technology 8:833-839).
Example 6
[0247] This example describes expression of transgenes in dicot
cells.
[0248] A seed-specific expression cassette composed of the promoter
and transcription terminator from the gene encoding the .beta.
subunit of the seed storage protein phaseolin from the bean
Phaseolus vulgaris (Doyle, et al., (1986) J. Biol. Chem.
261:9228-9238) can be used for expression of the instant
polypeptides in transformed soybean. The phaseolin cassette
includes about 500 nucleotides upstream (5') from the translation
initiation codon and about 1650 nucleotides downstream (3') from
the translation stop codon of phaseolin. Between the 5' and 3'
regions are the unique restriction endonuclease sites Nco I (which
includes the ATG translation initiation codon), SmaI, KpnI and
XbaI. The entire cassette is flanked by Hind III sites.
[0249] The cDNA fragment of this gene may be generated by
polymerase chain reaction (PCR) of the cDNA clone using appropriate
oligonucleotide primers. Cloning sites can be incorporated into the
oligonucleotides to provide proper orientation of the DNA fragment
when inserted into the expression vector. Amplification is then
performed as described above, and the isolated fragment is inserted
into a pUC18 vector carrying the seed expression cassette.
[0250] Soybean embryos may then be transformed with the expression
vector comprising sequences encoding the instant polypeptides. To
induce somatic embryos, cotyledons, 3-5 mm in length dissected from
surface sterilized, immature seeds of the soybean cultivar A2872,
can be cultured in the light or dark at 26.degree. C. on an
appropriate agar medium for 6-10 weeks. Somatic embryos which
produce secondary embryos are then excised and placed into a
suitable liquid medium. After repeated selection for clusters of
somatic embryos which multiplied as early, globular staged embryos,
the suspensions are maintained as described below.
[0251] Soybean embryogenic suspension cultures can maintained in 35
mL liquid media on a rotary shaker, 150 rpm, at 26.degree. C. with
florescent lights on a 16:8 hour day/night schedule. Cultures are
subcultured every two weeks by inoculating approximately 35 mg of
tissue into 35 mL of liquid medium.
[0252] Soybean embryogenic suspension cultures may then be
transformed by the method of particle gun bombardment (Klein, et
al., (1987) Nature (London) 327:70-73, U.S. Pat. No. 4,945,050). A
DuPont Biolistic PDS1000/HE instrument (helium retrofit) can be
used for these transformations.
[0253] A selectable marker gene which can be used to facilitate
soybean transformation is a transgene composed of the 35S promoter
from Cauliflower Mosaic Virus (Odell, et al., (1985) Nature
313:810-812), the hygromycin phosphotransferase gene from plasmid
pJR225 (from E. coli; Gritz, et al., (1983) Gene 25:179-188) and
the 3' region of the nopaline synthase gene from the T-DNA of the
Ti plasmid of Agrobacterium tumefaciens. The seed expression
cassette comprising the phaseolin 5' region, the fragment encoding
the instant polypeptides and the phaseolin 3' region can be
isolated as a restriction fragment. This fragment can then be
inserted into a unique restriction site of the vector carrying the
marker gene.
[0254] To 50 .mu.L of a 60 mg/mL 1 .mu.mgold particle suspension is
added (in order): 5 .mu.L DNA (1 .mu.g/4), 20 .mu.l spermidine (0.1
M), and 50 .mu.L CaCl.sub.2 (2.5 M). The particle preparation is
then agitated for three minutes, spun in a microfuge for 10 seconds
and the supernatant removed. The DNA-coated particles are then
washed once in 400 .mu.L 70% ethanol and resuspended in 40 .mu.L of
anhydrous ethanol. The DNA/particle suspension can be sonicated
three times for one second each. Five microliters of the DNA-coated
gold particles are then loaded on each macro carrier disk.
[0255] Approximately 300-400 mg of a two-week-old suspension
culture is placed in an empty 60.times.15 mm petri dish and the
residual liquid removed from the tissue with a pipette. For each
transformation experiment, approximately 5-10 plates of tissue are
normally bombarded. Membrane rupture pressure is set at 1100 psi
and the chamber is evacuated to a vacuum of 28 inches mercury. The
tissue is placed approximately 3.5 inches away from the retaining
screen and bombarded three times. Following bombardment, the tissue
can be divided in half and placed back into liquid and cultured as
described above.
[0256] Five to seven days post bombardment, the liquid media may be
exchanged with fresh media and eleven to twelve days post
bombardment with fresh media containing 50 mg/mL hygromycin. This
selective media can be refreshed weekly. Seven to eight weeks post
bombardment, green, transformed tissue may be observed growing from
untransformed, necrotic embryogenic clusters. Isolated green tissue
is removed and inoculated into individual flasks to generate new,
clonally propagated, transformed embryogenic suspension cultures.
Each new line may be treated as an independent transformation
event. These suspensions can then be subcultured and maintained as
clusters of immature embryos or regenerated into whole plants by
maturation and germination of individual somatic embryos.
Example 7
[0257] This example describes expression of a transgene in
microbial cells.
[0258] The cDNAs encoding the instant polypeptides can be inserted
into the T7 E. coli expression vector pBT430. This vector is a
derivative of pET-3a (Rosenberg, et al., (1987) Gene 56:125-135)
which employs the bacteriophage T7 RNA polymerase/T7 promoter
system. Plasmid pBT430 was constructed by first destroying the EcoR
I and Hind III sites in pET-3a at their original positions. An
oligonucleotide adaptor containing EcoR I and Hind III sites was
inserted at the BamH I site of pET-3a. This created pET-3aM with
additional unique cloning sites for insertion of genes into the
expression vector. Then, the Nde I site at the position of
translation initiation was converted to an Nco I site using
oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM
in this region, 5'-CATATGG, was converted to 5'-CCCATGG in
pBT430.
[0259] Plasmid DNA containing a cDNA may be appropriately digested
to release a nucleic acid fragment encoding the protein. This
fragment may then be purified on a 1% NuSieve GTG low melting
agarose gel (FMC). Buffer and agarose contain 10 .mu.g/ml ethidium
bromide for visualization of the DNA fragment. The fragment can
then be purified from the agarose gel by digestion with GELase
(Epicentre Technologies) according to the manufacturer's
instructions, ethanol precipitated, dried and resuspended in 20
.mu.L of water. Appropriate oligonucleotide adapters may be ligated
to the fragment using T4 DNA ligase (New England Biolabs, Beverly,
Mass.). The fragment containing the ligated adapters can be
purified from the excess adapters using low melting agarose as
described above. The vector pBT430 is digested, dephosphorylated
with alkaline phosphatase (NEB) and deproteinized with
phenol/chloroform as described above. The prepared vector pBT430
and fragment can then be ligated at 16.degree. C. for 15 hours
followed by transformation into DH5 electrocompetent cells (GIBCO
BRL). Transformants can be selected on agar plates containing LB
media and 100 .mu.g/mL ampicillin. Transformants containing the
gene encoding the instant polypeptides are then screened for the
correct orientation with respect to the T7 promoter by restriction
enzyme analysis.
[0260] For high level expression, a plasmid clone with the cDNA
insert in the correct orientation relative to the T7 promoter can
be transformed into E. coli strain BL21(DE3) (Studier, et al.,
(1986) J. Mol. Biol. 189:113-130). Cultures are grown in LB medium
containing ampicillin (100 mg/L) at 25.degree. C. At an optical
density at 600 nm of approximately 1, IPTG
(isopropylthio-.beta.-galactoside, the inducer) can be added to a
final concentration of 0.4 mM and incubation can be continued for 3
h at 25.degree. C. Cells are then harvested by centrifugation and
re-suspended in 50 .mu.L of 50 mM Tris-HCl at pH 8.0 containing 0.1
mM DTT and 0.2 mM phenyl methylsulfonyl fluoride. A small amount of
1 mm glass beads can be added and the mixture sonicated 3 times for
about 5 seconds each time with a microprobe sonicator. The mixture
is centrifuged and the protein concentration of the supernatant
determined. One microgram of protein from the soluble fraction of
the culture can be separated by SDS-polyacrylamide gel
electrophoresis. Gels can be observed for protein bands migrating
at the expected molecular weight.
Example 8
[0261] Isolation of the CesA10, 11 and 12 genes and their relevance
to cell wall synthesis and stalk strength in maize.
[0262] All three genes were isolated from a library made from the
zone of an elongating corn stalk internode between the elongation
zone and the most mature part of the internode, the "transition
zone". The library was made, subtracted, and sequenced as described
in the preceding Examples 1, 2 and 3. A genomic database search was
conducted as described in Example 4. Derived polypeptide sequences
of all the Expressed Tag Sequences (ESTs) showing homology to the 1
kb 5'-end of any of the 9 previously known ZmCesA genes were
aligned with the protein sequences of the latter. The sequences
that did not fully match any of the known genes were sequenced from
both ends of the respective cDNA clones. Three new, full-length
genes, ZmCesA10 (SEQ ID NO: 25), ZmCesA11 (SEQ ID NO: 27) and
ZmCesA12 (SEQ ID NO: 29) were isolated by this method.
[0263] The polypeptide sequences of the three genes derived from
the cDNA sequences (SEQ ID NOS: 26, 28 and 30, respectively)
clustered with the CesA genes from other species where they are
known to be involved in secondary wall formation (FIG. 4). AtCesA7
and AtCesA8 have been found to make secondary wall in the vascular
bundles (Taylor, et al., (2000). Multiple cellulose synthase
catalytic subunits are required for cellulose synthesis in
Arabidopsis. Plant Cell, (2000) 12:2529-2539.). Retrotransposon
insertions into OsCesA4 and OsCesA7 resulted in a brittle culm
phenotype in rice (Katsuyuki Tanaka, Akio Miyao, Kazumasa Murata,
Katsura Onosato, Naoko Kojima, Yumiko Yamashita, Mayuko Harada,
Takuji Sasaki, Hirohiko Hirochika, 2002, Analysis of rice brittle
mutants caused by disruption of cellulose synthase genes OsCesA4
and OsCesA11 with the retrotransposon tos17. Plant, Animal &
Microbe Genomes X. San Diego, Calif. Abs. Number 324). Each of the
genes, ZmCesA 10, 11 or 12, groups with one or the other CesA gene
from Arabidopsis or rice known to be involved in secondary wall
formation and thus in determining tissue strength (FIG. 4). The
CesA genes derived from the tissues specializing in secondary wall
formation from other species (Gossypium, Zinnia, Populus) also
group into the same clades with the aforementioned genes.
[0264] Further evidence that the maize genes are involved in
secondary wall formation and thus in determining stalk strength was
obtained from their expression pattern using the Massively Parallel
Signature Sequencing (MPSS) technology (Brenner, et al., (2000), In
vitro cloning of complex mixtures of DNA on microbeads: Physical
separation of differentially expressed cDNAs.
Proceedings-of-the-National-Academy-of-Sciences-of-the-United-States-of-A-
merica (Feb. 15, 2000) 97:1665-1670; see also, Brenner, et al.,
(2000) Gene expression analysis by massively parallel signature
sequencing (MPSS) on microbead arrays. Nature-Biotechnolog, [print]
(June 2000) 18:630-634; see also, Dhugga, (2001), Building the
wall: genes and enzyme complexes for polysaccharide synthases,
Curr. Opin. Plant Biol. 4:488-493). All three genes are expressed
in the tissues rich in cell wall content, supporting their
involvement in secondary wall formation as deduced from their
relationship to the genes from the other, aforementioned species
know to play this role (FIG. 5). All three genes are expressed
nearly identically across multiple tissues as seen from the
correlation coefficient matrix (Table 3), further strengthening the
argument that they are involved in secondary wall formation in the
vascular bundles and thus in determining tissue strength.
[0265] Correlation among the expression level of the different CesA
genes from maize as studied from Lynx are shown in Table 3.
TABLE-US-00018 TABLE 3 CesA1 CesA2 CesA3 CesA4 CesA5 CesA6 CesA7
CesA8 CesA10 CesA11 CesA12 CesA1 1 CesA2 0.59 1.00 CesA3 0.07 -0.15
1.00 CesA4 0.44 0.55 -0.10 1.00 CesA5 -0.20 -0.29 0.45 -0.33 1.00
CesA6 0.56 0.14 0.14 0.08 -0.13 1.00 CesA7 0.68 0.76 -0.06 0.57
-0.29 0.32 1.00 CesA8 0.59 0.73 -0.16 0.58 -0.36 0.26 0.61 1.00
CesA10 0.27 0.37 -0.27 0.33 -0.26 0.02 0.33 0.36 1.00 CesA11 0.39
0.47 -0.22 0.38 -0.28 0.11 0.40 0.42 0.95 1.00 CesA12 0.34 0.49
-0.27 0.37 -0.31 0.08 0.44 0.45 0.95 0.95 1
[0266] The correlation matrix was derived from the expression,
measured in PPM, from 65 different tissue libraries. Note the
nearly perfect correlation among the expression pattern of the
CesA10, 11 and 12 genes.
Example 9
[0267] This example describes a procedure to identify plants
containing Mu inserted into genes of interest and a strategy to
identify the function of those genes. This procedure was also
described in U.S. patent application Ser. No. 09/371,383 which
disclosed members of the same gene family as the present
application. One of skill in the art could readily conceive of use
of this procedure with the any of the Cellulose Synthase (CesA)
sequences disclosed in the current application. The current example
is based on work with the CesA11 gene, identified as SEQ ID NO: 27
herein.
[0268] The Trait Utility System for Corn (TUSC) is a method that
employs genetic and molecular techniques to facilitate the study of
gene function in maize. Studying gene function implies that the
gene's sequence is already known, thus the method works in reverse:
from sequence to phenotype. This kind of application is referred to
as "reverse genetics", which contrasts with "forward" methods that
are designed to identify and isolate the gene(s) responsible for a
particular trait (phenotype).
[0269] Pioneer Hi-Bred International, Inc., has a proprietary
collection of maize genomic DNA from approximately 42,000
individual F.sub.1 plants (Reverse genetics for maize, Meeley and
Briggs, (1995) Maize Genet. Coop. Newslett. 69:67-82). The genome
of each of these individuals contains multiple copies of the
transposable element family, Mutator (Mu). The Mu family is highly
mutagenic; in the presence of the active element Mu-DR, these
elements transpose throughout the genome, inserting into genic
regions, and often disrupting gene function. By collecting genomic
DNA from a large number (42,000) of individuals, Pioneer has
assembled a library of the mutagenized maize genome.
[0270] Mu insertion events are predominantly heterozygous; given
the recessive nature of most insertional mutations, the F.sub.1
plants appear wild-type. Each of the F.sub.1 plants is selfed to
produce F.sub.2 seed, which is collected. In generating the F.sub.2
progeny, insertional mutations segregate in a Mendelian fashion so
are useful for investigating a mutant allele's effect on the
phenotype. The TUSC system has been successfully used by a number
of laboratories to identify the function of a variety of genes
(Cloning and characterization of the maize An1 gene, Bensen, et
al., (1995) Plant Cell 7:75-84; Diversification of C-function
activity in maize flower development, Mena, et al., (1996) Science
274:1537-1540; Analysis of a chemical plant defense mechanism in
grasses, Frey, et al., (1997) Science 277:696-699; The control of
maize spikelet meristem fate by the APETALA2-like gene
Indeterminate spikelet 1, Chuck, et al., (1998) Genes and
Development 12:1145-1154; A SecY homologue is required for the
elaboration of the chloroplast thylakoid membrane and for normal
chloroplast gene expression, Roy and Barkan, (1998) J. Cell Biol.
141:1-11).
[0271] PCR Screening for Mu insertions in CesA11:
[0272] Two primers were designed from within the CesA11 cDNA and
designated as gene-specific primers (GSPs):
TABLE-US-00019 Forward primer (GSP1/SEQ ID NO. 32): 5'-
TACGATGAGTACGAGAGGTCCATGCTCA -3' Reverse primer (GSP2/SEQ ID NO.
33): 5'- GGCAAAAGCCCAGATGCGAGATAGAC -3' Mu TIR primer (SEQ ID NO.
34): 5'- AGAGAAGCCAACGCCAWCGCCTCYATTTCGTC -3'
[0273] Pickoligo was used to select primers for PCR. This program
chooses the Tm according to the following equation:
Tm=[((GC*3+AT*2)*37-562)/length]-5
[0274] PCR reactions were run with an annealing temperature of
62.degree. C. and a thermocycling profile as follows:
##STR00001##
[0275] Gel electrophoresis of the PCR products confirmed that there
was no false priming in single primer reactions and that only one
fragment was amplified in paired GSP reactions.
[0276] The genomic DNA from 42,000 plants, combined into pools of
48 plants each, was subjected to PCR with either GSP1 or GSP2 and
Mu TIR. The pools that were confirmed to be positive by dot-blot
hybridization using CesA11 cDNA as a probe were subjected to
gel-blot analysis in order to determine the size of fragments
amplified. The pools in which clean fragments were identified were
subjected to further analysis to identify the individual plants
within those pools that contained Mu insertion(s).
[0277] Seed from F.sub.1 plants identified in this manner was
planted in the field. Leaf discs from twenty plants in each F.sub.2
row were collected and genomic DNA was isolated. The same twenty
plants were selfed and the F.sub.3 seed saved. Pooled DNA (from 20
plants) from each of twelve rows was subjected to PCR using GSP1 or
GSP2 and Mu TIR primer as mentioned above. Three pools identified
to contain Mu insertions were subjected to individual plant
analysis and homozygotes identified. The Mu insertion sites with
the surrounding signature sequences are identified below:
TABLE-US-00020 Allele 1: 5'-TGGCGGCCG (SEQ ID NO: 35)- Mu-TCTGAAATG
(SEQ ID NO: 36)-3' Allele 2: 5'-GCCCACAAG (SEQ ID NO: 37)-
Mu-CATCCTGGT (SEQ ID NO: 38)-3' Allele 3: 5'-GTGTTCTTC (SEQ ID NO:
39)- Mu-GCCATGTGG (SEQ ID NO: 40)-3'
[0278] All three insertions are within 500 nucleotides of each
other in the open reading frame, suggesting that this region in the
gene might represent a hot spot for Mu insertion. One of the
insertions, allele 1, is in the region upstream of the predicted
six transmembrane domains near the C-terminal end of the protein.
Each of these insertions is expected to inactivate the gene since
they are all in the exonic regions of the gene.
Example 10
[0279] This example describes the method used to measure mechanical
strength of the maize stalks as well as the effect of the
overexpression of different CesA genes on stalk strength. The
mechanical strength of the mature corn stalks was measured with an
electromechanical test system. The internodes below the ear were
subjected to a 3-point bend test using an Instron, model 4411
(Instron Corporation, 100 Royall Street, Canton, Mass. 02021), with
a span-width of 200 mm between the anchoring points and a speed of
200 mm/min of the 3.sup.rd point attached to a load cell. For
measuring rind puncture strength, a needle was mounted on the load
cell of the Instron and the load taken to puncture the rind was
used as a measure of rind puncture strength.
[0280] Load needed to break the internode was used as a measure of
mechanical strength. The internodes are stronger toward the base of
the stalk. This mechanical stalk breaking strength or the "load to
break" was used to classify the hybrids with known stalk
characteristics into respective categories based on the internodal
breaking strength. The load to break the internodal zone was very
similar to the lodging score that had been assigned to the hybrids
based on field observations (see, FIG. 1). Approximately 90% of the
variation for internodal breaking strength was explained by unit
stalk dry matter below the ear (47%), stalk diameter (30%) and rind
puncture resistance (10%). Moisture levels above 30% in the stalk
tissue masked the contribution of the rind tissue to breaking
strength. The internodal breaking strength was highly correlated
with the amount of cellulose per unit length of the stalk.
[0281] Four of the CesA genes were expressed under the control of a
weak constitutive promoter, F3.7 (see, Coughlin, et al., U.S.
patent application Ser. No. 09/387,720, filed Aug. 30, 1999). Table
4 discloses the construct numbers, corresponding sequence IDs from
the patent, promoters, and the gene names. In2 is an inducible
promoter from the In2 gene from maize. The In2 promoter responds to
benzenesulfonamide herbicide safeners (see, Hershey, et al., (1991)
Mol. Gen. Genetics 227:229-237 and Gatz, et al., (1994) Mol. Gen
Genetics 243:32-38).
TABLE-US-00021 TABLE 4 Construct CesA SEQ ID NO. Promoter Gene name
1 1 F3.7 CesA1 2 9 F3.7 CesA4 3 13 F3.7 CesA5 4 17 F3.7 CesA8 5
Control IN2 GUSINT
[0282] Twenty-five individual T.sub.0 events for each construct
were generated in a hybrid maize background using
Agrobacterium-mediated transformation. Data for various traits,
such as plant height, stalk mass below ear, stalk diameter,
internodal breaking strength and structural material and cellulose
percentages in the internodal tissue were collected.
[0283] The plants from the transgenic events generated using the
CesA8 gene were significantly taller in comparison to the control
plants containing a GUS gene. Interestingly, a reduction in height
was observed when the CesA1 gene was introduced. The other two
genes, CesA4 and CesA5, did not differ from the control plants.
(See, FIG. 6.) It has long been known that cellulose synthase
occurs as a terminal rosette complex consisting of multiple
functional cellulose synthase polypeptides that are organized in a
ring with a hexagonal symmetry. Each of the six members of the ring
is believed to contain six or more functional enzyme units. In
general, 36 or more cellulose chains are extruded simultaneous to
their synthesis through the plasma membrane into the apoplast.
These chains are crystallized into a microfibril right as they come
in contact with each other after extrusion through the rosette
complex. A functional cellulose synthase is believed to consist of
two polypeptides derived form different CesA genes, forming a
heterodimer, resulting in a total of 72 or more CesA polypeptides
in each rosette.
[0284] While not intending to be limited to a single theory, it is
possible that a homodimer could also form a functional enzyme.
Therefore, the possible reasons for a reduction in plant height in
the events where CesA1 was overexpressed are: 1) the other CesA
gene with which its polypeptide forms a heterodimer is
down-regulated and 2) the expression of the other gene is not
affected but the CESA1 homodimer forms a nonfunctional enzyme, in
which case the functional dimers are competed out of the rosette
complex. In the latter case, the overexpressed gene behaves as a
dominant repressor of cellulose synthesis. This should manifest in
the form of microfibrils with fewer cellulose chains. This could be
detected by some physical techniques such as differential scanning
calorimetry (DSC). The reverse could be true for the CesA8 gene
whose homodimers may be functional, and/or whose overexpression
might induce the expression of its partner gene the product of
which it uses to make a functional enzyme. The fact that an
increase in height is observed may result from stalk becoming an
active sink when CesA8 is overexpressed. Stalk is usually
considered to be a passive sink which cannot compete well with the
developing ear. This argument is supported by the observation that
the plants containing CesA8 as a transgene had smaller ears.
[0285] Cellulose content and stalk length below the ear is highly
correlated with the breaking strength of the stalk (see, FIG. 3).
An increase in cellulose production can be accommodated by the
following alterations: 1) synthesis of the other cell wall
constituents stays constant, leading to an increased cellulose
percentage in the wall and 2) increase in cellulose synthesis
upregulates the synthesis of the other cell wall constituents as
well, in which case the percentage of cellulose does not change in
the wall but the amount of cellulose in a unit length does. Two of
the CesA genes, CesA4 and CesA8, showed an increase in the amount
of cellulose in a unit length of the stalk below the ear (see, FIG.
7). One of the genes, CesA5, did not have any effect on the amount
of cellulose in the stalk. It was recently suggested, based on its
expression pattern in different tissues, that CesA5 might actually
be involved in the formation of some non-cellulosic polysaccharide,
most probably mixed-linked glucan (Dhugga, (2001) Curr. Opin. Plant
Biol. 4:488-493). The data in the accompanying figure seem to
support this argument.
[0286] The internodes were subjected to breakage with a 3-point
Instron and the load to break plotted as a function of unit
cellulose amount. (See, FIG. 2.) A high correlation between these
two traits is observed from the multiple events, particularly for
CesA8 (FIG. 3). We have found from other studies that this gene is
involved in cellulose synthesis in the vascular bundles in the
elongating cells (Holland, et al., (2000) Plant Physiol.
123:1313-1323). These data support our previous observations and
supports the observation that the amount of cellulose in a unit
length of stalk below the ear results in an increased stalk
strength.
Example 11
[0287] This example describes the method used to overexpress CesA
genes which will increase the quality of harvested stover, leading
to an increase in ethanol yield per unit stover.
[0288] Transgenic plants expressing the Ces A gene of interest
could be produced by the method outlined in Example 5 or other
suitable methods. These plants containing increased quantities of
cellulose would then be used to produce higher quality stover.
[0289] The following is an example of the applications of the
present invention in applications of ethanol biorefineries. In
addition the cellulose biosynthetic pathway's role as primary
determinant of tissue strength, a trait that is of significant
interest in agriculture, where cellulose constitutes the most
abundant renewable energy resource. More than 200 million metric
tons of stover is produced just from maize in the United States
every year. About one-third of this could potentially be utilized
in ethanol biorefineries (Kadam and McMillan, 2003). The worldwide
production of lignocellulosic wastes from cereal stover and straw
is estimated to be .about.3 billion tons per year (Kuhad and Singh,
1993). Stover material containing higher amounts of cellulose and
lower amounts of lignin is expected to increase ethanol production
in the biorefineries. Lignin is a target for reduction because it
is an undesirable constituent in paper industry as well as in
silage digestibility (Hu, et al., 1999; Li, et al., 2003).
[0290] Corn stover alone offers a significant target as a feedstock
for the ethanol biorefineries (see, the World Wide Web at
ctic.purdue.edu/Core4/ctic-dc.ppt;
and_bioproducts-bioenergy.gov/pdfs/bcota/abstracts/31/z263.pdf.)
Aside from its use in biorefineries, it can substitute hardwood
fiber for paper production. With rapid progress being made in
streamlining the process of fermentation of stover material and
increasing cost of imported oil, corn stover is expected to become
a key feedstock in ethanol and paper production (Wheals, et al.,
1999; Atistidou and Penttila, 2000). In addition to supplying 5-8
billion gallons of ethanol per year with no additional land use, it
is expected to contribute to an annual farm income of $2.3 billion
and reduce the greenhouse gases by 60-95 million metric tons, which
is 12-20% of the US-Kyoto commitment (see, the World Wide Web at
ctic.purdue.edu/Core4/ctic-dc.ppt; and
bioproducts--bioenergy.gov/pdfs/bcota/abstracts/31/z263.pdf).
Ethanol combustion results in carbon dioxide and water, the same
molecules plant primarily uses to make biomass.
[0291] The concern about there being an effect on the soil organic
matter by the removal of the aboveground biomass is mitigated by
the findings that over a 30-year period, no significant difference
was observed in the soil organic matter between a field where the
aboveground stover was removed for silage and the one where the
stover was ploughed into the ground after grain harvest. Most of
the ploughed stover is lost as carbon dioxide into the
atmosphere.
[0292] During pretreatment of the corn stover for enzymatic
digestion, the soluble sugars are discarded. Also, pentose sugars
are not as well fermented as the hexose sugars despite the progress
made in the fermentation process, which involves using Zymomonas
bacteria instead of the traditional yeast (Atistidou and Penttila,
2000; Badger, 2002). The polysaccharide fraction of the corn stalk
contains .about.20% pentose sugars, the remainder being hexose
sugars (Dhugga, unpublished). Also, the free sugar concentration
ranges from 4-12%. Lignin content averages .about.19% and ranges
from 18-23%. By overexpressing the CesA genes of the present
invention, the free sugars can be converted into polymeric
(cellulosic) form, which will increase ethanol yield per unit of
the harvested stover. The claimed invention also teaches an
increase cellulose at the expense of pentose-containing polymers
(e.g., arabinoxylan) and lignin.
Example 12
[0293] This example discusses the application of CesA genes in late
season stalk strength.
[0294] Stalk lodging results in significant yield losses in crop
plants, particularly in cereals (Duvick and Cassman, 1999). Stalk
standability is dependent upon the amount of dry matter per unit
length of the stalk and is thus a function of resource partitioning
and allocation. Harvest index, the ratio of the grain to total
aboveground biomass, is an indicator of dry matter partitioning
efficiency. It has remained around 50% for over a hundred years in
maize (Sinclair, 1998). In comparison to maize, harvest index
acquired a different role in increasing plant standability in small
grain cereals where it was significantly increased with the
introduction of dwarfing genes. Reduced stature made these cereals
less likely to lodge by reducing torque on the top-heavy straw,
which allowed for higher inputs such as fertilizers and irrigation,
resulting in increased biomass production per unit land area.
Whereas yield increases in small grain cereals have resulted from
an increase in both harvest index and total biomass production per
unit land area, those in maize have been the consequence of mainly
an increase in total biomass. Increased planting density as a means
of increasing grain yield in maize has affected changes in leaf
angle and shape as adaptations to this environment and has in
general resulted in increased plant and ear heights (Duvick and
Cassman, 1999). The stalk becomes mechanically weaker with
increasing planting density because of reduction in individual
plant vigor that results from a nonlinear relationship between
planting density and biomass increase.
[0295] The understanding that cellulose in a unit length of the
stalk is indeed the main determinant of mechanical strength had
been proposed. (Appenzeller, et al., 2004). Most of the dry matter
and thus cellulose in the stalk is concentrated in the outer
layers, collectively referred to as rind, which is composed of
densely packed vascular bundles. Vascular bundles are surrounded by
sclerenchymatous cells. Although vascular bundles are also sparsely
distributed in the internal tissue, a great majority of them are
present in the outer layers as judged from the dry matter
distribution (FIG. 8). FIG. 8 describes the contribution of
different stalk components to dry matter, diameter, volume and
stalk strength in maize hybrids. The data are derived from seven
hybrids grown at three densities (27, 43 and 59 K per acre) in
three replications each in 2001. Two stalks were sampled from each
replication. Internodes 3 and 4 below the ear were broken with
Instron. After breaking, the 3rd internode was separated into rind
and inner tissue. Path coefficient analyses were performed using
rind and inner tissue as independent variables (X.sub.1 and
X.sub.2, respectively) and the whole stalk as the dependent
variable (Y). The multiple regression equation:
Y=a+b.sub.1X.sub.1+b.sub.2X.sub.2+e where a is the intercept and e
error. Path coefficients were calculated as follows:
.SIGMA.YXn=b.sub.n*.delta..sub.n/.delta..sub.Y where n is 1 or 2.
The contribution of each independent variable to whole stalk (Y)
was calculated as follows: .rho.Yxn*rYxn where r is the correlation
coefficient. Note: the unexplained variation for diameter is
attributable to the corn stalk not being perfectly round and the
difficulty thus associated with determining the cross-sectional
area accurately. Some other variable, like size and number of
vascular bundles and their density, may account for the remaining
variation in strength. The introduced transgene, by removing the
limitation of the particular step it encodes the enzyme for
catalyzing, may either lead to an increase in the percentage of
that particular polysaccharide (composition changed) or of the
whole cell wall (composition not changed). In the latter case, the
additional dry matter could be accommodated in enlarged vascular
bundles which could, in turn, result in an increased diameter.
[0296] Isolation of genes that affect cellulose formation has made
it possible to test their respective roles in stalk strength by
transgenic and reverse genetics approaches (Appenzeller, et al.,
2004). Transgenic plants expressing the Ces A gene of interest are
produced by the method outlined in Example 5 or other suitable
methods. Expression of the cellulose synthase gene is measured
Three of the twelve cellulose synthase genes are preferentially
expressed in the secondary wall-forming cells (Appenzeller, et al.,
2004). Whereas two of these genes, CesA10 and CesA11, are expressed
more highly in the vascular bundles, CesA12 appears to be more
highly expressed in the surrounding, sclerenchymatous cells
(Appenzeller, et al., 2004). Overexpression of the three CesA genes
individually and in combinations is used to increase cellulose
production in the rind cells as well as the internal tissue cells.
Internal tissue cells, as shown in FIG. 8, account for a majority
of the volume but only a small amount of biomass and thus offer
suitable targets for making more cellulose. Isolated promoters for
each of these genes are used to drive the expression of these genes
in different cell types. In addition, promoters from other genes
can be used to express the CesA genes in other cell types.
Example 13
[0297] This example discusses the application of the CesA genes in
improving nodal strength to reduce mid-season green snap.
[0298] Mid-season green snap is a significant problem in the
Western plains, e.g., Nebraska, North and South Dakota and Western
Minnesota, whereby the stalk snaps at the nodal plate before
flowering in a severe windstorm at or below the ear node, resulting
in yield losses of up to 80%. The underlying reason for this lesion
is the disparity in the rates of elongation growth and dry matter
deposition in the corn plant before flowering. Whereas a plant
doubles in height in approximately two weeks before flowering, the
most rapid rate of elongation growth, it accumulates only 30%
additional dry matter during the same period, resulting in a 3-fold
disparity (Dhugga, unpublished data). The plant thus becomes
susceptible to breakage. It has been determined that the breakage
occurs through the pulvinal zone at the base of the leaf
sheath.
[0299] Transgenic plants expressing the CesA genes are produced by
the method outlined in Example 5 or other suitable methods. The
expression pattern of eleven of the twelve maize CesA genes in the
pulvinal zone tissue is shown in FIG. 9. The twelfth, CesA9, had
the same tag at CesA4 to which it is very highly related. Seven of
the genes, CesA1, 4, 7, 8, 10, 11 and 12 are expressed at a higher
level than the remaining genes. CesA8 shows the highest expression
in this tissue. The expression of the various CesA genes,
particularly CesA8, in this tissue can be used to increase its
strength.
[0300] The above examples are provided to illustrate the invention
but not to limit its scope. Other variants of the invention will be
readily apparent to one of ordinary skill in the art and are
encompassed by the appended claims. All publications, patents,
patent applications, and computer programs cited herein are hereby
incorporated by reference.
Sequence CWU 1
1
5213780DNAZea mays 1gtcgacccac gcgtccgcag cagcagaagc actgcgcggc
attgcagcga tcgagcggga 60ggaatttggg gcatggtggt cgccaacgcc gctcggatct
agaggcccgc acgggccgat 120tggtctccgc ccgcctcgtc ggtgttggtg
tcgttggcgt gtggagccgt ctcggtggga 180gcagcgggga gggagcggag
atggcggcca acaaggggat ggtggcgggc tcgcacaacc 240gcaacgagtt
cgtcatgatc cgccacgacg gcgatgtgcc gggctcggct aagcccacaa
300agagtgcgaa tggacaggtc tgccagattt gcggtgactc tgtgggtgtt
tcagccactg 360gtgatgtctt tgttgcctgc aatgagtgtg ccttccctgt
ctgccgccca tgctatgagt 420atgagcgcaa ggaggggaac caatgctgcc
cccagtgcaa gactagatac aagagacaga 480aaggtagccc tcgagttcat
ggtgatgagg atgaggaaga tgttgatgac ctagacaatg 540aattcaacta
caagcaaggc agtgggaaag gcccagagtg gcaactgcaa ggagatgatg
600ctgatctgtc ttcatctgct cgccatgagc cacatcatcg gattccacgc
ctgacaagcg 660gtcaacagat atctggagag attcctgatg cttcccctga
ccgtcattct atccgcagtc 720caacatcgag ctatgttgat ccaagcgtcc
cagttcctgt gaggattgtg gacccctcga 780aggacttgaa ttcctatggg
cttaatagtg ttgactggaa ggaaagagtt gagagctgga 840gggttaaaca
ggacaaaaat atgatgcaag tgactaataa atatccagag gctagaggag
900gagacatgga ggggactggc tcaaatggag aagatatgca aatggttgat
gatgcacggc 960tacctttgag ccgtatcgtg ccaatttcct caaaccagct
caacctttac cgggtagtga 1020tcattctccg tcttatcatc ctgtgcttct
tcttccagta tcgtgtcagt catccagtgc 1080gtgatgctta tggattatgg
ctagtatctg ttatctgcga ggtctggttt gccttgtctt 1140ggcttctaga
tcagttccca aaatggtatc caatcaaccg tgagacatat cttgacaggc
1200ttgcattgag gtatgataga gagggagagc catcacagct ggctcccatt
gatgtcttcg 1260tcagtacagt ggatccattg aaggaacctc cactgatcac
agccaacact gttttgtcca 1320ttctttctgt ggattaccct gttgacaaag
tgtcatgcta tgtttctgat gatggttcag 1380ctatgctgac ttttgagtct
ctctcagaaa ccgcagaatt tgctagaaag tgggttccct 1440tttgtaagaa
gcacaatatt gaaccaagag ctccagaatt ttactttgct caaaaaatag
1500attacctgaa ggacaaaatt caaccttcat ttgttaagga aagacgcgca
atgaagaggg 1560agtatgaaga attcaaagta agaatcaatg cccttgttgc
caaagcacag aaagtgcctg 1620aagaggggtg gaccatggct gatggaactg
catggcctgg gaataatcct agggaccatc 1680ctggcatgat tcaggttttc
ttggggcaca gtggtgggct cgacactgat ggaaatgagt 1740taccacgtct
tgtctatgtc tctcgtgaaa agagaccagg ctttcagcat cacaagaagg
1800ctggtgcaat gaatgcgctg attcgtgtat ctgctgtgct gacaaatggt
gcctatcttc 1860tcaatgtgga ttgcgaccat tacttcaata gcagcaaagc
tcttagagaa gcaatgtgct 1920tcatgatgga tccggctcta ggaaggaaaa
cttgttatgt acaatttcca cagagatttg 1980atggcattga cttgcacgat
cgatatgcta atcggaacat agttttcttt gatatcaaca 2040tgaaaggtct
ggatggcatt cagggtccag tttacgtggg aacaggatgc tgtttcaata
2100gacaggcttt gtatggatac gatcctgttt tgactgaagc tgatctggag
ccaaacattg 2160ttattaagag ctgctgtggt agaaggaaga aaaagaacaa
gagttatatg gatagtcaaa 2220gccgtattat gaagagaaca gaatcttcag
ctcccatctt caatatggaa gacatcgaag 2280agggtattga aggttacgag
gatgaaaggt cagtgcttat gtcccagagg aaattggaga 2340aacgctttgg
tcagtctcct attttcattg catccacctt tatgacacaa ggtggcatac
2400caccttcaac aaacccagct tctctactaa aggaagctat ccatgtcatc
agttgtggat 2460atgaggacaa aactgaatgg ggaaaagaga ttggctggat
ctatggttca gtaacggagg 2520atattctgac tgggtttaaa atgcatgcaa
ggggctggca atcaatctac tgcatgccac 2580cacgaccttg tttcaagggt
tctgcaccaa tcaatctttc cgatcgtctt aatcaggtgc 2640tccgttgggc
tcttgggtca gtggaaattc tgcttagtag acattgtcct atctggtatg
2700gttacaatgg acgattgaag cttttggaga ggctggctta catcaacact
attgtatatc 2760caatcacatc cattccgctt attgcctatt gtgtgcttcc
cgctatctgc ctccttacca 2820ataaatttat cattcctgag attagcaatt
atgctgggat gttcttcatt cttcttttcg 2880cctccatttt tgccactggt
atattggagc ttagatggag tggtgttggc attgaagatt 2940ggtggagaaa
tgagcagttt tgggttattg gtggcacctc tgcccatctc ttcgcagtgt
3000tccagggtct gctgaaagtg ttggctggga ttgataccaa cttcacagtt
acctcaaagg 3060catctgatga ggatggcgac tttgctgagc tatatgtgtt
caagtggacc agtttgctca 3120ttcctccgac cactgttctt gtcattaacc
tggtcggaat ggtggcagga atttcttatg 3180ccattaacag tggctaccaa
tcctggggtc cgctctttgg aaagctgttc ttctcgatct 3240gggtgatcct
ccatctctac cccttcctca agggtctcat gggaaggcag aaccgcacac
3300caacaatcgt cattgtctgg tccatccttc ttgcatctat cttctccttg
ctgtgggtga 3360agatcgatcc tttcatctcc ccgacacaga aagctgctgc
cttggggcaa tgtggcgtca 3420actgctgatc gagacagtga ctcttatttg
aagaggctca atcaagatct gccccctcgt 3480gtaaatacct gaggaggcta
gatgggaatt ccttttgttg taggtgagga tggatttgca 3540tctaagttat
gcctctgttc attagcttct tccgtgccgg tgctgctgcg gactaagaat
3600cacggagcct ttctaccttc catgtagcgc cagccagcag cgtaagatgt
gaattttgaa 3660gttttgttat gcgtgcagtt tattgtttta gagtaaatta
tcatttgttt gtgggaactg 3720ttcacacgag cttataatgg caatgctgtt
atttaaaaaa aaaaaaaaaa gggcggccgc 378021075PRTZea mays 2Met Ala Ala
Asn Lys Gly Met Val Ala Gly Ser His Asn Arg Asn Glu1 5 10 15 Phe
Val Met Ile Arg His Asp Gly Asp Val Pro Gly Ser Ala Lys Pro 20 25
30 Thr Lys Ser Ala Asn Gly Gln Val Cys Gln Ile Cys Gly Asp Ser Val
35 40 45 Gly Val Ser Ala Thr Gly Asp Val Phe Val Ala Cys Asn Glu
Cys Ala 50 55 60 Phe Pro Val Cys Arg Pro Cys Tyr Glu Tyr Glu Arg
Lys Glu Gly Asn65 70 75 80 Gln Cys Cys Pro Gln Cys Lys Thr Arg Tyr
Lys Arg Gln Lys Gly Ser 85 90 95 Pro Arg Val His Gly Asp Glu Asp
Glu Glu Asp Val Asp Asp Leu Asp 100 105 110 Asn Glu Phe Asn Tyr Lys
Gln Gly Ser Gly Lys Gly Pro Glu Trp Gln 115 120 125 Leu Gln Gly Asp
Asp Ala Asp Leu Ser Ser Ser Ala Arg His Glu Pro 130 135 140 His His
Arg Ile Pro Arg Leu Thr Ser Gly Gln Gln Ile Ser Gly Glu145 150 155
160 Ile Pro Asp Ala Ser Pro Asp Arg His Ser Ile Arg Ser Pro Thr Ser
165 170 175 Ser Tyr Val Asp Pro Ser Val Pro Val Pro Val Arg Ile Val
Asp Pro 180 185 190 Ser Lys Asp Leu Asn Ser Tyr Gly Leu Asn Ser Val
Asp Trp Lys Glu 195 200 205 Arg Val Glu Ser Trp Arg Val Lys Gln Asp
Lys Asn Met Met Gln Val 210 215 220 Thr Asn Lys Tyr Pro Glu Ala Arg
Gly Gly Asp Met Glu Gly Thr Gly225 230 235 240 Ser Asn Gly Glu Asp
Met Gln Met Val Asp Asp Ala Arg Leu Pro Leu 245 250 255 Ser Arg Ile
Val Pro Ile Ser Ser Asn Gln Leu Asn Leu Tyr Arg Val 260 265 270 Val
Ile Ile Leu Arg Leu Ile Ile Leu Cys Phe Phe Phe Gln Tyr Arg 275 280
285 Val Ser His Pro Val Arg Asp Ala Tyr Gly Leu Trp Leu Val Ser Val
290 295 300 Ile Cys Glu Val Trp Phe Ala Leu Ser Trp Leu Leu Asp Gln
Phe Pro305 310 315 320 Lys Trp Tyr Pro Ile Asn Arg Glu Thr Tyr Leu
Asp Arg Leu Ala Leu 325 330 335 Arg Tyr Asp Arg Glu Gly Glu Pro Ser
Gln Leu Ala Pro Ile Asp Val 340 345 350 Phe Val Ser Thr Val Asp Pro
Leu Lys Glu Pro Pro Leu Ile Thr Ala 355 360 365 Asn Thr Val Leu Ser
Ile Leu Ser Val Asp Tyr Pro Val Asp Lys Val 370 375 380 Ser Cys Tyr
Val Ser Asp Asp Gly Ser Ala Met Leu Thr Phe Glu Ser385 390 395 400
Leu Ser Glu Thr Ala Glu Phe Ala Arg Lys Trp Val Pro Phe Cys Lys 405
410 415 Lys His Asn Ile Glu Pro Arg Ala Pro Glu Phe Tyr Phe Ala Gln
Lys 420 425 430 Ile Asp Tyr Leu Lys Asp Lys Ile Gln Pro Ser Phe Val
Lys Glu Arg 435 440 445 Arg Ala Met Lys Arg Glu Tyr Glu Glu Phe Lys
Val Arg Ile Asn Ala 450 455 460 Leu Val Ala Lys Ala Gln Lys Val Pro
Glu Glu Gly Trp Thr Met Ala465 470 475 480 Asp Gly Thr Ala Trp Pro
Gly Asn Asn Pro Arg Asp His Pro Gly Met 485 490 495 Ile Gln Val Phe
Leu Gly His Ser Gly Gly Leu Asp Thr Asp Gly Asn 500 505 510 Glu Leu
Pro Arg Leu Val Tyr Val Ser Arg Glu Lys Arg Pro Gly Phe 515 520 525
Gln His His Lys Lys Ala Gly Ala Met Asn Ala Leu Ile Arg Val Ser 530
535 540 Ala Val Leu Thr Asn Gly Ala Tyr Leu Leu Asn Val Asp Cys Asp
His545 550 555 560 Tyr Phe Asn Ser Ser Lys Ala Leu Arg Glu Ala Met
Cys Phe Met Met 565 570 575 Asp Pro Ala Leu Gly Arg Lys Thr Cys Tyr
Val Gln Phe Pro Gln Arg 580 585 590 Phe Asp Gly Ile Asp Leu His Asp
Arg Tyr Ala Asn Arg Asn Ile Val 595 600 605 Phe Phe Asp Ile Asn Met
Lys Gly Leu Asp Gly Ile Gln Gly Pro Val 610 615 620 Tyr Val Gly Thr
Gly Cys Cys Phe Asn Arg Gln Ala Leu Tyr Gly Tyr625 630 635 640 Asp
Pro Val Leu Thr Glu Ala Asp Leu Glu Pro Asn Ile Val Ile Lys 645 650
655 Ser Cys Cys Gly Arg Arg Lys Lys Lys Asn Lys Ser Tyr Met Asp Ser
660 665 670 Gln Ser Arg Ile Met Lys Arg Thr Glu Ser Ser Ala Pro Ile
Phe Asn 675 680 685 Met Glu Asp Ile Glu Glu Gly Ile Glu Gly Tyr Glu
Asp Glu Arg Ser 690 695 700 Val Leu Met Ser Gln Arg Lys Leu Glu Lys
Arg Phe Gly Gln Ser Pro705 710 715 720 Ile Phe Ile Ala Ser Thr Phe
Met Thr Gln Gly Gly Ile Pro Pro Ser 725 730 735 Thr Asn Pro Ala Ser
Leu Leu Lys Glu Ala Ile His Val Ile Ser Cys 740 745 750 Gly Tyr Glu
Asp Lys Thr Glu Trp Gly Lys Glu Ile Gly Trp Ile Tyr 755 760 765 Gly
Ser Val Thr Glu Asp Ile Leu Thr Gly Phe Lys Met His Ala Arg 770 775
780 Gly Trp Gln Ser Ile Tyr Cys Met Pro Pro Arg Pro Cys Phe Lys
Gly785 790 795 800 Ser Ala Pro Ile Asn Leu Ser Asp Arg Leu Asn Gln
Val Leu Arg Trp 805 810 815 Ala Leu Gly Ser Val Glu Ile Leu Leu Ser
Arg His Cys Pro Ile Trp 820 825 830 Tyr Gly Tyr Asn Gly Arg Leu Lys
Leu Leu Glu Arg Leu Ala Tyr Ile 835 840 845 Asn Thr Ile Val Tyr Pro
Ile Thr Ser Ile Pro Leu Ile Ala Tyr Cys 850 855 860 Val Leu Pro Ala
Ile Cys Leu Leu Thr Asn Lys Phe Ile Ile Pro Glu865 870 875 880 Ile
Ser Asn Tyr Ala Gly Met Phe Phe Ile Leu Leu Phe Ala Ser Ile 885 890
895 Phe Ala Thr Gly Ile Leu Glu Leu Arg Trp Ser Gly Val Gly Ile Glu
900 905 910 Asp Trp Trp Arg Asn Glu Gln Phe Trp Val Ile Gly Gly Thr
Ser Ala 915 920 925 His Leu Phe Ala Val Phe Gln Gly Leu Leu Lys Val
Leu Ala Gly Ile 930 935 940 Asp Thr Asn Phe Thr Val Thr Ser Lys Ala
Ser Asp Glu Asp Gly Asp945 950 955 960 Phe Ala Glu Leu Tyr Val Phe
Lys Trp Thr Ser Leu Leu Ile Pro Pro 965 970 975 Thr Thr Val Leu Val
Ile Asn Leu Val Gly Met Val Ala Gly Ile Ser 980 985 990 Tyr Ala Ile
Asn Ser Gly Tyr Gln Ser Trp Gly Pro Leu Phe Gly Lys 995 1000 1005
Leu Phe Phe Ser Ile Trp Val Ile Leu His Leu Tyr Pro Phe Leu Lys
1010 1015 1020 Gly Leu Met Gly Arg Gln Asn Arg Thr Pro Thr Ile Val
Ile Val Trp1025 1030 1035 1040Ser Ile Leu Leu Ala Ser Ile Phe Ser
Leu Leu Trp Val Lys Ile Asp 1045 1050 1055 Pro Phe Ile Ser Pro Thr
Gln Lys Ala Ala Ala Leu Gly Gln Cys Gly 1060 1065 1070 Val Asn Cys
1075325DNAZea mays 3atggcggcca acaaggggat ggtgg 25425DNAZea mays
4tcagcagttg acgccacatt gcccc 2552830DNAZea maysmisc_feature2809,
2818, 2824, 2826, 2829n = A,T,C or G 5tacctctaag tcgcatagtt
ccgatatctc caaacgagct taacctttat cggatcgtga 60ttgttctccg gcttatcatc
ctatgtttct tctttcaata tcgtataact catccagtgg 120aagatgctta
tgggttgtgg cttgtatctg ttatttgtga agtttggttt gccttgtctt
180ggcttctaga tcagttccca aagtggtatc ctatcaaccg tgaaacttac
ctcgatagac 240ttgcattgag atatgatagg gagggtgagc catcccagtt
ggctccaatc gatgtctttg 300ttagtacagt ggatccactt aaggaacctc
ctctaattac tggcaacact gtcctgtcca 360ttcttgctgt ggattaccct
gttgacaaag tatcatgtta tgtttctgat gacggttcag 420ctatgttgac
ttttgaagcg ctatctgaaa ccgcagagtt tgcaaggaaa tgggttccct
480tttgcaagaa acacaatatt gaacctaggg ctccagagtt ttactttgct
cgaaagatag 540attacctaaa ggacaaaata caaccttctt ttgtgaaaga
aaggcgggct atgaagaggg 600agtgtgaaga gttcaaagta cggatcgatg
cccttgttgc aaaagcgcaa aaaatacctg 660aggagggctg gaccatggct
gatggcactc cttggcctgg gaataaccct agagatcatc 720caggaatgat
ccaagtattc ttgggccaca gtggtgggct tgacacggat gggaatgagt
780tgccacggct tgtttatgtt tctcgtgaaa agaggccagg cttccagcac
cacaagaagg 840ctggtgccat gaatgctttg attcgcgtat cagctgtcct
gacgaatggt gcttatcttc 900ttaatgtgga ttgtgatcac tacttcaata
gcagcaaagc tcttagagag gctatgtgtt 960tcatgatgga tccagcacta
ggaaggaaaa cttgctatgt tcagtttcca caaagatttg 1020atggtataga
cttgcatgat cgatatgcaa accggaacat tgtcttcttt gatattaata
1080tgaagggtct agatggcatt caaggacctg tttatgtggg aacaggatgc
tgtttcaata 1140ggcaggcctt gtatggctat gatcctgtat tgacagaagc
tgatttggag cctaacatta 1200tcattaaaag ttgctgtggc ggaagaaaaa
agaaggacaa gagctatatt gattccaaaa 1260accgtgatat gaagagaaca
gaatcttcgg ctcccatctt caacatggaa gatatagaag 1320agggatttga
aggttacgag gatgaaaggt cactgcttat gtctcagaag agcttggaga
1380aacgctttgg ccagtctcca atttttattg catccacctt tatgactcaa
ggtggcatac 1440ccccttcaac aaacccaggt tccctgctaa aggaagctat
acatgtcatt agttgtggat 1500atgaggataa aacagaatgg gggaaagaga
tcggatggat atatggctct gttactgaag 1560atattttaac tggtttcaag
atgcatgcaa gaggttggat atccatctac tgcatgccac 1620ttcggccttg
cttcaagggt tctgctccaa ttaatctttc tgatcgtctc aaccaagtgt
1680tacgctgggc tcttggttca gttgaaattc tacttagcag acactgtcct
atctggtatg 1740gttacaatgg aaggctaaag cttctggaga gactggcata
catcaacacc attgtttatc 1800caattacatc tatcccacta gtagcatact
gcgtccttcc tgctatctgt ttactcacca 1860acaaatttat tattcctgcg
attagcaatt atgctggggc gttcttcatc ctgctttttg 1920cttccatctt
cgccactggt attttggagc ttcgatggag tggtgttggc attgaggatt
1980ggtggagaaa tgagcagttt tgggtcattg gtggcacctc tgcacatctc
tttgctgtgt 2040tccaaggtct cttaaaagtg ctagcaggga tcgacacaaa
cttcacggtc acatcaaagg 2100caaccgatga tgatggtgat tttgctgagc
tgtatgtgtt caagtggaca actcttctga 2160tcccccccac cactgtgctt
gtgattaacc tggttggtat agtggctgga gtgtcgtatg 2220ctatcaacag
tggctaccaa tcatggggtc cactattcgg gaagctgttc tttgcaatct
2280gggtgatcct ccacctctac cctttcctga agggtctcat ggggaagcag
aaccgcacac 2340cgaccatcgt catcgtttgg tccgtccttc ttgcttccat
attctcgctg ctgtgggtga 2400agatcgaccc cttcatatcc cctacccaga
aggctctttc ccgtgggcag tgtggtgtaa 2460actgctgaaa tgatccgaac
tgcctgctga ataacattgc tccggcacaa tcatgatcta 2520ccccttcgtg
taaataccag aggttaggca agacttttct tggtaggtgg cgaagatgtg
2580tcgtttaagt tcactctact gcatttgggg tgggcagcat gaaactttgt
caacttatgt 2640cgtgctactt atttgtagct aagtagcagt aagtagtgcc
tgtttcatgt tgactgtcgt 2700gactacctgt tcaccgtggg ctctggactg
tcgtgatgta acctgtatgt tggaacttca 2760agtactgatt gagctgtttg
gtcaatgaca ttgagggatt ctctctctng aaattaanac 2820aaantnggnt
28306821PRTZea mays 6Pro Leu Ser Arg Ile Val Pro Ile Ser Pro Asn
Glu Leu Asn Leu Tyr1 5 10 15 Arg Ile Val Ile Val Leu Arg Leu Ile
Ile Leu Cys Phe Phe Phe Gln 20 25 30 Tyr Arg Ile Thr His Pro Val
Glu Asp Ala Tyr Gly Leu Trp Leu Val 35 40 45 Ser Val Ile Cys Glu
Val Trp Phe Ala Leu Ser Trp Leu Leu Asp Gln 50 55 60 Phe Pro Lys
Trp Tyr Pro Ile Asn Arg Glu Thr Tyr Leu Asp Arg Leu65 70 75 80 Ala
Leu Arg Tyr Asp Arg Glu Gly Glu Pro Ser Gln Leu Ala Pro Ile 85 90
95 Asp Val Phe Val Ser Thr Val Asp Pro Leu Lys Glu Pro Pro Leu Ile
100 105 110 Thr Gly Asn Thr Val Leu Ser Ile Leu Ala Val Asp Tyr Pro
Val Asp 115 120 125 Lys Val Ser Cys Tyr Val Ser Asp Asp Gly Ser Ala
Met Leu Thr Phe 130 135 140 Glu Ala Leu Ser Glu Thr Ala Glu Phe Ala
Arg Lys Trp Val Pro Phe145 150 155 160 Cys Lys Lys His Asn Ile Glu
Pro Arg Ala Pro Glu Phe Tyr Phe Ala 165 170 175 Arg Lys Ile Asp
Tyr Leu Lys Asp Lys Ile Gln Pro Ser Phe Val Lys 180 185 190 Glu Arg
Arg Ala Met Lys Arg Glu Cys Glu Glu Phe Lys Val Arg Ile 195 200 205
Asp Ala Leu Val Ala Lys Ala Gln Lys Ile Pro Glu Glu Gly Trp Thr 210
215 220 Met Ala Asp Gly Thr Pro Trp Pro Gly Asn Asn Pro Arg Asp His
Pro225 230 235 240 Gly Met Ile Gln Val Phe Leu Gly His Ser Gly Gly
Leu Asp Thr Asp 245 250 255 Gly Asn Glu Leu Pro Arg Leu Val Tyr Val
Ser Arg Glu Lys Arg Pro 260 265 270 Gly Phe Gln His His Lys Lys Ala
Gly Ala Met Asn Ala Leu Ile Arg 275 280 285 Val Ser Ala Val Leu Thr
Asn Gly Ala Tyr Leu Leu Asn Val Asp Cys 290 295 300 Asp His Tyr Phe
Asn Ser Ser Lys Ala Leu Arg Glu Ala Met Cys Phe305 310 315 320 Met
Met Asp Pro Ala Leu Gly Arg Lys Thr Cys Tyr Val Gln Phe Pro 325 330
335 Gln Arg Phe Asp Gly Ile Asp Leu His Asp Arg Tyr Ala Asn Arg Asn
340 345 350 Ile Val Phe Phe Asp Ile Asn Met Lys Gly Leu Asp Gly Ile
Gln Gly 355 360 365 Pro Val Tyr Val Gly Thr Gly Cys Cys Phe Asn Arg
Gln Ala Leu Tyr 370 375 380 Gly Tyr Asp Pro Val Leu Thr Glu Ala Asp
Leu Glu Pro Asn Ile Ile385 390 395 400 Ile Lys Ser Cys Cys Gly Gly
Arg Lys Lys Lys Asp Lys Ser Tyr Ile 405 410 415 Asp Ser Lys Asn Arg
Asp Met Lys Arg Thr Glu Ser Ser Ala Pro Ile 420 425 430 Phe Asn Met
Glu Asp Ile Glu Glu Gly Phe Glu Gly Tyr Glu Asp Glu 435 440 445 Arg
Ser Leu Leu Met Ser Gln Lys Ser Leu Glu Lys Arg Phe Gly Gln 450 455
460 Ser Pro Ile Phe Ile Ala Ser Thr Phe Met Thr Gln Gly Gly Ile
Pro465 470 475 480 Pro Ser Thr Asn Pro Gly Ser Leu Leu Lys Glu Ala
Ile His Val Ile 485 490 495 Ser Cys Gly Tyr Glu Asp Lys Thr Glu Trp
Gly Lys Glu Ile Gly Trp 500 505 510 Ile Tyr Gly Ser Val Thr Glu Asp
Ile Leu Thr Gly Phe Lys Met His 515 520 525 Ala Arg Gly Trp Ile Ser
Ile Tyr Cys Met Pro Leu Arg Pro Cys Phe 530 535 540 Lys Gly Ser Ala
Pro Ile Asn Leu Ser Asp Arg Leu Asn Gln Val Leu545 550 555 560 Arg
Trp Ala Leu Gly Ser Val Glu Ile Leu Leu Ser Arg His Cys Pro 565 570
575 Ile Trp Tyr Gly Tyr Asn Gly Arg Leu Lys Leu Leu Glu Arg Leu Ala
580 585 590 Tyr Ile Asn Thr Ile Val Tyr Pro Ile Thr Ser Ile Pro Leu
Val Ala 595 600 605 Tyr Cys Val Leu Pro Ala Ile Cys Leu Leu Thr Asn
Lys Phe Ile Ile 610 615 620 Pro Ala Ile Ser Asn Tyr Ala Gly Ala Phe
Phe Ile Leu Leu Phe Ala625 630 635 640 Ser Ile Phe Ala Thr Gly Ile
Leu Glu Leu Arg Trp Ser Gly Val Gly 645 650 655 Ile Glu Asp Trp Trp
Arg Asn Glu Gln Phe Trp Val Ile Gly Gly Thr 660 665 670 Ser Ala His
Leu Phe Ala Val Phe Gln Gly Leu Leu Lys Val Leu Ala 675 680 685 Gly
Ile Asp Thr Asn Phe Thr Val Thr Ser Lys Ala Thr Asp Asp Asp 690 695
700 Gly Asp Phe Ala Glu Leu Tyr Val Phe Lys Trp Thr Thr Leu Leu
Ile705 710 715 720 Pro Pro Thr Thr Val Leu Val Ile Asn Leu Val Gly
Ile Val Ala Gly 725 730 735 Val Ser Tyr Ala Ile Asn Ser Gly Tyr Gln
Ser Trp Gly Pro Leu Phe 740 745 750 Gly Lys Leu Phe Phe Ala Ile Trp
Val Ile Leu His Leu Tyr Pro Phe 755 760 765 Leu Lys Gly Leu Met Gly
Lys Gln Asn Arg Thr Pro Thr Ile Val Ile 770 775 780 Val Trp Ser Val
Leu Leu Ala Ser Ile Phe Ser Leu Leu Trp Val Lys785 790 795 800 Ile
Asp Pro Phe Ile Ser Pro Thr Gln Lys Ala Leu Ser Arg Gly Gln 805 810
815 Cys Gly Val Asn Cys 820 725DNAZea mays 7cctctaagtc gcatagttcc
gatat 25825DNAZea mays 8tcagcagttt acaccacact gccca 2593773DNAZea
mays 9gtcgacccac gcgtccgcta ggatcaaaac cgtctcgccg ctgcaataat
cttttgtcaa 60ttcttaatcc ctcgcgtcga cagcgacagc ggaaccaact cacgttgccg
cggcttcctc 120catcggtgcg gtgccctgtc cttttctctc gtccctcctc
cccccgtata gttaagcccc 180gccccgctac tactactact agcagcagca
gcgctctcgc agcgggagat gcggtgttga 240tccgtgcccc gctcggatct
cgggactggt gccggctctg cccaggcccc aggctccagg 300ccagctccct
cgacgtttct cggcgagctc gcttgccatg gagggcgacg cggacggcgt
360gaagtcgggg aggcgcggtg gcggacaggt gtgccagatc tgcggcgacg
gcgtgggcac 420cacggcggag ggggacgtct tcgccgcctg cgacgtctgc
gggtttccgg tgtgccgccc 480ctgctacgag tacgagcgca aggacggcac
gcaggcgtgc ccccagtgca agaccaagta 540caagcgccac aaggggagcc
cggcgatccg tggggaggaa ggagacgaca ctgatgccga 600tagcgacttc
aattaccttg catctggcaa tgaggaccag aagcagaaga ttgccgacag
660aatgcgcagc tggcgcatga acgttggggg cagcggggat gttggtcgcc
ccaagtatga 720cagtggcgag atcgggctta ccaagtatga cagtggcgag
attcctcggg gatacatccc 780atcagtcact aacagccaga tctcaggaga
aatccctggt gcttcccctg accatcatat 840gatgtcccca actgggaaca
ttggcaagcg tgctccattt ccctatgtga accattcgcc 900aaatccgtca
agggagttct ctggtagcat tgggaatgtt gcctggaaag agagggttga
960tggctggaaa atgaagcagg acaaggggac gattcccatg acgaatggca
caagcattgc 1020tccctctgag ggtcggggtg ttggtgatat tgatgcatca
actgattaca acatggaaga 1080tgccttattg aacgacgaaa ctcgacagcc
tctatctagg aaagttccac ttccttcctc 1140caggataaat ccatacagga
tggtcattgt gctgcgattg attgttctaa gcatcttctt 1200gcactaccgt
atcacaaatc ctgtgcgcaa tgcataccca ttatggcttc tatctgttat
1260atgtgagatc tggtttgctc tttcgtggat attggatcag ttccctaagt
ggtttccaat 1320caaccgggag acgtaccttg ataggctggc attaaggtat
gaccgggaag gtgagccatc 1380tcagttggct gctgttgaca ttttcgtcag
tacagtcgac ccaatgaagg agcctcctct 1440tgtcactgcc aataccgtgc
tatccattct tgctgtggat taccctgtgg ataaggtctc 1500ttgctatgta
tctgatgatg gagctgcgat gctgacattt gatgcactag ctgagacttc
1560agagtttgct agaaaatggg taccatttgt taagaagtac aacattgaac
ctagagctcc 1620tgaatggtac ttctcccaga aaattgatta cttgaaggac
aaagtgcacc cttcatttgt 1680taaagaccgc cgggccatga agagagaata
tgaagaattc aaagttaggg taaatggcct 1740tgttgctaag gcacagaaag
ttcctgagga aggatggatc atgcaagatg gcacaccatg 1800gccaggaaac
aataccaggg accatcctgg aatgattcag gttttccttg gtcacagtgg
1860tggccttgat actgagggca atgagctacc ccgtttggtc tatgtttctc
gtgaaaagcg 1920tcctggattc cagcatcaca agaaagctgg tgccatgaat
gctcttgttc gtgtctcagc 1980tgtgcttacc aatggacaat acatgttgaa
tcttgattgt gatcactaca ttaacaacag 2040taaggctctc agggaagcta
tgtgcttcct tatggaccct aacctaggaa ggagtgtctg 2100ctacgtccag
tttccccaga gattcgatgg cattgacagg aatgatcgat atgccaacag
2160gaacaccgtg tttttcgata ttaacttgag aggtcttgat ggcatccaag
gaccagttta 2220tgtcggaact ggctgtgttt tcaaccgaac agctctatat
ggttatgagc ccccaattaa 2280gcagaagaag ggtggtttct tgtcatcact
atgtggcggt aggaagaagg caagcaaatc 2340aaagaagggc tcggacaaga
agaagtcgca gaagcatgtg gacagttctg tgccagtatt 2400caaccttgaa
gatatagagg agggagttga aggcgctgga tttgacgacg agaaatcact
2460tcttatgtct caaatgagcc tggagaagag atttggccag tccgcagcgt
ttgttgcctc 2520cactctgatg gagtatggtg gtgttcctca gtccgcaact
ccggagtctc ttctgaaaga 2580agctatccat gttataagct gtggctatga
ggacaagact gaatggggaa ctgagatcgg 2640gtggatctac ggttctgtga
cagaagacat tctcaccgga ttcaagatgc acgcgcgagg 2700ctggcggtcg
atctactgca tgcccaagcg gccagctttc aaggggtctg cccccatcaa
2760tctttcggac cgtctgaacc aggtgctccg gtgggctctt gggtccgtgg
agatcctctt 2820cagccggcac tgccccctgt ggtacggcta cggagggcgg
ctcaagttcc tggagagatt 2880cgcgtacatc aacaccacca tctacccgct
cacgtccatc ccgcttctca tctactgcat 2940cctgcccgcc atctgtctgc
tcaccggaaa gttcatcatt ccagagatca gcaacttcgc 3000cagcatctgg
ttcatctccc tcttcatctc gatcttcgcc acgggcatcc tggagatgag
3060gtggagcggg gtgggcatcg acgagtggtg gaggaacgag cagttctggg
tgatcggggg 3120catctccgcg cacctcttcg ccgtgttcca gggcctgctc
aaggtgctgg ccggcatcga 3180caccaacttc accgtcacct ccaaggcctc
ggacgaggac ggcgacttcg cggagctgta 3240catgttcaag tggacgacgc
tcctgatccc gcccaccacc atcctgatca tcaacctggt 3300cggcgtcgtc
gccggcatct cctacgccat caacagcgga taccagtcgt ggggcccgct
3360cttcggcaag ctcttcttcg ccttctgggt catcgtccac ctgtacccgt
tcctcaaggg 3420cctcatgggc aggcagaacc gcaccccgac catcgtcgtc
gtctgggcca tcctgctggc 3480gtccatcttc tccttgctgt gggttcgcat
cgaccccttc accacccgcg tcactggccc 3540ggatacccag acgtgtggca
tcaactgcta gggaagtgga aggtttgtac tttgtagaaa 3600cggaggaata
ccacgtgcca tctgttgtct gttaagttat atatatataa gcagcaagtg
3660gcgttattta cagctacgta cagaccagtg gatattgttt accacaaagt
tttacttgtg 3720ttaatatgca ttcttttgtt gatataaaaa aaaaaaaaaa
aaagggcggc cgc 3773101077PRTZea mays 10Met Glu Gly Asp Ala Asp Gly
Val Lys Ser Gly Arg Arg Gly Gly Gly1 5 10 15 Gln Val Cys Gln Ile
Cys Gly Asp Gly Val Gly Thr Thr Ala Glu Gly 20 25 30 Asp Val Phe
Ala Ala Cys Asp Val Cys Gly Phe Pro Val Cys Arg Pro 35 40 45 Cys
Tyr Glu Tyr Glu Arg Lys Asp Gly Thr Gln Ala Cys Pro Gln Cys 50 55
60 Lys Thr Lys Tyr Lys Arg His Lys Gly Ser Pro Ala Ile Arg Gly
Glu65 70 75 80 Glu Gly Asp Asp Thr Asp Ala Asp Ser Asp Phe Asn Tyr
Leu Ala Ser 85 90 95 Gly Asn Glu Asp Gln Lys Gln Lys Ile Ala Asp
Arg Met Arg Ser Trp 100 105 110 Arg Met Asn Val Gly Gly Ser Gly Asp
Val Gly Arg Pro Lys Tyr Asp 115 120 125 Ser Gly Glu Ile Gly Leu Thr
Lys Tyr Asp Ser Gly Glu Ile Pro Arg 130 135 140 Gly Tyr Ile Pro Ser
Val Thr Asn Ser Gln Ile Ser Gly Glu Ile Pro145 150 155 160 Gly Ala
Ser Pro Asp His His Met Met Ser Pro Thr Gly Asn Ile Gly 165 170 175
Lys Arg Ala Pro Phe Pro Tyr Val Asn His Ser Pro Asn Pro Ser Arg 180
185 190 Glu Phe Ser Gly Ser Ile Gly Asn Val Ala Trp Lys Glu Arg Val
Asp 195 200 205 Gly Trp Lys Met Lys Gln Asp Lys Gly Thr Ile Pro Met
Thr Asn Gly 210 215 220 Thr Ser Ile Ala Pro Ser Glu Gly Arg Gly Val
Gly Asp Ile Asp Ala225 230 235 240 Ser Thr Asp Tyr Asn Met Glu Asp
Ala Leu Leu Asn Asp Glu Thr Arg 245 250 255 Gln Pro Leu Ser Arg Lys
Val Pro Leu Pro Ser Ser Arg Ile Asn Pro 260 265 270 Tyr Arg Met Val
Ile Val Leu Arg Leu Ile Val Leu Ser Ile Phe Leu 275 280 285 His Tyr
Arg Ile Thr Asn Pro Val Arg Asn Ala Tyr Pro Leu Trp Leu 290 295 300
Leu Ser Val Ile Cys Glu Ile Trp Phe Ala Leu Ser Trp Ile Leu Asp305
310 315 320 Gln Phe Pro Lys Trp Phe Pro Ile Asn Arg Glu Thr Tyr Leu
Asp Arg 325 330 335 Leu Ala Leu Arg Tyr Asp Arg Glu Gly Glu Pro Ser
Gln Leu Ala Ala 340 345 350 Val Asp Ile Phe Val Ser Thr Val Asp Pro
Met Lys Glu Pro Pro Leu 355 360 365 Val Thr Ala Asn Thr Val Leu Ser
Ile Leu Ala Val Asp Tyr Pro Val 370 375 380 Asp Lys Val Ser Cys Tyr
Val Ser Asp Asp Gly Ala Ala Met Leu Thr385 390 395 400 Phe Asp Ala
Leu Ala Glu Thr Ser Glu Phe Ala Arg Lys Trp Val Pro 405 410 415 Phe
Val Lys Lys Tyr Asn Ile Glu Pro Arg Ala Pro Glu Trp Tyr Phe 420 425
430 Ser Gln Lys Ile Asp Tyr Leu Lys Asp Lys Val His Pro Ser Phe Val
435 440 445 Lys Asp Arg Arg Ala Met Lys Arg Glu Tyr Glu Glu Phe Lys
Val Arg 450 455 460 Val Asn Gly Leu Val Ala Lys Ala Gln Lys Val Pro
Glu Glu Gly Trp465 470 475 480 Ile Met Gln Asp Gly Thr Pro Trp Pro
Gly Asn Asn Thr Arg Asp His 485 490 495 Pro Gly Met Ile Gln Val Phe
Leu Gly His Ser Gly Gly Leu Asp Thr 500 505 510 Glu Gly Asn Glu Leu
Pro Arg Leu Val Tyr Val Ser Arg Glu Lys Arg 515 520 525 Pro Gly Phe
Gln His His Lys Lys Ala Gly Ala Met Asn Ala Leu Val 530 535 540 Arg
Val Ser Ala Val Leu Thr Asn Gly Gln Tyr Met Leu Asn Leu Asp545 550
555 560 Cys Asp His Tyr Ile Asn Asn Ser Lys Ala Leu Arg Glu Ala Met
Cys 565 570 575 Phe Leu Met Asp Pro Asn Leu Gly Arg Ser Val Cys Tyr
Val Gln Phe 580 585 590 Pro Gln Arg Phe Asp Gly Ile Asp Arg Asn Asp
Arg Tyr Ala Asn Arg 595 600 605 Asn Thr Val Phe Phe Asp Ile Asn Leu
Arg Gly Leu Asp Gly Ile Gln 610 615 620 Gly Pro Val Tyr Val Gly Thr
Gly Cys Val Phe Asn Arg Thr Ala Leu625 630 635 640 Tyr Gly Tyr Glu
Pro Pro Ile Lys Gln Lys Lys Gly Gly Phe Leu Ser 645 650 655 Ser Leu
Cys Gly Gly Arg Lys Lys Ala Ser Lys Ser Lys Lys Gly Ser 660 665 670
Asp Lys Lys Lys Ser Gln Lys His Val Asp Ser Ser Val Pro Val Phe 675
680 685 Asn Leu Glu Asp Ile Glu Glu Gly Val Glu Gly Ala Gly Phe Asp
Asp 690 695 700 Glu Lys Ser Leu Leu Met Ser Gln Met Ser Leu Glu Lys
Arg Phe Gly705 710 715 720 Gln Ser Ala Ala Phe Val Ala Ser Thr Leu
Met Glu Tyr Gly Gly Val 725 730 735 Pro Gln Ser Ala Thr Pro Glu Ser
Leu Leu Lys Glu Ala Ile His Val 740 745 750 Ile Ser Cys Gly Tyr Glu
Asp Lys Thr Glu Trp Gly Thr Glu Ile Gly 755 760 765 Trp Ile Tyr Gly
Ser Val Thr Glu Asp Ile Leu Thr Gly Phe Lys Met 770 775 780 His Ala
Arg Gly Trp Arg Ser Ile Tyr Cys Met Pro Lys Arg Pro Ala785 790 795
800 Phe Lys Gly Ser Ala Pro Ile Asn Leu Ser Asp Arg Leu Asn Gln Val
805 810 815 Leu Arg Trp Ala Leu Gly Ser Val Glu Ile Leu Phe Ser Arg
His Cys 820 825 830 Pro Leu Trp Tyr Gly Tyr Gly Gly Arg Leu Lys Phe
Leu Glu Arg Phe 835 840 845 Ala Tyr Ile Asn Thr Thr Ile Tyr Pro Leu
Thr Ser Ile Pro Leu Leu 850 855 860 Ile Tyr Cys Ile Leu Pro Ala Ile
Cys Leu Leu Thr Gly Lys Phe Ile865 870 875 880 Ile Pro Glu Ile Ser
Asn Phe Ala Ser Ile Trp Phe Ile Ser Leu Phe 885 890 895 Ile Ser Ile
Phe Ala Thr Gly Ile Leu Glu Met Arg Trp Ser Gly Val 900 905 910 Gly
Ile Asp Glu Trp Trp Arg Asn Glu Gln Phe Trp Val Ile Gly Gly 915 920
925 Ile Ser Ala His Leu Phe Ala Val Phe Gln Gly Leu Leu Lys Val Leu
930 935 940 Ala Gly Ile Asp Thr Asn Phe Thr Val Thr Ser Lys Ala Ser
Asp Glu945 950 955 960 Asp Gly Asp Phe Ala Glu Leu Tyr Met Phe Lys
Trp Thr Thr Leu Leu 965 970 975 Ile Pro Pro Thr Thr Ile Leu Ile Ile
Asn Leu Val Gly Val Val Ala 980 985 990 Gly Ile Ser Tyr Ala Ile Asn
Ser Gly Tyr Gln Ser Trp Gly Pro Leu 995 1000 1005 Phe Gly Lys Leu
Phe Phe Ala Phe Trp Val Ile Val His Leu Tyr Pro 1010 1015 1020 Phe
Leu Lys Gly Leu Met Gly Arg Gln Asn Arg Thr Pro Thr Ile Val1025
1030 1035 1040Val Val Trp Ala Ile Leu Leu Ala Ser Ile Phe Ser Leu
Leu Trp Val 1045 1050 1055 Arg Ile Asp Pro Phe Thr Thr Arg Val Thr
Gly Pro Asp Thr Gln Thr
1060 1065 1070 Cys Gly Ile Asn Cys 1075 1125DNAZea mays
11atggagggcg acgcggacgg cgtga 251225DNAZea mays 12ctagcagttg
atgccacacg tctgg 25133704DNAZea mays 13gtcgacccac gcttccggtc
ggttccgcgt cccttttccc ctcccccctc cgtcgccgcc 60tcgagcgagc tccaccactt
gctcctgcgc gaggtgaaca ctgggttagg gccactgcca 120ccgctgggct
gcctctgctt ctgcctctcc cgccagcgcg cgagcccggg ggcgattcgg
180cgccggcacg cgggagggga agccgaggaa tgcggtgagt cggcgggggt
ccggcgtttg 240tgaactcgtg gagggctcgg attggtgcgc catggacggc
ggcgacgcca cgaattcggg 300gaagcatgtg gccgggcagg tgtgccagat
ctgcggcgac ggcgtgggca ccgcggcgga 360cggcgacctc ttcaccgcct
gcgacgtctg cggcttcccc gtgtgccgcc catgctacga 420gtacgagcgc
aaggacggca cccaggcgtg cccgcagtgc aagactaagt acaagcgcca
480caaagggagc ccaccagtac acggtgagga aaatgaggat gtggatgctg
acgatgtgag 540tgactacaac taccaagcat ctggcaacca ggatcagaag
caaaagattg ctgagagaat 600gctcacttgg cggacaaact cacgtggcag
tgatattggc ctggctaagt atgacagcgg 660tgaaattggg catgggaagt
atgacagtgg tgagatccct cgtggatata tcccgtcact 720aactcatagc
cagatctcag gagagattcc tggagcttcc cctgatcata tgatgtctcc
780tgttgggaac attggcaggc gtggacatca atttccttat gtaaatcatt
ctccaaaccc 840atcgagggag ttctccggta gccttggcaa tgttgcatgg
aaagagaggg tggatggatg 900gaaaatgaag gataaaggtg caattcctat
gaccaatgga acaagcattg ctccatcaga 960agggcgtgga gttgctgata
ttgatgcttc tactgattat aacatggaag atgccttact 1020gaatgatgaa
actcggcaac ctctatctag aaaagtgcca attccttcat ccagaataaa
1080tccgtacaga atggtcattg tgctacgttt ggctgttcta tgcatattct
tgcgctaccg 1140tatcacacat cctgtgaaca atgcatatcc actgtggctt
ttatccgtca tatgtgagat 1200ctggtttgct ttgtcctgga ttttggatca
gttcccaaag tggtccccaa tcaaccgtga 1260aacatacctt gatagactgg
ctttaaggta tgaccgagaa ggtgaaccat ctcaattagc 1320tcctgttgat
atttttgtca gtactgtgga tccaatgaag gagcctcctc ttgtcactgc
1380aaatactgtg ctttccatcc ttgctgtcga ttatccggtt gacaaggtat
cttgctatgt 1440ttcggatgat ggagctgcta tgctgacttt tgatgctctc
tctgaaactt cagagtttgc 1500tagaaaatgg gttccgttct gtaagaagta
caacatagag cctagggccc cggaatggta 1560ctttgctcag aaaattgatt
acttgaaaga caaagttcaa acctcatttg tgaaagaacg 1620ccgggccatg
aagagagaat atgaagaatt caaagttcgt atcaatggtc ttgtagccaa
1680ggcacaaaaa gttcccgagg agggatggat catgcaagat ggtacacctt
ggcctgggaa 1740caatactagg gaccatcctg gaatgattca ggttttcctg
ggtcacagtg gagggcttga 1800cgttgaaggc aatgaacttc ctcgtttggt
ttatgtgtct cgtgaaaaac gtcctggatt 1860ccaacatcac aagaaggctg
gtgccatgaa tgcacttgtt cgtgtatcag ctgtccttac 1920taatgggcaa
tacatgttga atcttgattg tgaccactac atcaataata gcaaggctct
1980tcgagaagct atgtgcttcc ttatggaccc aaacctagga aggaatgtct
gttatgtcca 2040atttcctcag aggtttgatg gtattgatag gaatgaccga
tatgcaaaca ggaacactgt 2100gtttttcgat attaacttga gaggtcttga
cggcattcaa gggccagttt atgtgggaac 2160tggttgtgtg tttaacagaa
cggccttata tggttatgag cctccagtca agaaaaaaaa 2220gccaggcttc
ttctcttcgc tttgtggggg aaggaaaaag acgtcaaaat ctaagaagag
2280ctcggaaaag aagaagtcac atagacacgc agacagttct gtaccagtat
ttaatctcga 2340agatatagag gaagggattg aaggttctca gtttgatgat
gagaaatcgc tgattatgtc 2400tcaaatgagc ttggagaaga gatttggcca
gtccagtgtt tttgtagcct ctactctgat 2460ggaatatggt ggtgttccac
aatctgcaac tccagagtct cttctgaaag aagctattca 2520tgtcatcagc
tgtggctatg aggacaaaac tgactgggga actgagattg ggtggatcta
2580tggttctgtt acagaagaca ttctcaccgg attcaagatg catgctcgag
gctggcgatc 2640aatctactgc atgcctaagc gaccagcttt caagggatct
gctcctatca acctttcgga 2700tcgtttgaat caagtgcttc ggtgggctct
tggttccatt gaaattcttt tcagcaggca 2760ttgtcccata tggtatggct
atggaggccg gcttaaattc ctggagagat ttgcttatat 2820caacacaaca
atttatccac tcacatcaat cccgctcctc ctgtactgca tattgccagc
2880agtttgtctt ctcactggga agttcatcat cccaaagatt agtaacctag
agagtgtttg 2940gtttatatcg ctctttatct caatctttgc cactggtatc
cttgagatga ggtggagtgg 3000tgttggcatt gatgaatggt ggaggaacga
gcagttctgg gtcattggtg gtatttctgc 3060gcatttattt gccgtcttcc
agggtctcct gaaggtgctt gctggtatcg acacgagctt 3120cactgtcacc
tctaaggcca ctgacgaaga aggtgatttt gccgagctct acatgttcaa
3180gtggacaacg cttctgatcc caccaaccac tattttgatc atcaacctgg
tcggcgtggt 3240cgctggcatt tcctacgcaa tcaatagcgg ttaccagtca
tggggacctc ttttcgggaa 3300gctcttcttt gcgttctggg tgattgtcca
cctgtacccc ttcctcaagg gcctcatggg 3360gaagcagaac cgcacgccga
ccattgtcgt tgtctgggct atcctccttg cgtcgatctt 3420ttccctgatg
tgggttcgta tcgatccatt caccacccgg gtcactggcc ctgatatcgc
3480gaaatgtggc atcaactgct aggatgagct gaagatagtt aaagagtgga
actagacgca 3540ttgtgcatcg taagttatca gtgggtggct ctttttatag
tatggtagga acttggtcgg 3600gagacgttaa ttacatatgc tatatgtacc
tccgctggtc tttatccgta agttaatata 3660tatactgctt tgagaattaa
aaaaaaaaaa aaaagggcgg ccgc 3704141076PRTZea mays 14Met Asp Gly Gly
Asp Ala Thr Asn Ser Gly Lys His Val Ala Gly Gln1 5 10 15 Val Cys
Gln Ile Cys Gly Asp Gly Val Gly Thr Ala Ala Asp Gly Asp 20 25 30
Leu Phe Thr Ala Cys Asp Val Cys Gly Phe Pro Val Cys Arg Pro Cys 35
40 45 Tyr Glu Tyr Glu Arg Lys Asp Gly Thr Gln Ala Cys Pro Gln Cys
Lys 50 55 60 Thr Lys Tyr Lys Arg His Lys Gly Ser Pro Pro Val His
Gly Glu Glu65 70 75 80 Asn Glu Asp Val Asp Ala Asp Asp Val Ser Asp
Tyr Asn Tyr Gln Ala 85 90 95 Ser Gly Asn Gln Asp Gln Lys Gln Lys
Ile Ala Glu Arg Met Leu Thr 100 105 110 Trp Arg Thr Asn Ser Arg Gly
Ser Asp Ile Gly Leu Ala Lys Tyr Asp 115 120 125 Ser Gly Glu Ile Gly
His Gly Lys Tyr Asp Ser Gly Glu Ile Pro Arg 130 135 140 Gly Tyr Ile
Pro Ser Leu Thr His Ser Gln Ile Ser Gly Glu Ile Pro145 150 155 160
Gly Ala Ser Pro Asp His Met Met Ser Pro Val Gly Asn Ile Gly Arg 165
170 175 Arg Gly His Gln Phe Pro Tyr Val Asn His Ser Pro Asn Pro Ser
Arg 180 185 190 Glu Phe Ser Gly Ser Leu Gly Asn Val Ala Trp Lys Glu
Arg Val Asp 195 200 205 Gly Trp Lys Met Lys Asp Lys Gly Ala Ile Pro
Met Thr Asn Gly Thr 210 215 220 Ser Ile Ala Pro Ser Glu Gly Arg Gly
Val Ala Asp Ile Asp Ala Ser225 230 235 240 Thr Asp Tyr Asn Met Glu
Asp Ala Leu Leu Asn Asp Glu Thr Arg Gln 245 250 255 Pro Leu Ser Arg
Lys Val Pro Ile Pro Ser Ser Arg Ile Asn Pro Tyr 260 265 270 Arg Met
Val Ile Val Leu Arg Leu Ala Val Leu Cys Ile Phe Leu Arg 275 280 285
Tyr Arg Ile Thr His Pro Val Asn Asn Ala Tyr Pro Leu Trp Leu Leu 290
295 300 Ser Val Ile Cys Glu Ile Trp Phe Ala Leu Ser Trp Ile Leu Asp
Gln305 310 315 320 Phe Pro Lys Trp Ser Pro Ile Asn Arg Glu Thr Tyr
Leu Asp Arg Leu 325 330 335 Ala Leu Arg Tyr Asp Arg Glu Gly Glu Pro
Ser Gln Leu Ala Pro Val 340 345 350 Asp Ile Phe Val Ser Thr Val Asp
Pro Met Lys Glu Pro Pro Leu Val 355 360 365 Thr Ala Asn Thr Val Leu
Ser Ile Leu Ala Val Asp Tyr Pro Val Asp 370 375 380 Lys Val Ser Cys
Tyr Val Ser Asp Asp Gly Ala Ala Met Leu Thr Phe385 390 395 400 Asp
Ala Leu Ser Glu Thr Ser Glu Phe Ala Arg Lys Trp Val Pro Phe 405 410
415 Cys Lys Lys Tyr Asn Ile Glu Pro Arg Ala Pro Glu Trp Tyr Phe Ala
420 425 430 Gln Lys Ile Asp Tyr Leu Lys Asp Lys Val Gln Thr Ser Phe
Val Lys 435 440 445 Glu Arg Arg Ala Met Lys Arg Glu Tyr Glu Glu Phe
Lys Val Arg Ile 450 455 460 Asn Gly Leu Val Ala Lys Ala Gln Lys Val
Pro Glu Glu Gly Trp Ile465 470 475 480 Met Gln Asp Gly Thr Pro Trp
Pro Gly Asn Asn Thr Arg Asp His Pro 485 490 495 Gly Met Ile Gln Val
Phe Leu Gly His Ser Gly Gly Leu Asp Val Glu 500 505 510 Gly Asn Glu
Leu Pro Arg Leu Val Tyr Val Ser Arg Glu Lys Arg Pro 515 520 525 Gly
Phe Gln His His Lys Lys Ala Gly Ala Met Asn Ala Leu Val Arg 530 535
540 Val Ser Ala Val Leu Thr Asn Gly Gln Tyr Met Leu Asn Leu Asp
Cys545 550 555 560 Asp His Tyr Ile Asn Asn Ser Lys Ala Leu Arg Glu
Ala Met Cys Phe 565 570 575 Leu Met Asp Pro Asn Leu Gly Arg Asn Val
Cys Tyr Val Gln Phe Pro 580 585 590 Gln Arg Phe Asp Gly Ile Asp Arg
Asn Asp Arg Tyr Ala Asn Arg Asn 595 600 605 Thr Val Phe Phe Asp Ile
Asn Leu Arg Gly Leu Asp Gly Ile Gln Gly 610 615 620 Pro Val Tyr Val
Gly Thr Gly Cys Val Phe Asn Arg Thr Ala Leu Tyr625 630 635 640 Gly
Tyr Glu Pro Pro Val Lys Lys Lys Lys Pro Gly Phe Phe Ser Ser 645 650
655 Leu Cys Gly Gly Arg Lys Lys Thr Ser Lys Ser Lys Lys Ser Ser Glu
660 665 670 Lys Lys Lys Ser His Arg His Ala Asp Ser Ser Val Pro Val
Phe Asn 675 680 685 Leu Glu Asp Ile Glu Glu Gly Ile Glu Gly Ser Gln
Phe Asp Asp Glu 690 695 700 Lys Ser Leu Ile Met Ser Gln Met Ser Leu
Glu Lys Arg Phe Gly Gln705 710 715 720 Ser Ser Val Phe Val Ala Ser
Thr Leu Met Glu Tyr Gly Gly Val Pro 725 730 735 Gln Ser Ala Thr Pro
Glu Ser Leu Leu Lys Glu Ala Ile His Val Ile 740 745 750 Ser Cys Gly
Tyr Glu Asp Lys Thr Asp Trp Gly Thr Glu Ile Gly Trp 755 760 765 Ile
Tyr Gly Ser Val Thr Glu Asp Ile Leu Thr Gly Phe Lys Met His 770 775
780 Ala Arg Gly Trp Arg Ser Ile Tyr Cys Met Pro Lys Arg Pro Ala
Phe785 790 795 800 Lys Gly Ser Ala Pro Ile Asn Leu Ser Asp Arg Leu
Asn Gln Val Leu 805 810 815 Arg Trp Ala Leu Gly Ser Ile Glu Ile Leu
Phe Ser Arg His Cys Pro 820 825 830 Ile Trp Tyr Gly Tyr Gly Gly Arg
Leu Lys Phe Leu Glu Arg Phe Ala 835 840 845 Tyr Ile Asn Thr Thr Ile
Tyr Pro Leu Thr Ser Ile Pro Leu Leu Leu 850 855 860 Tyr Cys Ile Leu
Pro Ala Val Cys Leu Leu Thr Gly Lys Phe Ile Ile865 870 875 880 Pro
Lys Ile Ser Asn Leu Glu Ser Val Trp Phe Ile Ser Leu Phe Ile 885 890
895 Ser Ile Phe Ala Thr Gly Ile Leu Glu Met Arg Trp Ser Gly Val Gly
900 905 910 Ile Asp Glu Trp Trp Arg Asn Glu Gln Phe Trp Val Ile Gly
Gly Ile 915 920 925 Ser Ala His Leu Phe Ala Val Phe Gln Gly Leu Leu
Lys Val Leu Ala 930 935 940 Gly Ile Asp Thr Ser Phe Thr Val Thr Ser
Lys Ala Thr Asp Glu Glu945 950 955 960 Gly Asp Phe Ala Glu Leu Tyr
Met Phe Lys Trp Thr Thr Leu Leu Ile 965 970 975 Pro Pro Thr Thr Ile
Leu Ile Ile Asn Leu Val Gly Val Val Ala Gly 980 985 990 Ile Ser Tyr
Ala Ile Asn Ser Gly Tyr Gln Ser Trp Gly Pro Leu Phe 995 1000 1005
Gly Lys Leu Phe Phe Ala Phe Trp Val Ile Val His Leu Tyr Pro Phe
1010 1015 1020 Leu Lys Gly Leu Met Gly Lys Gln Asn Arg Thr Pro Thr
Ile Val Val1025 1030 1035 1040Val Trp Ala Ile Leu Leu Ala Ser Ile
Phe Ser Leu Met Trp Val Arg 1045 1050 1055 Ile Asp Pro Phe Thr Thr
Arg Val Thr Gly Pro Asp Ile Ala Lys Cys 1060 1065 1070 Gly Ile Asn
Cys 1075 1525DNAZea mays 15atggacggcg gcgacgccac gaatt 251625DNAZea
mays 16ctagcagttg atgccacatt tcgcg 25173813DNAZea mays 17ccacagctca
tataccaaga gccggagcag cttagcgcag cccagagcgg cgccgcgcca 60agcacaaccc
ccacccgcca cagccgcgtg cgcatgtgag cggtcgccgc ggccgggaga
120ccagaggagg ggaggactac gtgcatttcg ctgtgccgcc gccgcggggt
tcgtgcgcga 180gcgagatccg gcggggcggg gcggggggcc tgagatggag
gctagcgcgg ggctggtggc 240cggctcgcat aaccggaacg agctggtggt
gatccgccgc gaccgcgagt cgggagccgc 300gggcggcggc gcggcgcgcc
gggcggaggc gccgtgccag atatgcggcg acgaggtcgg 360ggtgggcttc
gacggggagc ccttcgtggc gtgcaacgag tgcgccttcc ccgtctgccg
420cgcctgctac gagtacgagc gccgcgaggg ctcgcaagcg tgcccgcagt
gcaggacccg 480ctacaagcgc ctcaagggct gcccgcgggt ggccggcgac
gaggaggagg acggcgtcga 540cgacctggag ggcgagttcg gcctgcagga
cggcgccgcc cacgaggacg acccgcagta 600cgtcgccgag tccatgctca
gggcgcagat gagctacggc cgcggcggcg acgcgcaccc 660cggcttcagc
cccgtcccca acgtgccgct cctcaccaac ggccagatgg ttgatgacat
720cccgccggag cagcacgcgc tcgtgccgtc ctacatgagc ggcggcggcg
gcgggggcaa 780gaggatccac ccgctccctt tcgcagatcc caaccttcca
gtgcaaccga gatccatgga 840cccgtccaag gatctggccg cctacggata
tggcagcgtg gcctggaagg agagaatgga 900gggctggaag cagaagcagg
agcgcctgca gcatgtcagg agcgagggtg gcggtgattg 960ggatggcgac
gatgcagatc tgccactaat ggatgaagct aggcagccat tgtccagaaa
1020agtccctata tcatcaagcc gaattaatcc ctacaggatg attatcgtta
tccggttggt 1080ggttttgggt ttcttcttcc actaccgagt gatgcatccg
gcgaaagatg catttgcatt 1140gtggctcata tctgtaatct gtgaaatctg
gtttgcgatg tcctggattc ttgatcagtt 1200cccaaagtgg cttccaatcg
agagagagac ttacctggac cgtttgtcac taaggtttga 1260caaggaaggt
caaccctctc agcttgctcc aatcgacttc tttgtcagta cggttgatcc
1320cacaaaggaa cctcccttgg tcacagcgaa cactgtcctt tccatccttt
ctgtggatta 1380tccggttgag aaggtctcct gctatgtttc tgatgatggt
gctgcaatgc ttacgtttga 1440agcattgtct gaaacatctg aatttgcaaa
gaaatgggtt cctttcagca aaaagtttaa 1500tatcgagcct cgtgctcctg
agtggtactt ccaacagaag atagactacc tgaaagacaa 1560ggttgctgct
tcatttgtta gggagaggag ggcgatgaag agagaatacg aggaattcaa
1620ggtaaggatc aatgccttgg ttgcaaaagc ccaaaaggtt cctgaggaag
gatggacaat 1680gcaagatgga agcccctggc ctggaaacaa cgtacgcgat
catcctggaa tgattcaggt 1740attccttggc caaagtggcg gtcgtgatgt
ggaaggaaat gagttgcctc gcctggttta 1800tgtctcgaga gaaaagaggc
caggttataa ccatcacaag aaggctggtg ccatgaatgc 1860actggtccgt
gtctctgctg tcttatcaaa tgctgcatac ctattgaact tggactgtga
1920tcactacatc aacaatagca aggccataaa agaggctatg tgtttcatga
tggatccttt 1980ggtggggaag aaagtgtgct atgtacagtt ccctcagagg
tttgatggta ttgacaaaaa 2040tgatcgatac gctaacagga acgttgtctt
ttttgacatc aacatgaaag gtttggacgg 2100tattcaagga cccatttatg
tgggtactgg atgtgttttc agacggcagg cactgtatgg 2160ttatgatgct
cctaaaacga agaagccacc atcaagaact tgcaactgct ggcccaagtg
2220gtgcctctct tgctgctgca gcaggaacaa gaataaaaag aagactacaa
aaccaaagac 2280ggagaagaag aaaagattat ttttcaagaa agcagaaaac
ccatctcctg catatgcttt 2340gggtgaaatt gatgaaggtg ctccaggtgc
tgatatcgag aaggccggaa tcgtaaatca 2400acagaaacta gagaagaaat
ttgggcagtc ttctgttttt gtcgcatcaa cacttcttga 2460gaacggaggg
accctgaaga gcgcaagtcc agcttctctt ctgaaggaag ctatacatgt
2520tatcagctgc ggctacgaag acaagaccga ctggggaaaa gagattggct
ggatttacgg 2580atcgatcaca gaggatatct tgactggatt taagatgcac
tgccatggct ggcggtctat 2640ttactgcatc ccgaagcggc ctgcattcaa
aggttctgcg cctctgaacc tttccgaccg 2700tcttcaccag gtccttcgct
gggcccttgg gtccgtcgaa attttcttca gcaagcactg 2760cccactttgg
tacggatacg gcggcgggct aaaattcctg gaaaggtttt cttatatcaa
2820ctccatcgtt tatccctgga cgtccattcc tctcctggct tactgtacct
tgcctgccat 2880ctgcctgctc acggggaagt ttatcacacc agagcttacc
aatgtcgcca gtatctggtt 2940catggcactt ttcatctgca tctccgtgac
cggcatcctg gaaatgaggt ggagtggcgt 3000ggccatcgac gactggtgga
ggaacgagca gttctgggtc atcggaggcg tttcggcgca 3060tctgttcgcg
gtgttccagg gcctgctgaa ggtgttcgcc ggcatcgaca cgagcttcac
3120cgtgacgtcg aaggccgggg acgacgagga gttctcggag ctgtacacgt
tcaagtggac 3180caccctgctg atacccccga ccacgctcct cctgctgaac
ttcatcgggg tggtggccgg 3240gatctcgaac gcgatcaaca acgggtacga
gtcgtggggc cccctgttcg ggaagctctt 3300cttcgccttc tgggtgatcg
tccacctgta cccgttcctc aagggtctgg tggggaggca 3360gaacaggacg
ccgacgatcg tcatcgtctg gtccatcctg ctggcctcga tcttctcgct
3420cctgtgggtc cgcgtcgacc cgttcctcgc caagagcaac ggcccgctcc
tggaggagtg 3480tggcctggac tgcaactgaa gtgggggccc cctgtcactc
gaagttctgt cacgggcgaa 3540ttacgcctga ttttttgttg ttgttgttgt
tggaattctt tgctgtagat agaaaccaca 3600tgtccacggc atctctgctg
tgtccattgg agcaggagag aggtgcctgc tgctgtttgt 3660tgagtaaatt
aaaagtttta aagttataca gtgatgcaca ttccagtgcc cagtgtattc
3720cctttttaca gtctgtatat tagcgacaaa ggacatattg gttaggagtt
tgattctttt 3780gtaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaa
3813181094PRTZea mays 18Met Glu Ala Ser Ala Gly Leu Val Ala Gly Ser
His Asn Arg Asn Glu1
5 10 15 Leu Val Val Ile Arg Arg Asp Arg Glu Ser Gly Ala Ala Gly Gly
Gly 20 25 30 Ala Ala Arg Arg Ala Glu Ala Pro Cys Gln Ile Cys Gly
Asp Glu Val 35 40 45 Gly Val Gly Phe Asp Gly Glu Pro Phe Val Ala
Cys Asn Glu Cys Ala 50 55 60 Phe Pro Val Cys Arg Ala Cys Tyr Glu
Tyr Glu Arg Arg Glu Gly Ser65 70 75 80 Gln Ala Cys Pro Gln Cys Arg
Thr Arg Tyr Lys Arg Leu Lys Gly Cys 85 90 95 Pro Arg Val Ala Gly
Asp Glu Glu Glu Asp Gly Val Asp Asp Leu Glu 100 105 110 Gly Glu Phe
Gly Leu Gln Asp Gly Ala Ala His Glu Asp Asp Pro Gln 115 120 125 Tyr
Val Ala Glu Ser Met Leu Arg Ala Gln Met Ser Tyr Gly Arg Gly 130 135
140 Gly Asp Ala His Pro Gly Phe Ser Pro Val Pro Asn Val Pro Leu
Leu145 150 155 160 Thr Asn Gly Gln Met Val Asp Asp Ile Pro Pro Glu
Gln His Ala Leu 165 170 175 Val Pro Ser Tyr Met Ser Gly Gly Gly Gly
Gly Gly Lys Arg Ile His 180 185 190 Pro Leu Pro Phe Ala Asp Pro Asn
Leu Pro Val Gln Pro Arg Ser Met 195 200 205 Asp Pro Ser Lys Asp Leu
Ala Ala Tyr Gly Tyr Gly Ser Val Ala Trp 210 215 220 Lys Glu Arg Met
Glu Gly Trp Lys Gln Lys Gln Glu Arg Leu Gln His225 230 235 240 Val
Arg Ser Glu Gly Gly Gly Asp Trp Asp Gly Asp Asp Ala Asp Leu 245 250
255 Pro Leu Met Asp Glu Ala Arg Gln Pro Leu Ser Arg Lys Val Pro Ile
260 265 270 Ser Ser Ser Arg Ile Asn Pro Tyr Arg Met Ile Ile Val Ile
Arg Leu 275 280 285 Val Val Leu Gly Phe Phe Phe His Tyr Arg Val Met
His Pro Ala Lys 290 295 300 Asp Ala Phe Ala Leu Trp Leu Ile Ser Val
Ile Cys Glu Ile Trp Phe305 310 315 320 Ala Met Ser Trp Ile Leu Asp
Gln Phe Pro Lys Trp Leu Pro Ile Glu 325 330 335 Arg Glu Thr Tyr Leu
Asp Arg Leu Ser Leu Arg Phe Asp Lys Glu Gly 340 345 350 Gln Pro Ser
Gln Leu Ala Pro Ile Asp Phe Phe Val Ser Thr Val Asp 355 360 365 Pro
Thr Lys Glu Pro Pro Leu Val Thr Ala Asn Thr Val Leu Ser Ile 370 375
380 Leu Ser Val Asp Tyr Pro Val Glu Lys Val Ser Cys Tyr Val Ser
Asp385 390 395 400 Asp Gly Ala Ala Met Leu Thr Phe Glu Ala Leu Ser
Glu Thr Ser Glu 405 410 415 Phe Ala Lys Lys Trp Val Pro Phe Ser Lys
Lys Phe Asn Ile Glu Pro 420 425 430 Arg Ala Pro Glu Trp Tyr Phe Gln
Gln Lys Ile Asp Tyr Leu Lys Asp 435 440 445 Lys Val Ala Ala Ser Phe
Val Arg Glu Arg Arg Ala Met Lys Arg Glu 450 455 460 Tyr Glu Glu Phe
Lys Val Arg Ile Asn Ala Leu Val Ala Lys Ala Gln465 470 475 480 Lys
Val Pro Glu Glu Gly Trp Thr Met Gln Asp Gly Ser Pro Trp Pro 485 490
495 Gly Asn Asn Val Arg Asp His Pro Gly Met Ile Gln Val Phe Leu Gly
500 505 510 Gln Ser Gly Gly Arg Asp Val Glu Gly Asn Glu Leu Pro Arg
Leu Val 515 520 525 Tyr Val Ser Arg Glu Lys Arg Pro Gly Tyr Asn His
His Lys Lys Ala 530 535 540 Gly Ala Met Asn Ala Leu Val Arg Val Ser
Ala Val Leu Ser Asn Ala545 550 555 560 Ala Tyr Leu Leu Asn Leu Asp
Cys Asp His Tyr Ile Asn Asn Ser Lys 565 570 575 Ala Ile Lys Glu Ala
Met Cys Phe Met Met Asp Pro Leu Val Gly Lys 580 585 590 Lys Val Cys
Tyr Val Gln Phe Pro Gln Arg Phe Asp Gly Ile Asp Lys 595 600 605 Asn
Asp Arg Tyr Ala Asn Arg Asn Val Val Phe Phe Asp Ile Asn Met 610 615
620 Lys Gly Leu Asp Gly Ile Gln Gly Pro Ile Tyr Val Gly Thr Gly
Cys625 630 635 640 Val Phe Arg Arg Gln Ala Leu Tyr Gly Tyr Asp Ala
Pro Lys Thr Lys 645 650 655 Lys Pro Pro Ser Arg Thr Cys Asn Cys Trp
Pro Lys Trp Cys Leu Ser 660 665 670 Cys Cys Cys Ser Arg Asn Lys Asn
Lys Lys Lys Thr Thr Lys Pro Lys 675 680 685 Thr Glu Lys Lys Lys Arg
Leu Phe Phe Lys Lys Ala Glu Asn Pro Ser 690 695 700 Pro Ala Tyr Ala
Leu Gly Glu Ile Asp Glu Gly Ala Pro Gly Ala Asp705 710 715 720 Ile
Glu Lys Ala Gly Ile Val Asn Gln Gln Lys Leu Glu Lys Lys Phe 725 730
735 Gly Gln Ser Ser Val Phe Val Ala Ser Thr Leu Leu Glu Asn Gly Gly
740 745 750 Thr Leu Lys Ser Ala Ser Pro Ala Ser Leu Leu Lys Glu Ala
Ile His 755 760 765 Val Ile Ser Cys Gly Tyr Glu Asp Lys Thr Asp Trp
Gly Lys Glu Ile 770 775 780 Gly Trp Ile Tyr Gly Ser Ile Thr Glu Asp
Ile Leu Thr Gly Phe Lys785 790 795 800 Met His Cys His Gly Trp Arg
Ser Ile Tyr Cys Ile Pro Lys Arg Pro 805 810 815 Ala Phe Lys Gly Ser
Ala Pro Leu Asn Leu Ser Asp Arg Leu His Gln 820 825 830 Val Leu Arg
Trp Ala Leu Gly Ser Val Glu Ile Phe Phe Ser Lys His 835 840 845 Cys
Pro Leu Trp Tyr Gly Tyr Gly Gly Gly Leu Lys Phe Leu Glu Arg 850 855
860 Phe Ser Tyr Ile Asn Ser Ile Val Tyr Pro Trp Thr Ser Ile Pro
Leu865 870 875 880 Leu Ala Tyr Cys Thr Leu Pro Ala Ile Cys Leu Leu
Thr Gly Lys Phe 885 890 895 Ile Thr Pro Glu Leu Thr Asn Val Ala Ser
Ile Trp Phe Met Ala Leu 900 905 910 Phe Ile Cys Ile Ser Val Thr Gly
Ile Leu Glu Met Arg Trp Ser Gly 915 920 925 Val Ala Ile Asp Asp Trp
Trp Arg Asn Glu Gln Phe Trp Val Ile Gly 930 935 940 Gly Val Ser Ala
His Leu Phe Ala Val Phe Gln Gly Leu Leu Lys Val945 950 955 960 Phe
Ala Gly Ile Asp Thr Ser Phe Thr Val Thr Ser Lys Ala Gly Asp 965 970
975 Asp Glu Glu Phe Ser Glu Leu Tyr Thr Phe Lys Trp Thr Thr Leu Leu
980 985 990 Ile Pro Pro Thr Thr Leu Leu Leu Leu Asn Phe Ile Gly Val
Val Ala 995 1000 1005 Gly Ile Ser Asn Ala Ile Asn Asn Gly Tyr Glu
Ser Trp Gly Pro Leu 1010 1015 1020 Phe Gly Lys Leu Phe Phe Ala Phe
Trp Val Ile Val His Leu Tyr Pro1025 1030 1035 1040Phe Leu Lys Gly
Leu Val Gly Arg Gln Asn Arg Thr Pro Thr Ile Val 1045 1050 1055 Ile
Val Trp Ser Ile Leu Leu Ala Ser Ile Phe Ser Leu Leu Trp Val 1060
1065 1070 Arg Val Asp Pro Phe Leu Ala Lys Ser Asn Gly Pro Leu Leu
Glu Glu 1075 1080 1085 Cys Gly Leu Asp Cys Asn 1090 1925DNAZea mays
19atggaggcta gcgcggggct ggtgg 252025DNAZea mays 20tcagttgcag
tccaggccac actcc 25213799DNAZea maysmisc_feature3757, 3775, 3777,
3782n = A,T,C or G 21caactcacgt tgccgcggct tcctccatcg gtgcggtgcc
ctgtcctttt ctctcctcca 60cctccctagt ccctcctccc ccccgcatac atagctacta
ctagtagcac cacgctcgca 120gcgggagatg cggtgctgat ccgtgcccct
gctcggatct cgggagtggt gccgacttgt 180gtcgcttcgg ctctgcctag
gccagctcct tgtcggttct gggcgagctc gcctgccatg 240gagggcgacg
cggacggcgt gaagtcgggg aggcgcgggg gagggcaggt gtgccagatc
300tgcggcgatg gcgtgggcac tacggcggag ggagacgtct tcaccgcctg
cgacgtctgc 360gggttcccgg tgtgccgccc ctgctacgag tacgagcgca
aggacggcac acaagcgtgc 420ccccagtgca aaaacaagta caagcgccac
aaggggagtc cagcgatccg aggggaggaa 480ggagacgata ctgatgccga
tgatgctagc gacttcaact accctgcatc tggcaatgac 540gaccagaagc
agaagattgc tgacaggatg cgcagctggc gcatgaatgc tgggggcagc
600ggggatgttg gccgccccaa gtatgacagt ggtgagatcg ggcttaccaa
gtacgacagt 660ggtgagatcc ctcggggata catcccgtca gtcactaaca
gccagatttc gggagaaatc 720cctggtgctt cccctgacca tcatatgatg
tctcctactg ggaacattgg caggcgcgcc 780ccatttccct atatgaatca
ttcatcaaat ccgtcgaggg aattctctgg tagcgttggg 840aatgttgcct
ggaaagagag ggttgatggc tggaaaatga agcaggacaa gggaacaatt
900cccatgacga atggcacaag cattgctccc tctgagggcc ggggtgttgg
tgatattgat 960gcatcaactg attacaacat ggaagatgcc ttattaaacg
atgaaactcg ccagcctcta 1020tctaggaaag ttccacttcc ttcctccagg
ataaatccat acaggatggt cattgtgcta 1080cgattgattg ttctaagcat
cttcttgcac taccggatca caaatcctgt gcgtaatgca 1140tacccactgt
ggcttctatc tgttatatgt gagatctggt ttgctctttc ctggatattg
1200gatcagtttc caaagtggtt tccaatcaac cgcgagactt accttgatag
actcgcatta 1260aggtatgacc gggaaggtga gccatctcag ttggctgctg
ttgacatttt tgtcagtact 1320gtcgacccaa tgaaggagcc tcctcttgtc
actgccaata ccgtgctatc cattctcgct 1380gtggactatc ctgtggataa
ggtctcttgc tatgtatctg atgatggagc tgctatgctg 1440acatttgatg
cactagctga gacttcagag tttgctagaa aatgggtgcc atttgttaag
1500aagtacaaca ttgaacctag agctcctgaa tggtacttct cccagaaaat
tgattacttg 1560aaggacaaag tgcacccttc atttgttaaa gaccgccggg
ccatgaagag agaatatgaa 1620gaattcaaaa ttagggtaaa tggccttgtt
gctaaggcac aaaaagtccc tgaggaagga 1680tggatcatgc aagatggcac
accatggcca ggaaacaata ccagggacca tcctggaatg 1740attcaggttt
tccttggtca cagtggtggt cttgatactg agggtaatga gctaccccgt
1800ttggtctatg tttctcgtga aaaacgtcct ggattccagc atcacaagaa
agctggtgcc 1860atgaatgctc ttgtccgcgt ctcagctgtg cttaccaatg
gacaatacat gttgaatctt 1920gattgtgatc actacatcaa caacagtaag
gctctcaggg aagctatgtg cttccttatg 1980gatcctaacc taggaaggag
tgtctgctat gttcagtttc cccagaggtt cgatggtatt 2040gataggaatg
atcgatatgc caacaggaac accgtgtttt tcgatattaa cttgagaggt
2100cttgatggca tccaaggacc agtttatgtg ggcactggct gtgttttcaa
cagaacagct 2160ctatatggtt atgagccccc aattaagcaa aagaagggtg
gtttcttgtc atcactatgt 2220ggtggcagga agaagggaag caaatcaaag
aagggctcag acaagaaaaa gtcacagaag 2280catgtggaca gttctgtgcc
agtattcaat cttgaagata tagaggaggg agttgaaggc 2340gctggatttg
atgatgagaa atcacttctt atgtctcaaa tgagcttgga gaagagattt
2400ggccaatctg cagcttttgt tgcgtccact ctgatggaat atggtggtgt
tcctcagtct 2460gcgactccag aatctcttct gaaagaagct atccatgtca
taagttgtgg ctacgaggac 2520aagattgaat ggggaactga gattgggtgg
atctatggtt ctgtgacgga agatattctc 2580actgggttca agatgcacgc
acgaggctgg cggtcgatct actgcatgcc taagcggccg 2640gccttcaagg
gatcggctcc catcaatctc tcagaccgtc tgaaccaggt gctccggtgg
2700gctctcggtt cagtggaaat ccttttcagc cggcattgcc ccctatggta
cgggtacgga 2760ggacgcctga agttcttgga gagattcgcc tacatcaaca
ccaccatcta cccgctcacg 2820tccctcccgc tcctcattta ctgtatcctg
cctgccatct gcctgctcac ggggaagttc 2880atcatcccag agatcagcaa
cttcgctagt atctggttca tctctctctt catctcgatc 2940ttcgccacgg
gtatcctgga gatgaggtgg agcggcgtgg gcatcgacga gtggtggagg
3000aacgagcagt tctgggtcat cggaggcatc tccgcccacc tcttcgccgt
cttccagggc 3060ctcctcaagg tgcttgccgg catcgacacc aacttcaccg
tcacctccaa ggcctcggat 3120gaagacggcg acttcgcgga gctgtacatg
ttcaagtgga cgacacttct gatcccgccc 3180accaccatcc tgatcatcaa
cctggtcggc gttgttgccg gcatctccta cgccatcaac 3240agcgggtacc
agtcgtgggg tccgctcttc ggcaagctct tcttcgcctt ctgggtgatc
3300gttcacctgt acccgttcct caagggtctc atgggtcggc agaaccgcac
cccgaccatc 3360gtggttgtct gggcgatcct gctggcgtcg atcttctcct
tgctgtgggt tcgcatcgat 3420ccgttcacca accgcgtcac tggcccggat
actcgaacgt gtggcatcaa ctgctaggga 3480ggtggaaggt ttgtagaaac
agagagatac cacgaatgtg ccgctgccac aaattgtctg 3540ttagtaagtt
atataggcag gtggcgttat ttacagctac gtacacacaa ggggatactc
3600cgtttatcac tggtgtgcat tcttttgttg atataagtta ctatatatac
gtattgcttc 3660tactttgtgg agagtggctg acaggaccag ttttgtaatg
ttatgaacag caaagaaata 3720agttagtttc caaaaaaaaa aaaaaaaaaa
aaaaaanaaa aaaaaaaaaa aaaananaaa 3780anaaaaaaaa aaaaacccc
3799221079PRTZea mays 22Met Glu Gly Asp Ala Asp Gly Val Lys Ser Gly
Arg Arg Gly Gly Gly1 5 10 15 Gln Val Cys Gln Ile Cys Gly Asp Gly
Val Gly Thr Thr Ala Glu Gly 20 25 30 Asp Val Phe Thr Ala Cys Asp
Val Cys Gly Phe Pro Val Cys Arg Pro 35 40 45 Cys Tyr Glu Tyr Glu
Arg Lys Asp Gly Thr Gln Ala Cys Pro Gln Cys 50 55 60 Lys Asn Lys
Tyr Lys Arg His Lys Gly Ser Pro Ala Ile Arg Gly Glu65 70 75 80 Glu
Gly Asp Asp Thr Asp Ala Asp Asp Ala Ser Asp Phe Asn Tyr Pro 85 90
95 Ala Ser Gly Asn Asp Asp Gln Lys Gln Lys Ile Ala Asp Arg Met Arg
100 105 110 Ser Trp Arg Met Asn Ala Gly Gly Ser Gly Asp Val Gly Arg
Pro Lys 115 120 125 Tyr Asp Ser Gly Glu Ile Gly Leu Thr Lys Tyr Asp
Ser Gly Glu Ile 130 135 140 Pro Arg Gly Tyr Ile Pro Ser Val Thr Asn
Ser Gln Ile Ser Gly Glu145 150 155 160 Ile Pro Gly Ala Ser Pro Asp
His His Met Met Ser Pro Thr Gly Asn 165 170 175 Ile Gly Arg Arg Ala
Pro Phe Pro Tyr Met Asn His Ser Ser Asn Pro 180 185 190 Ser Arg Glu
Phe Ser Gly Ser Val Gly Asn Val Ala Trp Lys Glu Arg 195 200 205 Val
Asp Gly Trp Lys Met Lys Gln Asp Lys Gly Thr Ile Pro Met Thr 210 215
220 Asn Gly Thr Ser Ile Ala Pro Ser Glu Gly Arg Gly Val Gly Asp
Ile225 230 235 240 Asp Ala Ser Thr Asp Tyr Asn Met Glu Asp Ala Leu
Leu Asn Asp Glu 245 250 255 Thr Arg Gln Pro Leu Ser Arg Lys Val Pro
Leu Pro Ser Ser Arg Ile 260 265 270 Asn Pro Tyr Arg Met Val Ile Val
Leu Arg Leu Ile Val Leu Ser Ile 275 280 285 Phe Leu His Tyr Arg Ile
Thr Asn Pro Val Arg Asn Ala Tyr Pro Leu 290 295 300 Trp Leu Leu Ser
Val Ile Cys Glu Ile Trp Phe Ala Leu Ser Trp Ile305 310 315 320 Leu
Asp Gln Phe Pro Lys Trp Phe Pro Ile Asn Arg Glu Thr Tyr Leu 325 330
335 Asp Arg Leu Ala Leu Arg Tyr Asp Arg Glu Gly Glu Pro Ser Gln Leu
340 345 350 Ala Ala Val Asp Ile Phe Val Ser Thr Val Asp Pro Met Lys
Glu Pro 355 360 365 Pro Leu Val Thr Ala Asn Thr Val Leu Ser Ile Leu
Ala Val Asp Tyr 370 375 380 Pro Val Asp Lys Val Ser Cys Tyr Val Ser
Asp Asp Gly Ala Ala Met385 390 395 400 Leu Thr Phe Asp Ala Leu Ala
Glu Thr Ser Glu Phe Ala Arg Lys Trp 405 410 415 Val Pro Phe Val Lys
Lys Tyr Asn Ile Glu Pro Arg Ala Pro Glu Trp 420 425 430 Tyr Phe Ser
Gln Lys Ile Asp Tyr Leu Lys Asp Lys Val His Pro Ser 435 440 445 Phe
Val Lys Asp Arg Arg Ala Met Lys Arg Glu Tyr Glu Glu Phe Lys 450 455
460 Ile Arg Val Asn Gly Leu Val Ala Lys Ala Gln Lys Val Pro Glu
Glu465 470 475 480 Gly Trp Ile Met Gln Asp Gly Thr Pro Trp Pro Gly
Asn Asn Thr Arg 485 490 495 Asp His Pro Gly Met Ile Gln Val Phe Leu
Gly His Ser Gly Gly Leu 500 505 510 Asp Thr Glu Gly Asn Glu Leu Pro
Arg Leu Val Tyr Val Ser Arg Glu 515 520 525 Lys Arg Pro Gly Phe Gln
His His Lys Lys Ala Gly Ala Met Asn Ala 530 535 540 Leu Val Arg Val
Ser Ala Val Leu Thr Asn Gly Gln Tyr Met Leu Asn545 550 555 560 Leu
Asp Cys Asp His Tyr Ile Asn Asn Ser Lys Ala Leu Arg Glu Ala 565 570
575 Met Cys Phe Leu Met Asp Pro Asn Leu Gly Arg Ser Val Cys Tyr Val
580 585 590 Gln Phe Pro Gln Arg Phe Asp Gly Ile Asp Arg Asn Asp Arg
Tyr Ala 595 600
605 Asn Arg Asn Thr Val Phe Phe Asp Ile Asn Leu Arg Gly Leu Asp Gly
610 615 620 Ile Gln Gly Pro Val Tyr Val Gly Thr Gly Cys Val Phe Asn
Arg Thr625 630 635 640 Ala Leu Tyr Gly Tyr Glu Pro Pro Ile Lys Gln
Lys Lys Gly Gly Phe 645 650 655 Leu Ser Ser Leu Cys Gly Gly Arg Lys
Lys Gly Ser Lys Ser Lys Lys 660 665 670 Gly Ser Asp Lys Lys Lys Ser
Gln Lys His Val Asp Ser Ser Val Pro 675 680 685 Val Phe Asn Leu Glu
Asp Ile Glu Glu Gly Val Glu Gly Ala Gly Phe 690 695 700 Asp Asp Glu
Lys Ser Leu Leu Met Ser Gln Met Ser Leu Glu Lys Arg705 710 715 720
Phe Gly Gln Ser Ala Ala Phe Val Ala Ser Thr Leu Met Glu Tyr Gly 725
730 735 Gly Val Pro Gln Ser Ala Thr Pro Glu Ser Leu Leu Lys Glu Ala
Ile 740 745 750 His Val Ile Ser Cys Gly Tyr Glu Asp Lys Ile Glu Trp
Gly Thr Glu 755 760 765 Ile Gly Trp Ile Tyr Gly Ser Val Thr Glu Asp
Ile Leu Thr Gly Phe 770 775 780 Lys Met His Ala Arg Gly Trp Arg Ser
Ile Tyr Cys Met Pro Lys Arg785 790 795 800 Pro Ala Phe Lys Gly Ser
Ala Pro Ile Asn Leu Ser Asp Arg Leu Asn 805 810 815 Gln Val Leu Arg
Trp Ala Leu Gly Ser Val Glu Ile Leu Phe Ser Arg 820 825 830 His Cys
Pro Leu Trp Tyr Gly Tyr Gly Gly Arg Leu Lys Phe Leu Glu 835 840 845
Arg Phe Ala Tyr Ile Asn Thr Thr Ile Tyr Pro Leu Thr Ser Leu Pro 850
855 860 Leu Leu Ile Tyr Cys Ile Leu Pro Ala Ile Cys Leu Leu Thr Gly
Lys865 870 875 880 Phe Ile Ile Pro Glu Ile Ser Asn Phe Ala Ser Ile
Trp Phe Ile Ser 885 890 895 Leu Phe Ile Ser Ile Phe Ala Thr Gly Ile
Leu Glu Met Arg Trp Ser 900 905 910 Gly Val Gly Ile Asp Glu Trp Trp
Arg Asn Glu Gln Phe Trp Val Ile 915 920 925 Gly Gly Ile Ser Ala His
Leu Phe Ala Val Phe Gln Gly Leu Leu Lys 930 935 940 Val Leu Ala Gly
Ile Asp Thr Asn Phe Thr Val Thr Ser Lys Ala Ser945 950 955 960 Asp
Glu Asp Gly Asp Phe Ala Glu Leu Tyr Met Phe Lys Trp Thr Thr 965 970
975 Leu Leu Ile Pro Pro Thr Thr Ile Leu Ile Ile Asn Leu Val Gly Val
980 985 990 Val Ala Gly Ile Ser Tyr Ala Ile Asn Ser Gly Tyr Gln Ser
Trp Gly 995 1000 1005 Pro Leu Phe Gly Lys Leu Phe Phe Ala Phe Trp
Val Ile Val His Leu 1010 1015 1020 Tyr Pro Phe Leu Lys Gly Leu Met
Gly Arg Gln Asn Arg Thr Pro Thr1025 1030 1035 1040Ile Val Val Val
Trp Ala Ile Leu Leu Ala Ser Ile Phe Ser Leu Leu 1045 1050 1055 Trp
Val Arg Ile Asp Pro Phe Thr Asn Arg Val Thr Gly Pro Asp Thr 1060
1065 1070 Arg Thr Cys Gly Ile Asn Cys 1075 2325DNAZea mays
23atggagggcg acgcggacgg cgtga 252425DNAZea mays 24ctagcagttg
atgccacacg ttcga 25253470DNAZea mays 25gcccccggtc gatcgctcgg
caatcggcat ggacgccggc tcggtcaccg gtggcctcgc 60cgcgggctcg cacatgcggg
acgagctgca tgtcatgcgc gcccgcgagg agccgaacgc 120caaggtccgg
agcgccgacg tgaagacgtg ccgcgtgtgc gccgacgagg tcgggacgcg
180ggaggacggg cagcccttcg tggcgtgcgc cgagtgcggc ttccccgtct
gccggccctg 240ctacgagtac gagcgcagcg agggcacgca gtgctgcccg
cagtgcaaca cccgctacaa 300gcgccagaaa gggtgcccga gggtggaagg
ggacgaggag gagggcccgg agatggacga 360cttcgaggac gagttccccg
ccaagagccc caagaagcct cacgagcctg tcgcgttcga 420cgtctactcg
gagaacggcg agcacccggc gcagaaatgg cggacgggtg gccagacgct
480gtcgtccttc accggaagcg tcgccgggaa ggacctggag gcggagaggg
agatggaggg 540gagcatggag tggaaggacc ggatcgacaa gtggaagacc
aagcaggaga agaggggcaa 600gctcaaccac gacgacagcg acgacgacga
cgacaagaac gaagacgagt acatgctgct 660tgccgaggcc cgacagccgc
tgtggcgcaa ggttccgatc ccgtcgagca tgatcaaccc 720gtaccgcatc
gtcatcgtgc tccgcctggt ggtgctctgc ttcttcctca agttccggat
780cacgacgccc gccacggacg ccgtgcctct gtggctggcg tccgtcatct
gcgagctctg 840gttcgccttc tcctggatcc tggaccagct gccaaagtgg
gcgccggtga cgcgggagac 900gtacctggac cgcctggcgc tgcggtacga
ccgtgagggc gaggcgtgcc ggctgtcccc 960catcgacttc ttcgtcagca
cggtggaccc gctcaaggag ccgcccatca tcaccgccaa 1020caccgtgctg
tccatcctcg ccgtcgacta ccccgtggac cgcgtcagct gctacgtctc
1080cgacgacggc gcgtccatgc tgctcttcga cgcgctgtcc gagaccgccg
agttcgcgcg 1140ccgctgggtg cccttctgca agaagttcgc cgtggagccg
cgcgccccgg agttctactt 1200ctcgcagaag atcgactacc tcaaggacaa
ggtgcagccg acgttcgtca aggagcgccg 1260cgccatgaag agggagtacg
aggagttcaa ggtgcgcatc aacgcgctgg tggccaaggc 1320gcagaagaag
cccgaggagg ggtgggtcat gcaggacggc acgccgtggc ccgggaacaa
1380cacgcgcgac cacccgggta tgatccaggt ctacctcggc aaccagggcg
cgctggacgt 1440ggagggccac gagctgccgc gcctcgtcta cgtgtcccgt
gagaagcgcc ccgggtacaa 1500ccaccacaag aaggcgggcg ccatgaacgc
gctggtgcgc gtctccgccg tgctcaccaa 1560cgcgcccttc atcctcaacc
tcgactgcga ccactacgtc aacaacagca aggccgtgcg 1620cgaggccatg
tgcttcctca tggacccgca gctggggaag aagctctgct acgtccagtt
1680cccgcagcgc ttcgatggca tcgatcgcca cgaccgatac gccaaccgca
acgtcgtctt 1740cttcgacatc aacatgaagg ggctggacgg catccagggc
ccggtgtacg tcggcacggg 1800gtgcgtgttc aaccgccagg cgctgtacgg
ctacgacccg ccgcggcccg agaagcggcc 1860caagatgacg tgcgactgct
ggccgtcgtg gtgctgctgc tgctgctgct tcggcggcgg 1920caagcgcggc
aaggcgcgca aggacaagaa gggcgacggc ggcgaggagc cgcgccgggg
1980cctgctcggc ttctacagga agcggagcaa gaaggacaag ctcggcggcg
ggtcggtggc 2040cggcagcaag aagggcggcg ggctgtacaa gaagcaccag
cgcgcgttcg agctggagga 2100gatcgaggag gggctggagg ggtacgacga
gctggagcgc tcctcgctca tgtcgcagaa 2160gagcttcgag aagcggttcg
gccagtcgcc cgtgttcatc gcctccacgc tcgtcgagga 2220cggcggcctg
ccgcagggcg ccgccgccga ccccgccgcg ctcatcaagg aggccatcca
2280cgtcatcagc tgcggatacg aggagaagac cgagtggggc aaggagattg
ggtggatcta 2340tgggtcggtg acagaggata tcctgacggg gttcaagatg
cactgccggg ggtggaagtc 2400cgtgtactgc acgccgacac ggccggcgtt
caaggggtcg gcgcccatca acttgtctga 2460tcgtctccac caggtgctgc
gctgggcgct ggggtccgtg gagatcttca tgagccgcca 2520ctgcccgctc
cggtacgcct acggcggccg gctcaagtgg ctggagcgct tcgcctacac
2580caacaccatc gtgtacccct tcacctccat cccgctcctc gcctactgca
ccatccccgc 2640cgtctgcctg ctcaccggca agttcatcat tcccacgctg
aacaacctcg ccagcatctg 2700gttcatcgcg ctcttcctgt ccatcatcgc
gacgagcgtc ctggagctgc ggtggagcgg 2760ggtgagcatc gaggactggt
ggcgcaacga gcagttctgg gtcatcggcg gcgtgtccgc 2820gcatctcttc
gccgtgttcc agggcttcct caaggttctg ggcggcgtgg acaccagctt
2880caccgtcacc tccaaggcgg ccggcgacga ggccgacgcc ttcggggacc
tctacctctt 2940caagtggacc accctgctgg tgccccccac cacgctcatc
atcatcaaca tggtgggcat 3000cgtggccggc gtgtccgacg ccgtcaacaa
cggctacggc tcctggggcc cgctcttcgg 3060caagctcttc ttctccttct
gggtcatcgt ccacctctac ccgttcctca aggggctcat 3120ggggaggcag
aaccggacgc ccaccatcgt cgtgctctgg tccatcctcc tcgcctccat
3180cttctcgctc gtctgggtca ggatcgaccc gtttatcccg aaggccaagg
gccccatcct 3240caagccatgc ggagtcgagt gctgagctca cctagctacc
ttcttgttgc atgtacggac 3300gccgccgtgc gtttggacat acaggcactt
ttgggccagg ctactcatgt tcgacttttt 3360ttttaatttt gtacaagatt
tgtgatcgag tgactgagtg agacagagtg ttgggtgtaa 3420gaactgtgat
ggaattcact caaattaatg gacatttttt ttcttcaaaa 3470261078PRTZea mays
26Met Asp Ala Gly Ser Val Thr Gly Gly Leu Ala Ala Gly Ser His Met1
5 10 15 Arg Asp Glu Leu His Val Met Arg Ala Arg Glu Glu Pro Asn Ala
Lys 20 25 30 Val Arg Ser Ala Asp Val Lys Thr Cys Arg Val Cys Ala
Asp Glu Val 35 40 45 Gly Thr Arg Glu Asp Gly Gln Pro Phe Val Ala
Cys Ala Glu Cys Gly 50 55 60 Phe Pro Val Cys Arg Pro Cys Tyr Glu
Tyr Glu Arg Ser Glu Gly Thr65 70 75 80 Gln Cys Cys Pro Gln Cys Asn
Thr Arg Tyr Lys Arg Gln Lys Gly Cys 85 90 95 Pro Arg Val Glu Gly
Asp Glu Glu Glu Gly Pro Glu Met Asp Asp Phe 100 105 110 Glu Asp Glu
Phe Pro Ala Lys Ser Pro Lys Lys Pro His Glu Pro Val 115 120 125 Ala
Phe Asp Val Tyr Ser Glu Asn Gly Glu His Pro Ala Gln Lys Trp 130 135
140 Arg Thr Gly Gly Gln Thr Leu Ser Ser Phe Thr Gly Ser Val Ala
Gly145 150 155 160 Lys Asp Leu Glu Ala Glu Arg Glu Met Glu Gly Ser
Met Glu Trp Lys 165 170 175 Asp Arg Ile Asp Lys Trp Lys Thr Lys Gln
Glu Lys Arg Gly Lys Leu 180 185 190 Asn His Asp Asp Ser Asp Asp Asp
Asp Asp Lys Asn Glu Asp Glu Tyr 195 200 205 Met Leu Leu Ala Glu Ala
Arg Gln Pro Leu Trp Arg Lys Val Pro Ile 210 215 220 Pro Ser Ser Met
Ile Asn Pro Tyr Arg Ile Val Ile Val Leu Arg Leu225 230 235 240 Val
Val Leu Cys Phe Phe Leu Lys Phe Arg Ile Thr Thr Pro Ala Thr 245 250
255 Asp Ala Val Pro Leu Trp Leu Ala Ser Val Ile Cys Glu Leu Trp Phe
260 265 270 Ala Phe Ser Trp Ile Leu Asp Gln Leu Pro Lys Trp Ala Pro
Val Thr 275 280 285 Arg Glu Thr Tyr Leu Asp Arg Leu Ala Leu Arg Tyr
Asp Arg Glu Gly 290 295 300 Glu Ala Cys Arg Leu Ser Pro Ile Asp Phe
Phe Val Ser Thr Val Asp305 310 315 320 Pro Leu Lys Glu Pro Pro Ile
Ile Thr Ala Asn Thr Val Leu Ser Ile 325 330 335 Leu Ala Val Asp Tyr
Pro Val Asp Arg Val Ser Cys Tyr Val Ser Asp 340 345 350 Asp Gly Ala
Ser Met Leu Leu Phe Asp Ala Leu Ser Glu Thr Ala Glu 355 360 365 Phe
Ala Arg Arg Trp Val Pro Phe Cys Lys Lys Phe Ala Val Glu Pro 370 375
380 Arg Ala Pro Glu Phe Tyr Phe Ser Gln Lys Ile Asp Tyr Leu Lys
Asp385 390 395 400 Lys Val Gln Pro Thr Phe Val Lys Glu Arg Arg Ala
Met Lys Arg Glu 405 410 415 Tyr Glu Glu Phe Lys Val Arg Ile Asn Ala
Leu Val Ala Lys Ala Gln 420 425 430 Lys Lys Pro Glu Glu Gly Trp Val
Met Gln Asp Gly Thr Pro Trp Pro 435 440 445 Gly Asn Asn Thr Arg Asp
His Pro Gly Met Ile Gln Val Tyr Leu Gly 450 455 460 Asn Gln Gly Ala
Leu Asp Val Glu Gly His Glu Leu Pro Arg Leu Val465 470 475 480 Tyr
Val Ser Arg Glu Lys Arg Pro Gly Tyr Asn His His Lys Lys Ala 485 490
495 Gly Ala Met Asn Ala Leu Val Arg Val Ser Ala Val Leu Thr Asn Ala
500 505 510 Pro Phe Ile Leu Asn Leu Asp Cys Asp His Tyr Val Asn Asn
Ser Lys 515 520 525 Ala Val Arg Glu Ala Met Cys Phe Leu Met Asp Pro
Gln Leu Gly Lys 530 535 540 Lys Leu Cys Tyr Val Gln Phe Pro Gln Arg
Phe Asp Gly Ile Asp Arg545 550 555 560 His Asp Arg Tyr Ala Asn Arg
Asn Val Val Phe Phe Asp Ile Asn Met 565 570 575 Lys Gly Leu Asp Gly
Ile Gln Gly Pro Val Tyr Val Gly Thr Gly Cys 580 585 590 Val Phe Asn
Arg Gln Ala Leu Tyr Gly Tyr Asp Pro Pro Arg Pro Glu 595 600 605 Lys
Arg Pro Lys Met Thr Cys Asp Cys Trp Pro Ser Trp Cys Cys Cys 610 615
620 Cys Cys Cys Phe Gly Gly Gly Lys Arg Gly Lys Ala Arg Lys Asp
Lys625 630 635 640 Lys Gly Asp Gly Gly Glu Glu Pro Arg Arg Gly Leu
Leu Gly Phe Tyr 645 650 655 Arg Lys Arg Ser Lys Lys Asp Lys Leu Gly
Gly Gly Ser Val Ala Gly 660 665 670 Ser Lys Lys Gly Gly Gly Leu Tyr
Lys Lys His Gln Arg Ala Phe Glu 675 680 685 Leu Glu Glu Ile Glu Glu
Gly Leu Glu Gly Tyr Asp Glu Leu Glu Arg 690 695 700 Ser Ser Leu Met
Ser Gln Lys Ser Phe Glu Lys Arg Phe Gly Gln Ser705 710 715 720 Pro
Val Phe Ile Ala Ser Thr Leu Val Glu Asp Gly Gly Leu Pro Gln 725 730
735 Gly Ala Ala Ala Asp Pro Ala Ala Leu Ile Lys Glu Ala Ile His Val
740 745 750 Ile Ser Cys Gly Tyr Glu Glu Lys Thr Glu Trp Gly Lys Glu
Ile Gly 755 760 765 Trp Ile Tyr Gly Ser Val Thr Glu Asp Ile Leu Thr
Gly Phe Lys Met 770 775 780 His Cys Arg Gly Trp Lys Ser Val Tyr Cys
Thr Pro Thr Arg Pro Ala785 790 795 800 Phe Lys Gly Ser Ala Pro Ile
Asn Leu Ser Asp Arg Leu His Gln Val 805 810 815 Leu Arg Trp Ala Leu
Gly Ser Val Glu Ile Phe Met Ser Arg His Cys 820 825 830 Pro Leu Arg
Tyr Ala Tyr Gly Gly Arg Leu Lys Trp Leu Glu Arg Phe 835 840 845 Ala
Tyr Thr Asn Thr Ile Val Tyr Pro Phe Thr Ser Ile Pro Leu Leu 850 855
860 Ala Tyr Cys Thr Ile Pro Ala Val Cys Leu Leu Thr Gly Lys Phe
Ile865 870 875 880 Ile Pro Thr Leu Asn Asn Leu Ala Ser Ile Trp Phe
Ile Ala Leu Phe 885 890 895 Leu Ser Ile Ile Ala Thr Ser Val Leu Glu
Leu Arg Trp Ser Gly Val 900 905 910 Ser Ile Glu Asp Trp Trp Arg Asn
Glu Gln Phe Trp Val Ile Gly Gly 915 920 925 Val Ser Ala His Leu Phe
Ala Val Phe Gln Gly Phe Leu Lys Val Leu 930 935 940 Gly Gly Val Asp
Thr Ser Phe Thr Val Thr Ser Lys Ala Ala Gly Asp945 950 955 960 Glu
Ala Asp Ala Phe Gly Asp Leu Tyr Leu Phe Lys Trp Thr Thr Leu 965 970
975 Leu Val Pro Pro Thr Thr Leu Ile Ile Ile Asn Met Val Gly Ile Val
980 985 990 Ala Gly Val Ser Asp Ala Val Asn Asn Gly Tyr Gly Ser Trp
Gly Pro 995 1000 1005 Leu Phe Gly Lys Leu Phe Phe Ser Phe Trp Val
Ile Val His Leu Tyr 1010 1015 1020 Pro Phe Leu Lys Gly Leu Met Gly
Arg Gln Asn Arg Thr Pro Thr Ile1025 1030 1035 1040Val Val Leu Trp
Ser Ile Leu Leu Ala Ser Ile Phe Ser Leu Val Trp 1045 1050 1055 Val
Arg Ile Asp Pro Phe Ile Pro Lys Ala Lys Gly Pro Ile Leu Lys 1060
1065 1070 Pro Cys Gly Val Glu Cys 1075 273231DNAZea mays
27ccacgcgtcc gggaggggcc atgatggagt cggcggcggc ccagtcctgc gcggcgtgcg
60gggacgacgc gcgcgctgcc tgccgcgcgt gcagctacgc gctctgcagg gcgtgcctcg
120acgaggacgc cgccgagggc cgcaccacat gcgcgcgctg cggaggggac
tacgccgcta 180tcaacccagc gcgcgccagc gagggaaccg aggcggagga
ggaggtggtg gagaaccacc 240acaccgccgg tggcctgcgt gagagggtca
ccatgggcag ccacctcaat gatcgccagg 300atgaagtaag ccacgccagg
accatgagca gcttgtcggg aattggtagt gaattgaatg 360atgaatctgg
taagcccatc tggaagaaca gggtggagag ttggaaggaa aagaagaatg
420agaagaaagc ctcggccaaa aagactgcag ctaaagcaca gcctccgcct
gtcgaagaac 480agatcatgga tgaaaaagac ttgacagatg catatgagcc
actctcccgg gtcatcccaa 540tatcaaagaa caagctcaca ccttacagag
cagtgatcat tatgcggtta attgttcttg 600ggctcttctt tcactaccgt
atcaccaatc ctgttaacag tgcctttggt ctctggatga 660catcagttat
atgtgagatc tggtttggtt tctcctggat attggatcaa ttcccgaagt
720ggtatcctat caatcgtgag acttatgttg ataggctgat tgcacgatat
ggagatggtg 780aagaatctgg gttagcacct gtagatttct ttgtcagtac
agtggatcca ttgaaagagc 840ctccactaat cactgcaaac actgtgctgt
ctattcttgc tgtggactat cccgttgaga 900agatctcatg ctatgtatct
gatgatggtt ctgctatgct cacatttgaa tcgctcgcag 960agactgcaga
atatgctaga aagtgggtgc cgttttgcaa gaagtacgcc attgagccac
1020gagctcctga gttctacttc tcacagaaaa ttgactactt gaaggacaag
atacacccat 1080cttttgtcaa ggagcgtagg gctatgaaga gagactatga
agagtacaag gtgaggataa 1140atgctttggt tgccaaggct caaaagacac
ctgatgaagg ctggatcatg caagacggta 1200caccatggcc tgggaacaat
cctcgtgacc accctggcat gatccaggtt ttcctgggtg 1260agactggtgc
acgggacttt gatggaaatg aacttcctcg
gttagtgtat gtgtcaagag 1320agaaaagacc aggctaccaa caccacaaga
aggcaggggc tatgaatgct ctggtccgag 1380tgtctgctgt tctgacaaat
gccccttaca ttcttaatct tgattgtgat cactatgtta 1440acaacagcaa
agctgttcgt gaagcaatgt gcttcatgat ggaccctact gttggcagag
1500atgtctgcta tgtacaattc ccccagaggt tcgatggcat tgatcgcagt
gatcgatatg 1560ccaataggaa cgttgtgttc tttgatgtta atatgaaagg
acttgatggc ctccaaggcc 1620cagtttatgt gggaactggt tgttgtttca
ataggcaagc actttatggt tatgggcctc 1680catctctgcc cgcacttcca
aagtcttcga tttgttcctg gtgttgctgc tgctgtccca 1740agaaaaaggt
tgaaagaagt gagagggaaa tcaacagaga ctctcggcga gaagacctcg
1800agtctgccat ttttaacctt cgcgaaattg acaactacga tgagtacgag
aggtccatgc 1860tcatctctca gatgagcttc gagaagtctt ttgggctgtc
ctcggtcttt attgaatcga 1920cccttatgga gaatgggggc gtccctgaat
ctgcaaaccc atctacccta attaaagaag 1980ccattcatgt cattagctgt
ggatatgaag agaaaactga atggggaaaa gagattggct 2040ggatctatgg
ttcagttaca gaggatattc tgactgggtt taagatgcac tgccgtggct
2100ggagatccat ctactgcatg ccggtgagac ctgcattcaa gggatcagcc
ccaatcaatc 2160tttccgatcg tcttcaccaa gttctccggt gggctcttgt
ttctgtcgag atcttcttca 2220gtcggcactg cccgctgtgg tacggttacg
gtggcggccg tctgaaatgg ctccagaggc 2280tctcctacat caacaccatc
gtgtacccgt tcacttctct tcctctcgtt gcctactgtt 2340gcctgcctgc
catttgcctg ctcacaggaa agttcattat acctacgctg tccaacgctg
2400caacgatatg gtttcttggc ctcttcatgt ccatcatcgt gacgagcgtg
ttggagctgc 2460ggtggagtgg catcgggatc gaggactggt ggcgcaacga
gcagttctgg gtcatcggag 2520gcgtgtccgc gcacctgttc gccgtgttcc
agggtatcct caagatgatt gccgggctgg 2580acaccaactt cacggtcacg
gcaaaggcca cggacgacac tgagttcggg gagctgtacc 2640tgttcaagtg
gacgacggtg ctgatcccgc ccacaagcat cctggtgctg aacctggtgg
2700gcgtggtggc tgggttctcg gccgcgctca acagcggcta cgagtcctgg
ggcccgctct 2760tcggtaaggt gttcttcgcc atgtgggtga tcatgcacct
gtacccgttc ctcaagggtc 2820tcatgggccg ccagaaccgc acgccgacca
tcgtggtgct ctggtccgtc ctcctcgcct 2880ccgtcttctc cctcctgtgg
gtcaagatcg acccattcgt tggaggaacc gagaccgtca 2940acaccaacaa
ctgcaacaca catctgctga ttcaccatcg gtcagctgct gtcgtgccgc
3000ggcggacgtg tttctggtgt tgcaaacgtg ggttgcctgc ctgatgcggg
tctcctctgt 3060ctatctcgca tctgggcttt tgccccagga tctgaagcgg
gtggtgtagg ttagctttat 3120tttgcgtcca agtgttgatt gatgttgtct
gtgttatgaa aagttttggt ggtgaaacct 3180gaaatgttaa aattcggctc
aattgtgaga aaaaaaaaaa aaaaaaaaaa a 3231281007PRTZea mays 28Met Met
Glu Ser Ala Ala Ala Gln Ser Cys Ala Ala Cys Gly Asp Asp1 5 10 15
Ala Arg Ala Ala Cys Arg Ala Cys Ser Tyr Ala Leu Cys Arg Ala Cys 20
25 30 Leu Asp Glu Asp Ala Ala Glu Gly Arg Thr Thr Cys Ala Arg Cys
Gly 35 40 45 Gly Asp Tyr Ala Ala Ile Asn Pro Ala Arg Ala Ser Glu
Gly Thr Glu 50 55 60 Ala Glu Glu Glu Val Val Glu Asn His His Thr
Ala Gly Gly Leu Arg65 70 75 80 Glu Arg Val Thr Met Gly Ser His Leu
Asn Asp Arg Gln Asp Glu Val 85 90 95 Ser His Ala Arg Thr Met Ser
Ser Leu Ser Gly Ile Gly Ser Glu Leu 100 105 110 Asn Asp Glu Ser Gly
Lys Pro Ile Trp Lys Asn Arg Val Glu Ser Trp 115 120 125 Lys Glu Lys
Lys Asn Glu Lys Lys Ala Ser Ala Lys Lys Thr Ala Ala 130 135 140 Lys
Ala Gln Pro Pro Pro Val Glu Glu Gln Ile Met Asp Glu Lys Asp145 150
155 160 Leu Thr Asp Ala Tyr Glu Pro Leu Ser Arg Val Ile Pro Ile Ser
Lys 165 170 175 Asn Lys Leu Thr Pro Tyr Arg Ala Val Ile Ile Met Arg
Leu Ile Val 180 185 190 Leu Gly Leu Phe Phe His Tyr Arg Ile Thr Asn
Pro Val Asn Ser Ala 195 200 205 Phe Gly Leu Trp Met Thr Ser Val Ile
Cys Glu Ile Trp Phe Gly Phe 210 215 220 Ser Trp Ile Leu Asp Gln Phe
Pro Lys Trp Tyr Pro Ile Asn Arg Glu225 230 235 240 Thr Tyr Val Asp
Arg Leu Ile Ala Arg Tyr Gly Asp Gly Glu Glu Ser 245 250 255 Gly Leu
Ala Pro Val Asp Phe Phe Val Ser Thr Val Asp Pro Leu Lys 260 265 270
Glu Pro Pro Leu Ile Thr Ala Asn Thr Val Leu Ser Ile Leu Ala Val 275
280 285 Asp Tyr Pro Val Glu Lys Ile Ser Cys Tyr Val Ser Asp Asp Gly
Ser 290 295 300 Ala Met Leu Thr Phe Glu Ser Leu Ala Glu Thr Ala Glu
Tyr Ala Arg305 310 315 320 Lys Trp Val Pro Phe Cys Lys Lys Tyr Ala
Ile Glu Pro Arg Ala Pro 325 330 335 Glu Phe Tyr Phe Ser Gln Lys Ile
Asp Tyr Leu Lys Asp Lys Ile His 340 345 350 Pro Ser Phe Val Lys Glu
Arg Arg Ala Met Lys Arg Asp Tyr Glu Glu 355 360 365 Tyr Lys Val Arg
Ile Asn Ala Leu Val Ala Lys Ala Gln Lys Thr Pro 370 375 380 Asp Glu
Gly Trp Ile Met Gln Asp Gly Thr Pro Trp Pro Gly Asn Asn385 390 395
400 Pro Arg Asp His Pro Gly Met Ile Gln Val Phe Leu Gly Glu Thr Gly
405 410 415 Ala Arg Asp Phe Asp Gly Asn Glu Leu Pro Arg Leu Val Tyr
Val Ser 420 425 430 Arg Glu Lys Arg Pro Gly Tyr Gln His His Lys Lys
Ala Gly Ala Met 435 440 445 Asn Ala Leu Val Arg Val Ser Ala Val Leu
Thr Asn Ala Pro Tyr Ile 450 455 460 Leu Asn Leu Asp Cys Asp His Tyr
Val Asn Asn Ser Lys Ala Val Arg465 470 475 480 Glu Ala Met Cys Phe
Met Met Asp Pro Thr Val Gly Arg Asp Val Cys 485 490 495 Tyr Val Gln
Phe Pro Gln Arg Phe Asp Gly Ile Asp Arg Ser Asp Arg 500 505 510 Tyr
Ala Asn Arg Asn Val Val Phe Phe Asp Val Asn Met Lys Gly Leu 515 520
525 Asp Gly Leu Gln Gly Pro Val Tyr Val Gly Thr Gly Cys Cys Phe Asn
530 535 540 Arg Gln Ala Leu Tyr Gly Tyr Gly Pro Pro Ser Leu Pro Ala
Leu Pro545 550 555 560 Lys Ser Ser Ile Cys Ser Trp Cys Cys Cys Cys
Cys Pro Lys Lys Lys 565 570 575 Val Glu Arg Ser Glu Arg Glu Ile Asn
Arg Asp Ser Arg Arg Glu Asp 580 585 590 Leu Glu Ser Ala Ile Phe Asn
Leu Arg Glu Ile Asp Asn Tyr Asp Glu 595 600 605 Tyr Glu Arg Ser Met
Leu Ile Ser Gln Met Ser Phe Glu Lys Ser Phe 610 615 620 Gly Leu Ser
Ser Val Phe Ile Glu Ser Thr Leu Met Glu Asn Gly Gly625 630 635 640
Val Pro Glu Ser Ala Asn Pro Ser Thr Leu Ile Lys Glu Ala Ile His 645
650 655 Val Ile Ser Cys Gly Tyr Glu Glu Lys Thr Glu Trp Gly Lys Glu
Ile 660 665 670 Gly Trp Ile Tyr Gly Ser Val Thr Glu Asp Ile Leu Thr
Gly Phe Lys 675 680 685 Met His Cys Arg Gly Trp Arg Ser Ile Tyr Cys
Met Pro Val Arg Pro 690 695 700 Ala Phe Lys Gly Ser Ala Pro Ile Asn
Leu Ser Asp Arg Leu His Gln705 710 715 720 Val Leu Arg Trp Ala Leu
Val Ser Val Glu Ile Phe Phe Ser Arg His 725 730 735 Cys Pro Leu Trp
Tyr Gly Tyr Gly Gly Gly Arg Leu Lys Trp Leu Gln 740 745 750 Arg Leu
Ser Tyr Ile Asn Thr Ile Val Tyr Pro Phe Thr Ser Leu Pro 755 760 765
Leu Val Ala Tyr Cys Cys Leu Pro Ala Ile Cys Leu Leu Thr Gly Lys 770
775 780 Phe Ile Ile Pro Thr Leu Ser Asn Ala Ala Thr Ile Trp Phe Leu
Gly785 790 795 800 Leu Phe Met Ser Ile Ile Val Thr Ser Val Leu Glu
Leu Arg Trp Ser 805 810 815 Gly Ile Gly Ile Glu Asp Trp Trp Arg Asn
Glu Gln Phe Trp Val Ile 820 825 830 Gly Gly Val Ser Ala His Leu Phe
Ala Val Phe Gln Gly Ile Leu Lys 835 840 845 Met Ile Ala Gly Leu Asp
Thr Asn Phe Thr Val Thr Ala Lys Ala Thr 850 855 860 Asp Asp Thr Glu
Phe Gly Glu Leu Tyr Leu Phe Lys Trp Thr Thr Val865 870 875 880 Leu
Ile Pro Pro Thr Ser Ile Leu Val Leu Asn Leu Val Gly Val Val 885 890
895 Ala Gly Phe Ser Ala Ala Leu Asn Ser Gly Tyr Glu Ser Trp Gly Pro
900 905 910 Leu Phe Gly Lys Val Phe Phe Ala Met Trp Val Ile Met His
Leu Tyr 915 920 925 Pro Phe Leu Lys Gly Leu Met Gly Arg Gln Asn Arg
Thr Pro Thr Ile 930 935 940 Val Val Leu Trp Ser Val Leu Leu Ala Ser
Val Phe Ser Leu Leu Trp945 950 955 960 Val Lys Ile Asp Pro Phe Val
Gly Gly Thr Glu Thr Val Asn Thr Asn 965 970 975 Asn Cys Asn Thr His
Leu Leu Ile His His Arg Ser Ala Ala Val Val 980 985 990 Pro Arg Arg
Thr Cys Phe Trp Cys Cys Lys Arg Gly Leu Pro Ala 995 1000 1005
293028DNAZea mays 29cacgagttca acatcgacga cgagaatcag cagaggcagc
tggagggcaa catgcagaac 60agccagatca ccgaggcgat gctgcacggc aggatgagct
acgggagggg ccccgacgac 120ggcgacggca acaacacccc gcagatcccg
cccatcatca ccggctcccg ctccgtgccg 180gtgagcggtg agtttccgat
taccaacggg tatggccacg gcgaggtctc gtcttccctg 240cacaagcgca
tccatccgta ccctgtgtct gagccaggga gtgccaagtg ggacgagaag
300aaagaagtga gctggaagga gaggatggac gactggaagt ccaagcaggg
catcctcggc 360ggcggcgccg atcccgaaga catggacgcc gacgtggcac
tgaacgacga ggcgaggcag 420ccgctgtcga ggaaggtgtc gatcgcgtcg
agcaaggtga acccgtaccg gatggtgatc 480gtggtgcgtc tcgttgtgct
cgccttcttc ctccggtacc gtatcctgca ccccgtcccg 540gacgccatcg
ggctgtggct cgtctccatc atctgcgaga tctggttcgc catctcctgg
600atcctcgacc agttccccaa gtggttcccc atcgaccgcg agacgtacct
cgaccgcctc 660tccctcaggt acgagaggga aggggagccg tcgctgctgt
cggcggtgga cctgttcgtg 720agcacggtgg acccgctcaa ggagccgccg
ctggtgaccg ccaacaccgt gctctccatc 780ctcgccgtag actaccccgt
ggacaaggtc tcctgctacg tctccgacga cggcgcgtcg 840atgctgacgt
tcgagtcgct gtcggagacg gccgagttcg cgcgcaagtg ggtgcccttc
900tgcaagaagt tcggcatcga gccccgcgcc ccggagttct acttctcgct
caaggtcgac 960tacctcaagg acaaggtgca gcccaccttc gtgcaggagc
gccgcgccat gaagagagag 1020tatgaggagt tcaaggtccg gatcaacgcg
ctggtggcca aggccatgaa ggtgccggca 1080gaggggtgga tcatgaagga
cggcacgccg tggcccggga acaacacccg cgaccacccc 1140ggcatgatcc
aggtgttcct gggccacagc ggcggccacg acaccgaggg caacgagctg
1200ccccgcctcg tgtacgtctc ccgtgagaag cgcccgggat tccagcacca
caagaaggcc 1260ggcgccatga acgctctgat tcgcgtctcc gccgtgctga
ccaacgcgcc attcatgctc 1320aacttggact gtgatcacta catcaacaac
agcaaggcca tccgggaggc catgtgcttc 1380ctcatggacc ctcaggtcgg
ccggaaggtc tgctacgttc agttcccgca gaggttcgac 1440ggcatcgacg
tgcacgaccg atacgctaac aggaacaccg tcttcttcga catcaacatg
1500aaggggctgg acggcatcca aggcccggtg tacgtcggga cagggtgcgt
gttccggcgc 1560caggcgctct acggctacaa ccctcccaag ggacccaaga
ggcccaagat ggtgacctgc 1620gactgctgcc cgtgcttcgg ccgcaagaag
cggaaacacg ccaaggacgg gctgccggag 1680ggcaccgctg atatgggagt
agatagcgac aaggagatgc tcatgtccca catgaacttc 1740gagaagcggt
tcgggcagtc cgcggcgttc gtcacgtcga cgctgatgga ggaaggcggc
1800gtccctcctt cgtcgagccc cgccgcgctc ctcaaggagg ccatccatgt
catcagctgc 1860ggctacgagg acaagaccga ctgggggctg gagctggggt
ggatctacgg gtcgatcacg 1920gaggacatcc tgacggggtt caagatgcac
tgccgcgggt ggcgctccgt gtactgcatg 1980ccgaagcggg cggcgttcaa
ggggtcggcg ccgatcaatc tatcggaccg tctcaaccag 2040gtgctccggt
gggcgctggg gtccgtcgag atcttcttca gccggcacag ccccctgctg
2100tacggctaca agaacggcaa cctcaagtgg ctggagcgct tcgcctacat
caacaccacc 2160atctacccct tcacctcgct cccgctgctc gcctactgca
ccctccccgc cgtctgcctc 2220ctcaccggca agttcatcat gccgtcgatt
agcacgttcg ccagcctctt cttcatcgcc 2280ctcttcatgt ccatcttcgc
gacgggcatc ctggagatgc ggtggagcgg ggtgagcatc 2340gaggagtggt
ggaggaacga gcagttctgg gtcatcggcg gcgtgtccgc gcatctcttc
2400gccgtcgtgc agggcctgct caaggtcctc gccgggatcg acaccaactt
caccgtcacc 2460tccaaggcca ccggcgacga ggacgacgag ttcgccgagc
tctacgcctt caagtggacc 2520acgctcctca tcccgcccac cacgctgctc
atcattaacg tcatcggcgt cgtggccggc 2580atctccgacg ccatcaacaa
cgggtaccag tcctgggggc ccctcttcgg caagctcttc 2640ttcgccttct
gggtcatcgt ccacctctac ccgttcctca aggggctcat ggggcgccag
2700aacaggacgc ccaccgttgt tgtcatctgg tccattctgc tggcctccat
cttctccctg 2760ctctgggtca ggatcgaccc tttcatcgtc aggaccaagg
gcccggacgt caggcagtgt 2820ggcatcaatt gctgagctgt ttattaaggt
tcaaaattct ggagcttgtg catagggaga 2880aaaaaacaat ttagaaattt
tgtaaggttg ttgtgtctgt aatgttatgg tacccagaat 2940tgtcggacga
ggaattgaac aaaggacaag gtttgattgt taaatggcaa aaaaaaaaaa
3000aaaaaaaaaa aaaaaaaaaa aaaaaaaa 302830927PRTZea mays 30Met Gln
Asn Ser Gln Ile Thr Glu Ala Met Leu His Gly Arg Met Ser1 5 10 15
Tyr Gly Arg Gly Pro Asp Asp Gly Asp Gly Asn Asn Thr Pro Gln Ile 20
25 30 Pro Pro Ile Ile Thr Gly Ser Arg Ser Val Pro Val Ser Gly Glu
Phe 35 40 45 Pro Ile Thr Asn Gly Tyr Gly His Gly Glu Val Ser Ser
Ser Leu His 50 55 60 Lys Arg Ile His Pro Tyr Pro Val Ser Glu Pro
Gly Ser Ala Lys Trp65 70 75 80 Asp Glu Lys Lys Glu Val Ser Trp Lys
Glu Arg Met Asp Asp Trp Lys 85 90 95 Ser Lys Gln Gly Ile Leu Gly
Gly Gly Ala Asp Pro Glu Asp Met Asp 100 105 110 Ala Asp Val Ala Leu
Asn Asp Glu Ala Arg Gln Pro Leu Ser Arg Lys 115 120 125 Val Ser Ile
Ala Ser Ser Lys Val Asn Pro Tyr Arg Met Val Ile Val 130 135 140 Val
Arg Leu Val Val Leu Ala Phe Phe Leu Arg Tyr Arg Ile Leu His145 150
155 160 Pro Val Pro Asp Ala Ile Gly Leu Trp Leu Val Ser Ile Ile Cys
Glu 165 170 175 Ile Trp Phe Ala Ile Ser Trp Ile Leu Asp Gln Phe Pro
Lys Trp Phe 180 185 190 Pro Ile Asp Arg Glu Thr Tyr Leu Asp Arg Leu
Ser Leu Arg Tyr Glu 195 200 205 Arg Glu Gly Glu Pro Ser Leu Leu Ser
Ala Val Asp Leu Phe Val Ser 210 215 220 Thr Val Asp Pro Leu Lys Glu
Pro Pro Leu Val Thr Ala Asn Thr Val225 230 235 240 Leu Ser Ile Leu
Ala Val Asp Tyr Pro Val Asp Lys Val Ser Cys Tyr 245 250 255 Val Ser
Asp Asp Gly Ala Ser Met Leu Thr Phe Glu Ser Leu Ser Glu 260 265 270
Thr Ala Glu Phe Ala Arg Lys Trp Val Pro Phe Cys Lys Lys Phe Gly 275
280 285 Ile Glu Pro Arg Ala Pro Glu Phe Tyr Phe Ser Leu Lys Val Asp
Tyr 290 295 300 Leu Lys Asp Lys Val Gln Pro Thr Phe Val Gln Glu Arg
Arg Ala Met305 310 315 320 Lys Arg Glu Tyr Glu Glu Phe Lys Val Arg
Ile Asn Ala Leu Val Ala 325 330 335 Lys Ala Met Lys Val Pro Ala Glu
Gly Trp Ile Met Lys Asp Gly Thr 340 345 350 Pro Trp Pro Gly Asn Asn
Thr Arg Asp His Pro Gly Met Ile Gln Val 355 360 365 Phe Leu Gly His
Ser Gly Gly His Asp Thr Glu Gly Asn Glu Leu Pro 370 375 380 Arg Leu
Val Tyr Val Ser Arg Glu Lys Arg Pro Gly Phe Gln His His385 390 395
400 Lys Lys Ala Gly Ala Met Asn Ala Leu Ile Arg Val Ser Ala Val Leu
405 410 415 Thr Asn Ala Pro Phe Met Leu Asn Leu Asp Cys Asp His Tyr
Ile Asn 420 425 430 Asn Ser Lys Ala Ile Arg Glu Ala Met Cys Phe Leu
Met Asp Pro Gln 435 440 445 Val Gly Arg Lys Val Cys Tyr Val Gln Phe
Pro Gln Arg Phe Asp Gly 450 455 460 Ile Asp Val His Asp Arg Tyr Ala
Asn Arg Asn Thr Val Phe Phe Asp465 470 475 480 Ile Asn Met Lys Gly
Leu Asp Gly Ile Gln Gly Pro Val Tyr Val Gly 485 490 495 Thr Gly Cys
Val Phe Arg Arg Gln Ala Leu Tyr Gly Tyr Asn Pro Pro 500 505 510 Lys
Gly Pro Lys Arg Pro Lys Met Val Thr Cys Asp Cys Cys Pro Cys 515 520
525 Phe Gly Arg Lys Lys Arg Lys His
Ala Lys Asp Gly Leu Pro Glu Gly 530 535 540 Thr Ala Asp Met Gly Val
Asp Ser Asp Lys Glu Met Leu Met Ser His545 550 555 560 Met Asn Phe
Glu Lys Arg Phe Gly Gln Ser Ala Ala Phe Val Thr Ser 565 570 575 Thr
Leu Met Glu Glu Gly Gly Val Pro Pro Ser Ser Ser Pro Ala Ala 580 585
590 Leu Leu Lys Glu Ala Ile His Val Ile Ser Cys Gly Tyr Glu Asp Lys
595 600 605 Thr Asp Trp Gly Leu Glu Leu Gly Trp Ile Tyr Gly Ser Ile
Thr Glu 610 615 620 Asp Ile Leu Thr Gly Phe Lys Met His Cys Arg Gly
Trp Arg Ser Val625 630 635 640 Tyr Cys Met Pro Lys Arg Ala Ala Phe
Lys Gly Ser Ala Pro Ile Asn 645 650 655 Leu Ser Asp Arg Leu Asn Gln
Val Leu Arg Trp Ala Leu Gly Ser Val 660 665 670 Glu Ile Phe Phe Ser
Arg His Ser Pro Leu Leu Tyr Gly Tyr Lys Asn 675 680 685 Gly Asn Leu
Lys Trp Leu Glu Arg Phe Ala Tyr Ile Asn Thr Thr Ile 690 695 700 Tyr
Pro Phe Thr Ser Leu Pro Leu Leu Ala Tyr Cys Thr Leu Pro Ala705 710
715 720 Val Cys Leu Leu Thr Gly Lys Phe Ile Met Pro Ser Ile Ser Thr
Phe 725 730 735 Ala Ser Leu Phe Phe Ile Ala Leu Phe Met Ser Ile Phe
Ala Thr Gly 740 745 750 Ile Leu Glu Met Arg Trp Ser Gly Val Ser Ile
Glu Glu Trp Trp Arg 755 760 765 Asn Glu Gln Phe Trp Val Ile Gly Gly
Val Ser Ala His Leu Phe Ala 770 775 780 Val Val Gln Gly Leu Leu Lys
Val Leu Ala Gly Ile Asp Thr Asn Phe785 790 795 800 Thr Val Thr Ser
Lys Ala Thr Gly Asp Glu Asp Asp Glu Phe Ala Glu 805 810 815 Leu Tyr
Ala Phe Lys Trp Thr Thr Leu Leu Ile Pro Pro Thr Thr Leu 820 825 830
Leu Ile Ile Asn Val Ile Gly Val Val Ala Gly Ile Ser Asp Ala Ile 835
840 845 Asn Asn Gly Tyr Gln Ser Trp Gly Pro Leu Phe Gly Lys Leu Phe
Phe 850 855 860 Ala Phe Trp Val Ile Val His Leu Tyr Pro Phe Leu Lys
Gly Leu Met865 870 875 880 Gly Arg Gln Asn Arg Thr Pro Thr Val Val
Val Ile Trp Ser Ile Leu 885 890 895 Leu Ala Ser Ile Phe Ser Leu Leu
Trp Val Arg Ile Asp Pro Phe Ile 900 905 910 Val Arg Thr Lys Gly Pro
Asp Val Arg Gln Cys Gly Ile Asn Cys 915 920 925 3136DNAArtificial
SequenceSal-A20 oligonucleotide 31tcgacccacg cgtccgaaaa aaaaaaaaaa
aaaaaa 363228DNAArtificial SequenceGSP1 forward primer 32tacgatgagt
acgagaggtc catgctca 283326DNAArtificial SequenceGSP2 reverse primer
33ggcaaaagcc cagatgcgag atagac 263432DNAArtificial SequenceMu TIR
primer 34agagaagcca acgccawcgc ctcyatttcg tc 32359DNAZea mays
35tggcggccg 9369DNAZea mays 36tctgaaatg 9379DNAZea mays 37gcccacaag
9389DNAZea mays 38catcctggt 9399DNAZea mays 39gtgttcttc 9409DNAZea
mays 40gccatgtgg 9413568DNAZea maysmisc_feature3487n = A,T,C or G
41gtcgacccac gcgtccggag ctcgtcgtca tccgccgcga tggcgagcca gggccgaagc
60ccatggacca gcggaacggc caggtgtgcc agatttgcgg cgacgacgtg gggcgcaacc
120ccgacgggga gcctttcgtg gcctgcaacg agtgcgcctt ccccatctgc
cgggactgct 180acgagtacga gcgccgcgag ggcacgcaga actgccccca
gtgcaagacc cgcttcaagc 240gcttcaaggg gtgcgcgcgc gtgcccgggg
acgaggagga ggacggcgtc gacgacctgg 300agaacgagtt caactggagc
gacaagcacg actcccagta cctcgccgag tccatgctcc 360acgcccacat
gagctacggc cgcggcgccg acctcgacgg cgtgccgcag ccattccacc
420ccatccccaa tgttcccctc ctcaccaacg gacagatggt cgatgacatc
ccgccggacc 480agcacgccct tgtgccctcg ttcgtgggtg gcggggggaa
gaggattcac cctctcccgt 540acgcggatcc caaccttcct gtgcaaccga
ggtctatgga cccttccaag gatctcgccg 600catatggcta cgggagcgta
gcatggaagg agaggatgga gagctggaag cagaagcagg 660agaggatgca
ccagacgagg aacgatggcg gcggcgatga tggtgatgat gcagatctac
720cactaatgga tgaagctaga cagccattgt ccagaaagat cccgcttcct
tcaagccaaa 780tcaaccccta taggatgatt ataataattc ggctagtggt
tttgtgtttc ttcttccact 840accgagtgat gcatccggtg cctgatgcat
ttgctttatg gctcatatct gtgatctgtg 900aaatttggtt tgccatgtct
tggattcttg accagtttcc aaagtggttt cctatcgaga 960gggaaaccta
tcttgaccgg ctgagtttaa ggtttgacaa ggaagggcat ccttctcaac
1020tcgcccctgt tgatttcttt gtcagtacgg ttgatccctt gaaggaacct
ccattggtca 1080ctgctaatac tgttctatct atcctttcgg tggattatcc
agttgataag gtttcatgct 1140acgtttctga tgatggtgct gccatgctga
catttgaagc attgtctgaa acatctgaat 1200ttgcaaagaa atgggttcct
ttctgcaaaa gatatagcct tgagcctcgt gctccagagt 1260ggtacttcca
acagaagata gactacctga aagacaaggt ggcgccaaac tttgttagag
1320aacggagagc aatgaagaga gagtatgagg aattcaaggt cagaatcaat
gccttggttg 1380ctaaagccca aaaggttcct gaggaaggat ggacaatgca
ggatggaact ccatggcccg 1440gaaataatgt ccgtgatcat cctggaatga
ttcaggtttt ccttggtcaa agtggtggcc 1500atgatgtgga aggaaatgag
ctgcctcgat tggtttatgt ttcaagagaa aaacggccag 1560gctacaacca
tcacaagaag gctggtgcta tgaatgcatt ggtccgagtc tctgctgtac
1620taactaatgc tccttatttg ctgaacttgg attgtgatca ctatatcaat
aatagtaagg 1680ctataaagga agcaatgtgt tttatgatgg atcctttgct
tggaaagaaa gtttgctatg 1740tgcagtttcc tcaaagattt gatgggattg
atcgccatga tcgatatgct aacagaaatg 1800ttgtcttttt cgatatcaac
atgaaaggtt tggatggtat ccagggccca atttatgtgg 1860gtactggatg
tgtcttcaga aggcaggcat tatatggcta cgatgctccc aaaacaaaga
1920agccaccatc aagaacttgc aactgctggc caaagtggtg catttgctgt
tgctgttttg 1980gtaacaggaa gaccaagaag aagaccaaga cctctaaacc
taaatttgag aagataaaga 2040aactttttaa gaaaaaggaa aatcaagccc
ctgcatatgc tcttggtgaa attgatgaag 2100ccgctccagg agctgaaaat
gaaaaggcta gtattgtaaa tcaacagaag ttggaaaaga 2160aatttggcca
gtcttcagtt tttgttgcat ccacacttct tgagaatggt ggaaccctga
2220agagtgccag tccagcttct cttctgaagg aagctataca tgtcatcagt
tgtggatatg 2280aagacaaaac aggctgggga aaagatattg gttggattta
tggatcagtc acagaagata 2340ttcttactgg gtttaagatg cactgccatg
gttggcggtc aatttactgc atacctaaac 2400gggccgcctt caaaggttcc
gcacctctca atctttccga tcgttttcac caggttcttc 2460ggtgggctct
tggttcaatt gaaattttgt tcagcaacca ctgccctctc tggtatgggt
2520atggtggtgg actaaagttc ctggaaaggt tttcgtacat taactccatc
gtataccctt 2580ggacatctat cccgctcttg gcctattgca cattgcctgc
catctgcttg ctgacaggga 2640aatttatcac gccagagctt aacaatgttg
ccagcctctg gttcatgtca cttttcatct 2700gcatttttgc tacgagcatc
ctggaaatga gatggagtgg tgtaggcatc gatgactggt 2760ggagaaacga
gcagttttgg gtcattggag gcgtgtcttc acatctcttt gctgtgttcc
2820agggactcct caaggtcata gctggtgtag acacgagctt cactgtgaca
tccaagggcg 2880gagacgacga ggagttctca gagctgtaca cattcaaatg
gacgaccctt ctgatacctc 2940cgacaaccct gctcctactg aacttcattg
gagtggtagc tggcatctcc aatgcgatca 3000acaacggata tgaatcatgg
ggccccctgt tcgggaagct cttctttgca ttttgggtga 3060tcgtccatct
ttacccgttc ctcaagggtc tggttgggag gcagaacagg acgccaacga
3120ttgtcattgt ctggtccatc ctcctggctt cgatcttctc gctgctttgg
gtccggatcg 3180acccgttcct tgcgaaggat gatggtcccc tgttggagga
gtgtggtctg gattgcaact 3240aggaggtcag cacgtggact tccccgtcag
tgtgtggtcg aagaagtatt tttgcagatg 3300ttttgtgccc atatttcttt
actcaatttt tgtccctctg tagattgaaa caaggggtga 3360aggggaaaaa
aagtacttgt atttcttttg ttccatggtg gtggtggtgg tgggcggctc
3420agcctcgtga gtgcaatatt gggcaaaccg gaggttgcgg caaccttgtg
cagttcgtcc 3480acgaatntac tagggatgat cgcgaccaat caatcaatcg
atgaccgagt tcaattgttc 3540aaaaaaaaaa aaaaaaaagg gcggccgc
3568421059PRTZea mays 42Met Asp Gln Arg Asn Gly Gln Val Cys Gln Ile
Cys Gly Asp Asp Val1 5 10 15 Gly Arg Asn Pro Asp Gly Glu Pro Phe
Val Ala Cys Asn Glu Cys Ala 20 25 30 Phe Pro Ile Cys Arg Asp Cys
Tyr Glu Tyr Glu Arg Arg Glu Gly Thr 35 40 45 Gln Asn Cys Pro Gln
Cys Lys Thr Arg Phe Lys Arg Phe Lys Gly Cys 50 55 60 Ala Arg Val
Pro Gly Asp Glu Glu Glu Asp Gly Val Asp Asp Leu Glu65 70 75 80 Asn
Glu Phe Asn Trp Ser Asp Lys His Asp Ser Gln Tyr Leu Ala Glu 85 90
95 Ser Met Leu His Ala His Met Ser Tyr Gly Arg Gly Ala Asp Leu Asp
100 105 110 Gly Val Pro Gln Pro Phe His Pro Ile Pro Asn Val Pro Leu
Leu Thr 115 120 125 Asn Gly Gln Met Val Asp Asp Ile Pro Pro Asp Gln
His Ala Leu Val 130 135 140 Pro Ser Phe Val Gly Gly Gly Gly Lys Arg
Ile His Pro Leu Pro Tyr145 150 155 160 Ala Asp Pro Asn Leu Pro Val
Gln Pro Arg Ser Met Asp Pro Ser Lys 165 170 175 Asp Leu Ala Ala Tyr
Gly Tyr Gly Ser Val Ala Trp Lys Glu Arg Met 180 185 190 Glu Ser Trp
Lys Gln Lys Gln Glu Arg Met His Gln Thr Arg Asn Asp 195 200 205 Gly
Gly Gly Asp Asp Gly Asp Asp Ala Asp Leu Pro Leu Met Asp Glu 210 215
220 Ala Arg Gln Pro Leu Ser Arg Lys Ile Pro Leu Pro Ser Ser Gln
Ile225 230 235 240 Asn Pro Tyr Arg Met Ile Ile Ile Ile Arg Leu Val
Val Leu Cys Phe 245 250 255 Phe Phe His Tyr Arg Val Met His Pro Val
Pro Asp Ala Phe Ala Leu 260 265 270 Trp Leu Ile Ser Val Ile Cys Glu
Ile Trp Phe Ala Met Ser Trp Ile 275 280 285 Leu Asp Gln Phe Pro Lys
Trp Phe Pro Ile Glu Arg Glu Thr Tyr Leu 290 295 300 Asp Arg Leu Ser
Leu Arg Phe Asp Lys Glu Gly His Pro Ser Gln Leu305 310 315 320 Ala
Pro Val Asp Phe Phe Val Ser Thr Val Asp Pro Leu Lys Glu Pro 325 330
335 Pro Leu Val Thr Ala Asn Thr Val Leu Ser Ile Leu Ser Val Asp Tyr
340 345 350 Pro Val Asp Lys Val Ser Cys Tyr Val Ser Asp Asp Gly Ala
Ala Met 355 360 365 Leu Thr Phe Glu Ala Leu Ser Glu Thr Ser Glu Phe
Ala Lys Lys Trp 370 375 380 Val Pro Phe Cys Lys Arg Tyr Ser Leu Glu
Pro Arg Ala Pro Glu Trp385 390 395 400 Tyr Phe Gln Gln Lys Ile Asp
Tyr Leu Lys Asp Lys Val Ala Pro Asn 405 410 415 Phe Val Arg Glu Arg
Arg Ala Met Lys Arg Glu Tyr Glu Glu Phe Lys 420 425 430 Val Arg Ile
Asn Ala Leu Val Ala Lys Ala Gln Lys Val Pro Glu Glu 435 440 445 Gly
Trp Thr Met Gln Asp Gly Thr Pro Trp Pro Gly Asn Asn Val Arg 450 455
460 Asp His Pro Gly Met Ile Gln Val Phe Leu Gly Gln Ser Gly Gly
His465 470 475 480 Asp Val Glu Gly Asn Glu Leu Pro Arg Leu Val Tyr
Val Ser Arg Glu 485 490 495 Lys Arg Pro Gly Tyr Asn His His Lys Lys
Ala Gly Ala Met Asn Ala 500 505 510 Leu Val Arg Val Ser Ala Val Leu
Thr Asn Ala Pro Tyr Leu Leu Asn 515 520 525 Leu Asp Cys Asp His Tyr
Ile Asn Asn Ser Lys Ala Ile Lys Glu Ala 530 535 540 Met Cys Phe Met
Met Asp Pro Leu Leu Gly Lys Lys Val Cys Tyr Val545 550 555 560 Gln
Phe Pro Gln Arg Phe Asp Gly Ile Asp Arg His Asp Arg Tyr Ala 565 570
575 Asn Arg Asn Val Val Phe Phe Asp Ile Asn Met Lys Gly Leu Asp Gly
580 585 590 Ile Gln Gly Pro Ile Tyr Val Gly Thr Gly Cys Val Phe Arg
Arg Gln 595 600 605 Ala Leu Tyr Gly Tyr Asp Ala Pro Lys Thr Lys Lys
Pro Pro Ser Arg 610 615 620 Thr Cys Asn Cys Trp Pro Lys Trp Cys Ile
Cys Cys Cys Cys Phe Gly625 630 635 640 Asn Arg Lys Thr Lys Lys Lys
Thr Lys Thr Ser Lys Pro Lys Phe Glu 645 650 655 Lys Ile Lys Lys Leu
Phe Lys Lys Lys Glu Asn Gln Ala Pro Ala Tyr 660 665 670 Ala Leu Gly
Glu Ile Asp Glu Ala Ala Pro Gly Ala Glu Asn Glu Lys 675 680 685 Ala
Ser Ile Val Asn Gln Gln Lys Leu Glu Lys Lys Phe Gly Gln Ser 690 695
700 Ser Val Phe Val Ala Ser Thr Leu Leu Glu Asn Gly Gly Thr Leu
Lys705 710 715 720 Ser Ala Ser Pro Ala Ser Leu Leu Lys Glu Ala Ile
His Val Ile Ser 725 730 735 Cys Gly Tyr Glu Asp Lys Thr Gly Trp Gly
Lys Asp Ile Gly Trp Ile 740 745 750 Tyr Gly Ser Val Thr Glu Asp Ile
Leu Thr Gly Phe Lys Met His Cys 755 760 765 His Gly Trp Arg Ser Ile
Tyr Cys Ile Pro Lys Arg Ala Ala Phe Lys 770 775 780 Gly Ser Ala Pro
Leu Asn Leu Ser Asp Arg Phe His Gln Val Leu Arg785 790 795 800 Trp
Ala Leu Gly Ser Ile Glu Ile Leu Phe Ser Asn His Cys Pro Leu 805 810
815 Trp Tyr Gly Tyr Gly Gly Gly Leu Lys Phe Leu Glu Arg Phe Ser Tyr
820 825 830 Ile Asn Ser Ile Val Tyr Pro Trp Thr Ser Ile Pro Leu Leu
Ala Tyr 835 840 845 Cys Thr Leu Pro Ala Ile Cys Leu Leu Thr Gly Lys
Phe Ile Thr Pro 850 855 860 Glu Leu Asn Asn Val Ala Ser Leu Trp Phe
Met Ser Leu Phe Ile Cys865 870 875 880 Ile Phe Ala Thr Ser Ile Leu
Glu Met Arg Trp Ser Gly Val Gly Ile 885 890 895 Asp Asp Trp Trp Arg
Asn Glu Gln Phe Trp Val Ile Gly Gly Val Ser 900 905 910 Ser His Leu
Phe Ala Val Phe Gln Gly Leu Leu Lys Val Ile Ala Gly 915 920 925 Val
Asp Thr Ser Phe Thr Val Thr Ser Lys Gly Gly Asp Asp Glu Glu 930 935
940 Phe Ser Glu Leu Tyr Thr Phe Lys Trp Thr Thr Leu Leu Ile Pro
Pro945 950 955 960 Thr Thr Leu Leu Leu Leu Asn Phe Ile Gly Val Val
Ala Gly Ile Ser 965 970 975 Asn Ala Ile Asn Asn Gly Tyr Glu Ser Trp
Gly Pro Leu Phe Gly Lys 980 985 990 Leu Phe Phe Ala Phe Trp Val Ile
Val His Leu Tyr Pro Phe Leu Lys 995 1000 1005 Gly Leu Val Gly Arg
Gln Asn Arg Thr Pro Thr Ile Val Ile Val Trp 1010 1015 1020 Ser Ile
Leu Leu Ala Ser Ile Phe Ser Leu Leu Trp Val Arg Ile Asp1025 1030
1035 1040Pro Phe Leu Ala Lys Asp Asp Gly Pro Leu Leu Glu Glu Cys
Gly Leu 1045 1050 1055 Asp Cys Asn4325DNAArtificial
Sequenceamplicon 43atggaccagc ggaacggcca ggtgt 254425DNAArtificial
Sequenceamplicon 44ctagttgcaa tccagaccac actcc 25453725DNAZea mays
45gcagcagcag caccaccact gcgcggcatt gcagcgagca agcgggaggg atctggggca
60tggtggcggt cgctgccgct gccgctcgga tctagagggc cgcacgggct gattgccctc
120cgccggcctc gtcggtgtcg gtggagtgtg aatcggtgtg tgtaggagga
gcgcggagat 180ggcggccaac aaggggatgg tggcaggctc tcacaaccgc
aacgagttcg tcatgatccg 240ccacgacggc gacgcgcctg tcccggctaa
gcccacgaag agtgcgaatg ggcaggtctg 300ccagatttgt ggcgacactg
ttggcgtttc agccactggt gatgtctttg ttgcctgcaa 360tgagtgtgcc
ttccctgtct gccgcccttg ctatgagtac gagcgcaagg aagggaacca
420atgctgccct cagtgcaaga ctagatacaa gagacagaaa ggtagccctc
gagttcatgg 480tgatgatgag gaggaagatg ttgatgacct ggacaatgaa
ttcaactata agcaaggcaa 540tgggaagggc ccagagtggc agcttcaagg
agatgacgct gatctgtctt catctgctcg 600ccatgaccca caccatcgga
ttccacgcct tacaagtgga caacagatat ctggagagat 660ccctgatgca
tcccctgacc gtcattctat ccgcagtcca acatcgagct atgttgatcc
720aagcgttcca gttcctgtga ggattgtgga cccctcgaag gacttgaatt
cctatgggct 780taatagtgtt gactggaagg aaagagttga gagctggagg
gttaaacagg acaaaaatat 840gttgcaagtg actaataaat atccagaggc
tagaggagac atggagggga ctggctcaaa
900tggagaagat atgcaaatgg ttgatgatgc acgcctacct ttgagccgca
ttgtgccaat 960ttcctcaaac cagctcaacc tttaccggat agtaatcatt
ctccgtctta tcatcctgtg 1020cttcttcttc caatatcgta tcagtcatcc
agtgcgtaat gcttatggat tgtggctagt 1080atctgttatc tgtgaggtct
ggtttgcctt gtcctggctt ctagatcagt tcccaaaatg 1140gtatccaatc
aaccgtgaga catatctcga caggcttgca ttgaggtatg atagagaggg
1200agagccatca cagctggctc ccattgatgt ctttgtcagt acagtggatc
cattgaagga 1260acctccactg atcacagcca acactgtttt gtccattctt
gctgtggatt accctgttga 1320caaagtgtca tgctatgttt ctgatgatgg
ctcagctatg ctgacttttg agtctctctc 1380tgaaactgcc gaatttgcta
gaaagtgggt tcccttttgt aagaagcaca atattgaacc 1440aagagctcca
gaattttact ttgctcaaaa aatagattac ctgaaggaca aaattcaacc
1500ttcatttgtt aaggaaagac gagcaatgaa gagagagtat gaagaattca
aaataagaat 1560caatgccctt gttgccaaag cacagaaagt gcctgaagag
gggtggacca tggctgatgg 1620aactgcttgg cctgggaata accctaggga
ccatcctggc atgattcagg tgttcttggg 1680gcacagtggt gggcttgaca
ctgatggaaa tgaattacca cgtcttgtct atgtctctcg 1740tgaaaagaga
ccaggctttc agcatcacaa gaaggctggt gcaatgaatg cactgattcg
1800tgtatctgct gtgctgacaa atggtgccta tcttctcaat gtggattgtg
accattactt 1860caatagcagc aaagctctta gagaagcaat gtgcttcatg
atggatccag ctctaggaag 1920gaaaacttgt tatgtacaat ttccacaaag
atttgatggc attgacttgc acgatcgata 1980tgctaatagg aacatagtct
tctttgatat caacatgaaa ggtctagatg gcattcaggg 2040tccagtctat
gtgggaacag gatgctgttt caataggcag gctttgtatg gatatgatcc
2100tgttttgact gaagctgatc tggaacctaa cattgttgtt aagagctgct
gtggtagaag 2160gaagagaaag aacaagagtt atatggatag tcaaagccgt
attatgaaga gaacagaatc 2220ttcagctccc atctttaaca tggaagacat
cgaggagggt attgaaggtt atgaggatga 2280aaggtcagtg cttatgtccc
agaggaaatt ggagaaacgc tttggtcagt ctccaatctt 2340cattgcatcc
acctttatga ctcaaggtgg cataccacct tcaacaaacc cagcttctct
2400actgaaggaa gctatccatg ttatcagctg tgggtacgag gacaaaactg
aatggggaaa 2460agagattggc tggatctatg gttcagttac agaggatatt
ctgactgggt ttaaaatgca 2520tgcaagaggc tggcaatcaa tctactgcat
gccaccacga ccttgtttca agggttctgc 2580accaatcaat ctttctgatc
gtcttaatca ggtgctccgt tgggctcttg ggtcagtgga 2640aattctgctt
agcagacatt gtcctatatg gtatggctac aatgggcgat tgaagctttt
2700ggagaggctg gcttacatta acaccattgt ttatccaatc acatctgttc
cgcttatcgc 2760ctattgtgtg cttcctgcta tctgtcttct taccaataaa
tttatcattc ctgagattag 2820taattatgct ggaatgttct tcattcttct
ttttgcctcc attttcgcaa ctggtatatt 2880ggagctcaga tggagtggtg
ttggcattga agattggtgg agaaatgagc agttttgggt 2940tattggtggc
acctctgccc atctcttcgc ggtgttccag ggtctgctga aagtgttggc
3000tgggattgat accaacttca cagttacctc aaaggcatct gatgaggatg
gcgactttgc 3060tgagctatat gtgttcaagt ggaccagttt gctcatccct
ccgaccactg ttcttgtcat 3120taacctggtc ggaatggtgg caggaatttc
gtatgccatt aacagcggct accaatcctg 3180gggtccgctc tttggaaagc
tgttcttctc gatctgggtg atcctccatc tctacccctt 3240cctcaagggt
ctcatgggca ggcagaaccg cacgccaaca atcgtcatcg tttggtccat
3300cctccttgcg tctatcttct ccttgctgtg ggtgaagatc gatcctttca
tctccccgac 3360acagaaagct gccgccttgg ggcaatgtgg tgtgaactgc
tgatccagat tgtgactctt 3420atctgaagag gctcagccaa agatctgccc
cctcgtgtaa atacctgagg gggctagatg 3480ggaatttttt gttgtagatg
aggatggatc tgcatccaag ttatgcctct gtttattagc 3540ttcttcggtg
ccggtgctgc tgcagacaat catggagcct ttctaccttg cttgtagtgc
3600tggccagcag cgtaaattgt gaattctgca tttttttata cgtggtgttt
attgttttag 3660agtaaattat catttgtttg aggtaactat tcacacgaac
tatatggcaa tgctgttatt 3720taaaa 3725461074PRTZea mays 46Met Ala Ala
Asn Lys Gly Met Val Ala Gly Ser His Asn Arg Asn Glu1 5 10 15 Phe
Val Met Ile Arg His Asp Gly Asp Ala Pro Val Pro Ala Lys Pro 20 25
30 Thr Lys Ser Ala Asn Gly Gln Val Cys Gln Ile Cys Gly Asp Thr Val
35 40 45 Gly Val Ser Ala Thr Gly Asp Val Phe Val Ala Cys Asn Glu
Cys Ala 50 55 60 Phe Pro Val Cys Arg Pro Cys Tyr Glu Tyr Glu Arg
Lys Glu Gly Asn65 70 75 80 Gln Cys Cys Pro Gln Cys Lys Thr Arg Tyr
Lys Arg Gln Lys Gly Ser 85 90 95 Pro Arg Val His Gly Asp Asp Glu
Glu Glu Asp Val Asp Asp Leu Asp 100 105 110 Asn Glu Phe Asn Tyr Lys
Gln Gly Asn Gly Lys Gly Pro Glu Trp Gln 115 120 125 Leu Gln Gly Asp
Asp Ala Asp Leu Ser Ser Ser Ala Arg His Asp Pro 130 135 140 His His
Arg Ile Pro Arg Leu Thr Ser Gly Gln Gln Ile Ser Gly Glu145 150 155
160 Ile Pro Asp Ala Ser Pro Asp Arg His Ser Ile Arg Ser Pro Thr Ser
165 170 175 Ser Tyr Val Asp Pro Ser Val Pro Val Pro Val Arg Ile Val
Asp Pro 180 185 190 Ser Lys Asp Leu Asn Ser Tyr Gly Leu Asn Ser Val
Asp Trp Lys Glu 195 200 205 Arg Val Glu Ser Trp Arg Val Lys Gln Asp
Lys Asn Met Leu Gln Val 210 215 220 Thr Asn Lys Tyr Pro Glu Ala Arg
Gly Asp Met Glu Gly Thr Gly Ser225 230 235 240 Asn Gly Glu Asp Met
Gln Met Val Asp Asp Ala Arg Leu Pro Leu Ser 245 250 255 Arg Ile Val
Pro Ile Ser Ser Asn Gln Leu Asn Leu Tyr Arg Ile Val 260 265 270 Ile
Ile Leu Arg Leu Ile Ile Leu Cys Phe Phe Phe Gln Tyr Arg Ile 275 280
285 Ser His Pro Val Arg Asn Ala Tyr Gly Leu Trp Leu Val Ser Val Ile
290 295 300 Cys Glu Val Trp Phe Ala Leu Ser Trp Leu Leu Asp Gln Phe
Pro Lys305 310 315 320 Trp Tyr Pro Ile Asn Arg Glu Thr Tyr Leu Asp
Arg Leu Ala Leu Arg 325 330 335 Tyr Asp Arg Glu Gly Glu Pro Ser Gln
Leu Ala Pro Ile Asp Val Phe 340 345 350 Val Ser Thr Val Asp Pro Leu
Lys Glu Pro Pro Leu Ile Thr Ala Asn 355 360 365 Thr Val Leu Ser Ile
Leu Ala Val Asp Tyr Pro Val Asp Lys Val Ser 370 375 380 Cys Tyr Val
Ser Asp Asp Gly Ser Ala Met Leu Thr Phe Glu Ser Leu385 390 395 400
Ser Glu Thr Ala Glu Phe Ala Arg Lys Trp Val Pro Phe Cys Lys Lys 405
410 415 His Asn Ile Glu Pro Arg Ala Pro Glu Phe Tyr Phe Ala Gln Lys
Ile 420 425 430 Asp Tyr Leu Lys Asp Lys Ile Gln Pro Ser Phe Val Lys
Glu Arg Arg 435 440 445 Ala Met Lys Arg Glu Tyr Glu Glu Phe Lys Ile
Arg Ile Asn Ala Leu 450 455 460 Val Ala Lys Ala Gln Lys Val Pro Glu
Glu Gly Trp Thr Met Ala Asp465 470 475 480 Gly Thr Ala Trp Pro Gly
Asn Asn Pro Arg Asp His Pro Gly Met Ile 485 490 495 Gln Val Phe Leu
Gly His Ser Gly Gly Leu Asp Thr Asp Gly Asn Glu 500 505 510 Leu Pro
Arg Leu Val Tyr Val Ser Arg Glu Lys Arg Pro Gly Phe Gln 515 520 525
His His Lys Lys Ala Gly Ala Met Asn Ala Leu Ile Arg Val Ser Ala 530
535 540 Val Leu Thr Asn Gly Ala Tyr Leu Leu Asn Val Asp Cys Asp His
Tyr545 550 555 560 Phe Asn Ser Ser Lys Ala Leu Arg Glu Ala Met Cys
Phe Met Met Asp 565 570 575 Pro Ala Leu Gly Arg Lys Thr Cys Tyr Val
Gln Phe Pro Gln Arg Phe 580 585 590 Asp Gly Ile Asp Leu His Asp Arg
Tyr Ala Asn Arg Asn Ile Val Phe 595 600 605 Phe Asp Ile Asn Met Lys
Gly Leu Asp Gly Ile Gln Gly Pro Val Tyr 610 615 620 Val Gly Thr Gly
Cys Cys Phe Asn Arg Gln Ala Leu Tyr Gly Tyr Asp625 630 635 640 Pro
Val Leu Thr Glu Ala Asp Leu Glu Pro Asn Ile Val Val Lys Ser 645 650
655 Cys Cys Gly Arg Arg Lys Arg Lys Asn Lys Ser Tyr Met Asp Ser Gln
660 665 670 Ser Arg Ile Met Lys Arg Thr Glu Ser Ser Ala Pro Ile Phe
Asn Met 675 680 685 Glu Asp Ile Glu Glu Gly Ile Glu Gly Tyr Glu Asp
Glu Arg Ser Val 690 695 700 Leu Met Ser Gln Arg Lys Leu Glu Lys Arg
Phe Gly Gln Ser Pro Ile705 710 715 720 Phe Ile Ala Ser Thr Phe Met
Thr Gln Gly Gly Ile Pro Pro Ser Thr 725 730 735 Asn Pro Ala Ser Leu
Leu Lys Glu Ala Ile His Val Ile Ser Cys Gly 740 745 750 Tyr Glu Asp
Lys Thr Glu Trp Gly Lys Glu Ile Gly Trp Ile Tyr Gly 755 760 765 Ser
Val Thr Glu Asp Ile Leu Thr Gly Phe Lys Met His Ala Arg Gly 770 775
780 Trp Gln Ser Ile Tyr Cys Met Pro Pro Arg Pro Cys Phe Lys Gly
Ser785 790 795 800 Ala Pro Ile Asn Leu Ser Asp Arg Leu Asn Gln Val
Leu Arg Trp Ala 805 810 815 Leu Gly Ser Val Glu Ile Leu Leu Ser Arg
His Cys Pro Ile Trp Tyr 820 825 830 Gly Tyr Asn Gly Arg Leu Lys Leu
Leu Glu Arg Leu Ala Tyr Ile Asn 835 840 845 Thr Ile Val Tyr Pro Ile
Thr Ser Val Pro Leu Ile Ala Tyr Cys Val 850 855 860 Leu Pro Ala Ile
Cys Leu Leu Thr Asn Lys Phe Ile Ile Pro Glu Ile865 870 875 880 Ser
Asn Tyr Ala Gly Met Phe Phe Ile Leu Leu Phe Ala Ser Ile Phe 885 890
895 Ala Thr Gly Ile Leu Glu Leu Arg Trp Ser Gly Val Gly Ile Glu Asp
900 905 910 Trp Trp Arg Asn Glu Gln Phe Trp Val Ile Gly Gly Thr Ser
Ala His 915 920 925 Leu Phe Ala Val Phe Gln Gly Leu Leu Lys Val Leu
Ala Gly Ile Asp 930 935 940 Thr Asn Phe Thr Val Thr Ser Lys Ala Ser
Asp Glu Asp Gly Asp Phe945 950 955 960 Ala Glu Leu Tyr Val Phe Lys
Trp Thr Ser Leu Leu Ile Pro Pro Thr 965 970 975 Thr Val Leu Val Ile
Asn Leu Val Gly Met Val Ala Gly Ile Ser Tyr 980 985 990 Ala Ile Asn
Ser Gly Tyr Gln Ser Trp Gly Pro Leu Phe Gly Lys Leu 995 1000 1005
Phe Phe Ser Ile Trp Val Ile Leu His Leu Tyr Pro Phe Leu Lys Gly
1010 1015 1020 Leu Met Gly Arg Gln Asn Arg Thr Pro Thr Ile Val Ile
Val Trp Ser1025 1030 1035 1040Ile Leu Leu Ala Ser Ile Phe Ser Leu
Leu Trp Val Lys Ile Asp Pro 1045 1050 1055 Phe Ile Ser Pro Thr Gln
Lys Ala Ala Ala Leu Gly Gln Cys Gly Val 1060 1065 1070 Asn
Cys4725DNAArtificial Sequenceamplicon 47atggcggcca acaaggggat ggtgg
254825DNAArtificial Sequenceamplicon 48tcagcagttc acaccacatt gcccc
25493969DNAZea mays 49cttctccctc gtcggtgcgg cgtggcgcgg ctcggcgttc
ggtgagaaac cactcggggg 60atgaggatct gctgctagag tgagaggagc tacggtcagt
atcctctgcc ttcgtcggcg 120gcggaagtgg aggggaggaa gcgatggagg
cgagcgccgg gctggtggcc ggctcccaca 180accgcaacga gctcgtcgtc
atccgccgcg acggcgatcc cgggccgaag ccgccgcggg 240agcagaacgg
gcaggtgtgc cagatttgcg gcgacgacgt cggccttgcc cccggcgggg
300accccttcgt ggcgtgcaac gagtgcgcct tccccgtctg ccgggactgc
tacgaatacg 360agcgccggga gggcacgcag aactgccccc agtgcaagac
tcgatacaag cgcctcaagg 420gctgccaacg tgtgaccggt gacgaggagg
aggacggcgt cgatgacctg gacaacgagt 480tcaactggga cggccatgac
tcgcagtctg tggccgagtc catgctctac ggccacatga 540gctacggccg
tggaggtgac cctaatggcg cgccacaagc tttccagctc aaccccaatg
600ttccactcct caccaacggg caaatggtgg atgacatccc accggagcag
cacgcgctgg 660tgccttcttt catgggtggt gggggaaaga ggatacatcc
ccttccttat gcggatccca 720gcttacctgt gcaacccagg tctatggacc
catccaagga tcttgctgca tatgggtatg 780gtagtgttgc ttggaaggaa
cggatggaga attggaagca gagacaagag aggatgcacc 840agacggggaa
tgatggtggt ggtgatgatg gtgacgatgc tgatctacca ctaatggatg
900aagcaagaca acaactgtcc aggaaaattc cacttccatc aagccagatt
aatccatata 960ggatgattat cattattcgg cttgtggttt tggggttctt
cttccactac cgagtgatgc 1020atccggtgaa tgatgcattt gctttgtggc
tcatatctgt tatctgtgaa atctggtttg 1080ccatgtcttg gattcttgat
caattcccaa agtggttccc tattgagaga gagacttacc 1140tagaccggct
gtcactgagg ttcgacaagg aaggccagcc atctcaactt gctccaattg
1200atttctttgt cagtacggtt gatcccttaa aggaacctcc tttggtcaca
acaaatactg 1260ttctatctat cctttcggtg gattatcctg ttgataaggt
ttcttgctat gtttctgatg 1320atggtgctgc aatgctaacg tttgaagcat
tatctgaaac atctgaattt gcaaagaaat 1380gggttccttt ctgcaaacgg
tacaatattg aacctcgcgc tccagagtgg tacttccaac 1440agaagataga
ctacttgaaa gacaaggtgg cagcaaactt tgttagggag aggagagcaa
1500tgaagagaga gtatgaggaa ttcaaggtga gaatcaatgc cttagttgcc
aaagcccaga 1560aagttcctga agaaggatgg acaatgcaag atggaacccc
ctggcctgga aacaatgttc 1620gtgatcatcc tggaatgatt caggtcttcc
ttggccaaag cggaggcctt gactgtgagg 1680gaaatgaact gccacgattg
gtttatgttt ctagagagaa acgaccaggc tataaccatc 1740ataagaaagc
tggtgctatg aatgcattgg tccgagtctc tgctgtacta acaaatgctc
1800catatttgtt aaacttggat tgtgatcact acatcaacaa cagcaaggct
ataaaggaag 1860caatgtgttt tatgatggac cctttactag gaaagaaggt
ttgctatgta cagttccctc 1920aaagatttga tgggattgat cgccatgacc
gatatgctaa ccggaatgtt gtcttttttg 1980atatcaacat gaaaggtttg
gatggtattc agggtccaat ttatgttggt actggatgtg 2040tatttagaag
gcaggcatta tatggttatg atgcccccaa aacaaagaag ccaccatcaa
2100ggacttgcaa ctgctggccc aagtggtgct tttgctgttg ctgctttggc
aataggaagc 2160aaaagaagac taccaaaccc aaaacagaga agaaaaagtt
attatttttc aagaaagaag 2220agaaccaatc ccctgcatat gctcttggtg
aaattgacga agctgctcca ggagctgaga 2280atgaaaaggc cggtattgta
aatcaacaaa aattagaaaa gaaatttggc caatcttctg 2340tttttgttac
atccacactt ctcgagaatg gtggaacctt gaagagtgca agtcctgctt
2400ctcttttgaa agaagctata catgtcatta gttgtggtta tgaagacaag
acagactggg 2460gaaaagagat tggctggatc tatggatcag ttacagaaga
tattctaact ggtttcaaga 2520tgcattgtca tggttggcgg tcaatttact
gcatacctaa acgggttgca ttcaaaggtt 2580ctgcacctct gaatctttca
gatcgtcttc accaggtgct tcggtgggct cttgggtcta 2640ttgagatctt
cttcagcaat cattgccctc tttggtatgg gtatggtggc ggtctgaaat
2700ttttggaaag attttcctac atcaactcca tcgtgtatcc ttggacatct
attcccctct 2760tggcttactg tacattgcct gccatctgtt tattgacagg
gaaatttatc actccagagc 2820tgaataatgt tgccagcctg tggttcatgt
cactttttat ctgcattttt gctacgagca 2880tcctagaaat gagatggagt
ggtgttggaa ttgatgactg gtggaggaat gagcagttct 2940gggtcattgg
aggtgtgtcc tcacacctct ttgctgtgtt ccagggactt ctcaaggtca
3000tagctggtgt tgatacaagc ttcaccgtga catcaaaggg tggagatgat
gaggagttct 3060cagagctata tacattcaaa tggactacct tattgatacc
tcctaccacc ttgcttctat 3120tgaacttcat tggtgtggtc gctggcgttt
caaatgcgat caataacgga tatgagtcat 3180ggggccccct ctttgggaag
ctattctttg cattttgggt gattgtccat ctttatccct 3240ttctcaaagg
tttggttgga aggcaaaaca ggacaccaac gattgtcatc gtctggtcca
3300ttctgctggc ttcaatcttc tcgctccttt gggttcggat tgatcctttc
cttgcgaagg 3360atgatggtcc gcttcttgag gagtgtggtt tggattgcaa
ctaggatgtc agtgcatcag 3420ctcccccaat ctgcatatgc ttgaagtata
ttttctggtg tttgtcccca tattcagtgt 3480ctgtagataa gagacatgaa
atgtcccaag tttcttttga tccatggtga acctacttaa 3540tatctgagag
atatactggg ggaaaatgga ggctgcggca atccttgtgc agttgggccg
3600tggaatacag catatgcaag tgtttgattg tgcagcattc tttattactt
ggtcgcaata 3660tagatgggct gagccgaaca gcaaggtatt ttgattctgc
actgctcccg tgtacaaact 3720tggttctcaa taaggcaggc aggaatgcat
ctgccagtgg aacagagcaa cctgcacatt 3780atttatgtat gcctgttcat
tggagggctt gttcattaca tgttcgtcta tactagaaaa 3840aacagaatat
tagcattaat ctatagttaa ttaaagtatg taaatgcgcc tgttttttgt
3900tgtgtactgt aatcatctga gttggttttg tgaaaaaaaa aaaaaaaaaa
aaaaaaaaaa 3960aaaaaaaaa 3969501086PRTZea mays 50Met Glu Ala Ser
Ala Gly Leu Val Ala Gly Ser His Asn Arg Asn Glu1 5 10 15 Leu Val
Val Ile Arg Arg Asp Gly Asp Pro Gly Pro Lys Pro Pro Arg 20 25 30
Glu Gln Asn Gly Gln Val Cys Gln Ile Cys Gly Asp Asp Val Gly Leu 35
40 45 Ala Pro Gly Gly Asp Pro Phe Val Ala Cys Asn Glu Cys Ala Phe
Pro 50 55 60 Val Cys Arg Asp Cys Tyr Glu Tyr Glu Arg Arg Glu Gly
Thr Gln Asn65 70 75 80 Cys Pro Gln Cys Lys Thr Arg Tyr Lys Arg Leu
Lys Gly Cys Gln Arg 85 90 95 Val Thr Gly Asp Glu Glu Glu Asp Gly
Val Asp Asp Leu Asp Asn Glu 100 105 110 Phe Asn Trp Asp Gly His Asp
Ser Gln Ser Val Ala Glu Ser Met Leu 115 120 125 Tyr Gly His Met Ser
Tyr Gly Arg Gly Gly Asp Pro Asn Gly Ala Pro 130 135 140
Gln Ala Phe Gln Leu Asn Pro Asn Val Pro Leu Leu Thr Asn Gly Gln145
150 155 160 Met Val Asp Asp Ile Pro Pro Glu Gln His Ala Leu Val Pro
Ser Phe 165 170 175 Met Gly Gly Gly Gly Lys Arg Ile His Pro Leu Pro
Tyr Ala Asp Pro 180 185 190 Ser Leu Pro Val Gln Pro Arg Ser Met Asp
Pro Ser Lys Asp Leu Ala 195 200 205 Ala Tyr Gly Tyr Gly Ser Val Ala
Trp Lys Glu Arg Met Glu Asn Trp 210 215 220 Lys Gln Arg Gln Glu Arg
Met His Gln Thr Gly Asn Asp Gly Gly Gly225 230 235 240 Asp Asp Gly
Asp Asp Ala Asp Leu Pro Leu Met Asp Glu Ala Arg Gln 245 250 255 Gln
Leu Ser Arg Lys Ile Pro Leu Pro Ser Ser Gln Ile Asn Pro Tyr 260 265
270 Arg Met Ile Ile Ile Ile Arg Leu Val Val Leu Gly Phe Phe Phe His
275 280 285 Tyr Arg Val Met His Pro Val Asn Asp Ala Phe Ala Leu Trp
Leu Ile 290 295 300 Ser Val Ile Cys Glu Ile Trp Phe Ala Met Ser Trp
Ile Leu Asp Gln305 310 315 320 Phe Pro Lys Trp Phe Pro Ile Glu Arg
Glu Thr Tyr Leu Asp Arg Leu 325 330 335 Ser Leu Arg Phe Asp Lys Glu
Gly Gln Pro Ser Gln Leu Ala Pro Ile 340 345 350 Asp Phe Phe Val Ser
Thr Val Asp Pro Leu Lys Glu Pro Pro Leu Val 355 360 365 Thr Thr Asn
Thr Val Leu Ser Ile Leu Ser Val Asp Tyr Pro Val Asp 370 375 380 Lys
Val Ser Cys Tyr Val Ser Asp Asp Gly Ala Ala Met Leu Thr Phe385 390
395 400 Glu Ala Leu Ser Glu Thr Ser Glu Phe Ala Lys Lys Trp Val Pro
Phe 405 410 415 Cys Lys Arg Tyr Asn Ile Glu Pro Arg Ala Pro Glu Trp
Tyr Phe Gln 420 425 430 Gln Lys Ile Asp Tyr Leu Lys Asp Lys Val Ala
Ala Asn Phe Val Arg 435 440 445 Glu Arg Arg Ala Met Lys Arg Glu Tyr
Glu Glu Phe Lys Val Arg Ile 450 455 460 Asn Ala Leu Val Ala Lys Ala
Gln Lys Val Pro Glu Glu Gly Trp Thr465 470 475 480 Met Gln Asp Gly
Thr Pro Trp Pro Gly Asn Asn Val Arg Asp His Pro 485 490 495 Gly Met
Ile Gln Val Phe Leu Gly Gln Ser Gly Gly Leu Asp Cys Glu 500 505 510
Gly Asn Glu Leu Pro Arg Leu Val Tyr Val Ser Arg Glu Lys Arg Pro 515
520 525 Gly Tyr Asn His His Lys Lys Ala Gly Ala Met Asn Ala Leu Val
Arg 530 535 540 Val Ser Ala Val Leu Thr Asn Ala Pro Tyr Leu Leu Asn
Leu Asp Cys545 550 555 560 Asp His Tyr Ile Asn Asn Ser Lys Ala Ile
Lys Glu Ala Met Cys Phe 565 570 575 Met Met Asp Pro Leu Leu Gly Lys
Lys Val Cys Tyr Val Gln Phe Pro 580 585 590 Gln Arg Phe Asp Gly Ile
Asp Arg His Asp Arg Tyr Ala Asn Arg Asn 595 600 605 Val Val Phe Phe
Asp Ile Asn Met Lys Gly Leu Asp Gly Ile Gln Gly 610 615 620 Pro Ile
Tyr Val Gly Thr Gly Cys Val Phe Arg Arg Gln Ala Leu Tyr625 630 635
640 Gly Tyr Asp Ala Pro Lys Thr Lys Lys Pro Pro Ser Arg Thr Cys Asn
645 650 655 Cys Trp Pro Lys Trp Cys Phe Cys Cys Cys Cys Phe Gly Asn
Arg Lys 660 665 670 Gln Lys Lys Thr Thr Lys Pro Lys Thr Glu Lys Lys
Lys Leu Leu Phe 675 680 685 Phe Lys Lys Glu Glu Asn Gln Ser Pro Ala
Tyr Ala Leu Gly Glu Ile 690 695 700 Asp Glu Ala Ala Pro Gly Ala Glu
Asn Glu Lys Ala Gly Ile Val Asn705 710 715 720 Gln Gln Lys Leu Glu
Lys Lys Phe Gly Gln Ser Ser Val Phe Val Thr 725 730 735 Ser Thr Leu
Leu Glu Asn Gly Gly Thr Leu Lys Ser Ala Ser Pro Ala 740 745 750 Ser
Leu Leu Lys Glu Ala Ile His Val Ile Ser Cys Gly Tyr Glu Asp 755 760
765 Lys Thr Asp Trp Gly Lys Glu Ile Gly Trp Ile Tyr Gly Ser Val Thr
770 775 780 Glu Asp Ile Leu Thr Gly Phe Lys Met His Cys His Gly Trp
Arg Ser785 790 795 800 Ile Tyr Cys Ile Pro Lys Arg Val Ala Phe Lys
Gly Ser Ala Pro Leu 805 810 815 Asn Leu Ser Asp Arg Leu His Gln Val
Leu Arg Trp Ala Leu Gly Ser 820 825 830 Ile Glu Ile Phe Phe Ser Asn
His Cys Pro Leu Trp Tyr Gly Tyr Gly 835 840 845 Gly Gly Leu Lys Phe
Leu Glu Arg Phe Ser Tyr Ile Asn Ser Ile Val 850 855 860 Tyr Pro Trp
Thr Ser Ile Pro Leu Leu Ala Tyr Cys Thr Leu Pro Ala865 870 875 880
Ile Cys Leu Leu Thr Gly Lys Phe Ile Thr Pro Glu Leu Asn Asn Val 885
890 895 Ala Ser Leu Trp Phe Met Ser Leu Phe Ile Cys Ile Phe Ala Thr
Ser 900 905 910 Ile Leu Glu Met Arg Trp Ser Gly Val Gly Ile Asp Asp
Trp Trp Arg 915 920 925 Asn Glu Gln Phe Trp Val Ile Gly Gly Val Ser
Ser His Leu Phe Ala 930 935 940 Val Phe Gln Gly Leu Leu Lys Val Ile
Ala Gly Val Asp Thr Ser Phe945 950 955 960 Thr Val Thr Ser Lys Gly
Gly Asp Asp Glu Glu Phe Ser Glu Leu Tyr 965 970 975 Thr Phe Lys Trp
Thr Thr Leu Leu Ile Pro Pro Thr Thr Leu Leu Leu 980 985 990 Leu Asn
Phe Ile Gly Val Val Ala Gly Val Ser Asn Ala Ile Asn Asn 995 1000
1005 Gly Tyr Glu Ser Trp Gly Pro Leu Phe Gly Lys Leu Phe Phe Ala
Phe 1010 1015 1020 Trp Val Ile Val His Leu Tyr Pro Phe Leu Lys Gly
Leu Val Gly Arg1025 1030 1035 1040Gln Asn Arg Thr Pro Thr Ile Val
Ile Val Trp Ser Ile Leu Leu Ala 1045 1050 1055 Ser Ile Phe Ser Leu
Leu Trp Val Arg Ile Asp Pro Phe Leu Ala Lys 1060 1065 1070 Asp Asp
Gly Pro Leu Leu Glu Glu Cys Gly Leu Asp Cys Asn 1075 1080 1085
5125DNAArtificial Sequenceamplicon 51atggaggcga gcgccgggct ggtgg
255225DNAArtificial Sequenceamplicon 52ctagttgcaa tccaaaccac actcc
25
* * * * *